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CHAPTER 1. GENERAL INTRODUCTION 
The etiology of respiratory diseases in sheep is considered to be very complex and 
has not been clearly defined. There is an apparent association of several microorganisms 
including Pasteurella sp.. Mycoplasma sp., chlamydia, viruses, nematode parasites, fungal 
agents and occasionally other bacteria such as Escherichia call, Corynebacterium sp.. 
Staphylococcus sp., and Neisseria sp. with the disease (Alley, 1975; Davies, 1985). 
Establishment of Koch's postulates has been difficult due to the complex etiology and 
poorly defined lesions. 
Surveys conducted in many countries have indicated that, other than 
Pasteurella sp.. Mycoplasma ovipneumoniae is the bacterium most commonly isolated from 
the ovine respiratory tract (Bakke, 1982; Pfeffer et al., 1983; Brogden et al., 1988; Malone 
et al., 1988). However, due to inconsistent results in experimental reproduction of the 
disease, its role as an important etiological factor in respiratory disease in sheep is not well 
accepted. In contrast, there is general acceptance that Pasteurella sp. are contributory to 
pneumonia in sheep, although they may have limited ability to induce pneumonia unless 
predisposing factors are present. Several viruses, chlamydia and M. ovipneumoniae may 
serve as predisposing factors. 
During the past several years, an ovine respiratory disease that we have termed the 
"coughing syndrome" has been observed in the mid-west states of the United States of 
America. The terminology stems from primary clinical signs which include a severe 
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paroxysmal cough. The disease is chronic in young lambs with morbidity and severity 
variable among flocks. 
While there is an obvious need for information on the role of viruses in this clinical 
syndrome, the evidence available does not favor viruses as being important in the etiology 
of this disease. Such evidence includes absence of serological responses in paired serum 
samples to several common sheep viruses and absence of histopathological lesions 
consistent with viral infections (unpublished observations). On the other hand, evidence for 
prevalence and association of mycoplasmas, in particular M. ovipneianoniae, with 
outbreaks of this syndrome have been suggested by stodies conducted in this laboratory 
(Kaeberle and Eness, 1988; Eness et al., 1990; Niang, 1992; Khan, 1993). Unfortunately, 
however, we have not been able to routinely reproduce the clinical syndrome by exposure 
of lambs to live M. ovipneianoniae or M. arginini organisms although infection and 
histopathological lung lesions can be consistently demonstrated, in particular with M. 
ovipneianoniae. This does not necessarily rule out a causal relationship since establishment 
of cause and effect, or fulfillment of Koch's postulates, has been difficult with several 
mycoplasma species, even with those proven to be highly virulent such as M. mycoides 
subsp. mycoides (Gourlay and Howard, 1982; Stalheim, 1983; Cassell et al., 1985). 
Microorganisms, including mycoplasmas, differ in their capacity to cause disease. 
Some are highly virulent and can readily produce disease when they infect; others with 
moderate virulence will produce disease by progressively deteriorating conditions of the 
host defense mechanisms, allowing opportunistic proliferation of secondary 
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microorganisms. Most pathogenic mycoplasmas, including those that are now being 
recognized as primary etiological agents in several respiratory diseases such as enzootic 
pneumonia in calves and swine, fall into the latter category. The etiological significance of 
such mycoplasmas may only be expressed fully in association with other organisms 
(Gourlay and Howard, 1978; Gourlay and Howard, 1982) 
Apart from the fiilfillment of Koch's postulates, evaluation of the pathogenic 
potential of an organism may be of value in determining its etiological significance 
(Gourlay and Howard, 1978; Gourlay and Howard, 1982). Such evidence can include the 
ability of the microorganism to produce certain factors that may be of pathogenic potential 
such as a toxin, capsule, hydrogen peroxide, attachment molecules, ability to cause damage 
to any host tissue (either in vivo or in vitro), or ability to manipulate or to affect the 
elements of the host immune system. 
In relation to the aforementioned concepts, we have attempted in the present 
investigation to determine the significance of mycoplasma species, in particular 
M. ovipneumoniae, isolated from lambs with the coughing syndrome. The approach used 
was to determine specific activities or factors that may contribute to the disease producing 
potential of M. ovipneumoniae. 
Characteristics of the disease and histopathologic lesions in the lungs of affected 
lambs suggested that immunopathological mechanisms contributed the disease process. 
Immune mechanisms have been implicated in mycoplasmal infection in humans and several 
other domestic animals (Cassell et al., 1985). One approach was to smdy the 
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microorganism for mechanisms of colonization (adherence to respiratory epithelimn) and 
effects on epithelial cells. This led to demonstration of a capsule on the microorganism and 
possible role of this capsule in adherence. Also, this adherence was associated with 
ciliostatic activity. A second general approach was to demonstrate aberrant immune 
responses in association with infection of lambs by mycoplasmas, and potential role of 
these responses in the pathogenesis of this disease. First, a serological smdy was conducted 
in order to gain a better understanding of the nature of immime response against these 
mycoplasmas. Secondly, an allergic type of hypersensitivity to M. ovipneumoniae in these 
lambs was demonstrated. Thirdly, an autoimmune response associated with mycoplasmal 
infection in these lambs was noted and led to a study on the effects of mycoplasmas on 
MHC molecule expression by sheep alveolar macrophages. 
Dissertation organization. This dissertation was written using the alternate format. 
It contains a general introduction, review of literature, four manuscripts, general summary 
and two appendices. References cited for each manuscript and each appendix follow the 
corresponding manuscript and the appendix, while references cited in the general 
introduction, literature review, and general conclusions are listed following the appendixes. 
Manuscripts were written in the style of the appropriate journal to which submission 
was intended. The doctoral candidate, Mamadou Niang, is the senior author and principal 
investigator for each of the manuscripts, with the advice of the major professor. Dr. Merlin 
L. Kaeberle, and other co-authors of the manuscripts. 
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CHAPTER 2. LITERATURE REVIEW 
Ovine pneumonia is one of tlie most common infectious diseases of sheep 
worldwide. Surveys conducted in many countries have shown that M. ovipneumoniae is 
probably the most conmionly isolated microbial species from the respiratory tract of 
pneumonic sheep (Bakke, 1982; Pfeffer et al., 1983; Brogden et al., 1988; Malone et al., 
1988; Khan, 1993). The agent has tropism for the respiratory tract where it colonizes, like 
many other respiratory mycoplasmas, the ciliated epithelial cells. There is, however, 
considerable controversy concerning the experimental reproduction of the disease with this 
mycoplasma and fulfillment of Koch's postulates, as with several proven highly virulent 
mycoplasmas, has been difficult to achieve. Still, the organism is regarded by several 
investigators (Nostvold and Bakke, 1982; Bakke and Nostvold, 1982; Rosendal, 1994) to 
be a confirmed pathogen for the sheep respiratory tract. 
The mechanism of pathogenesis of mycoplasma diseases is complex and can be 
divided into a number of interrelated events including attachment, toxin production, and 
suppression of the host defense mechanisms. Also, in addition to eliciting specific immune 
responses, mycoplasmas have the ability of inducing immune responses that are detrimental 
to the host (Cassell et al., 1985). However, there is very litde information available 
regarding these aberrant immtme responses although they may play an important role in the 
pathogenesis of several diseases caused by the organisms. Therefore, this literature review 
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will address the pathogenesis of mycoplasmal infections, in general. Prior to that, a brief 
review of respiratory mycoplasmas in sheep is presented. 
Respiratory Mycoplasmas in Sheep 
The etiology of sheep respiratory diseases is extremely complex and relates to 
synergistic effects of several factors including environment and microorganisms. A wide 
variety of microorganisms have been isolated from the respiratory tract of pneumonic 
sheep. These include Pasteurella sp.. Mycoplasma sp., chlamydia, viruses, nematode 
parasites, ftmgal agents, and occasionally other bacteria such as £. coli, Corynebaaerium 
sp.. Staphylococcus sp.. Neisseria sp. (Alley, 1975; Davies, 1985; Malone, 1988). 
Historically, the isolation of Mycoplasma sp. from the respiratory tract of sheep was 
first reported by Greig (1955). However, a potential role for mycoplasmas in ovine 
pneumonia was initially suggested by Hamdy et al. (1959) who consistently were able to 
reproduce the disease by stressing lambs inoculated intratrachealy with a mycoplasma agent 
and Pasteurella multocida. Meanwhile, there were reports of isolation of mycoplasma from 
the respiratory tract of pneumonic sheep in many countries (Jones et al., 1976). Also, some 
investigations conducted in Australia associated Mycoplasma sp. with many cases of 
pneumonia appearing in lambs between the age of 5-10 weeks (St. George et al., 1971; 
Sullivan et al., 1973). Clinical signs reported were coughing, sneezing, a mucoid nasal 
discharge and reduced weight gain. While the morbidity was high the mortality was low. 
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The lungs from all animals that died or were sacrificed had pnemnonic lesions that were 
characterized as proliferative interstitial pneumonia. At the same time, a cytopathogenic 
agent was cultivated in bovine testicular cell culture and pneumonia similar to the natural 
disease was produced in lambs by intratracheal inoculation of the cell culture grown 
organisms. Further studies by Cannichael et al. (1972) confirmed the nature of the agent 
and they named it M. ovipneumoniae. 
Since then, there have been several reports of isolation of M. oynpnewnoniae from 
different parts of the world, mostly in connection with respiratory disease in sheep (Bakke, 
1982; Pfeffer et al., 1983; Brogden et al., 1988; Malone et al., 1988; Khan, 1993). Other 
Mycoplasma sp. including M. arginini, M. conjunctivae, Acholeplasma laidlawii and 
ureaplasmas have also been isolated from the respiratory tract of both healthy and 
pneumonic sheep (Brogden et al., 1988; Davies, 1985). However, these mycoplasmas are 
not considered to play a major role in the disease process (Foggie and Angus, 1972; 
Davies, 1985). 
Attempts to produce pneumonia in sheep with pure cultures of M. ovipneumoniae 
have yielded conflicting results. In some early smdies conducted in Australia, nearly all 
animals developed severe pneumonia (St. George et al., 1971; Sullivan et al., 1973). On 
the other hand, only 25 to 50% of the animals developed mild pneumonia in smdies 
conducted in Scotland (Foggie et al., 1976; Gilmour et al., 1979), and less than 20% 
showed lesions in experiments conducted in New Zealand (Alley and Clarke, 1977; Davies 
et al., 1981). Attempts to recover M. ovipneumoniae from the pneimionic lungs in all these 
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experiments usually were unsuccessfiil and, even when M. ovipneumoniae was present, 
bacterial numbers in both healthy and pneumonic lungs were similar. These observations 
and theiact that M. ovipneumoniae could also be isolated from the respiratory tract of 
normal sheep raised the question of whether the organism is part of normal flora of sheep. 
However, attempts to produce disease in lambs with a homogenate of pneumonic limg 
containing M. ovipneumoniae alone or in combination with P. haemofytica yielded 
proliferative pneumonia in most animals (Jones et al., 1982a). These findings led to the 
hypothesis that the challenge organisms in the early smdies might have been attenuated 
during isolation and cloning on artificial medium or that strains varied in virulence (lonas 
et al., 1985; Jones et al., 1982a; Jones et al., 1982b). In this regard, it is interesting to note 
that the early Australian smdies were conducted utilizing tissue culture grown organisms 
(Sullivan et al., 1973) while the other investigators utilized artificial mediimi grown 
organisms. Another factor contributing to variability in the challenge studies could be the 
nature of the experimental animals. Naturally reared lambs were more likely to develop 
pneumonia than were specific-pathogen free animals (Jones et al., 1982a). It was also 
suggested that isolation of M. ovipneumoniae from normal sheep should not be an 
indication that the organism is part of the normal flora of sheep since only a low percentage 
of normal sheep carried the organism and many of these normal positive sheep were 
negative when retested (lonas, 1985). This transitory carriage of M. ovipneumoniae in 
normal sheep was probably important and would provide an obvious source from which 
young lambs could be naturally infected (lonas al., 1985). Moreover, reported 
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experimentation indicated presence of M. ovipneumoniae in large numbers in pneumonic 
sheep and absence or presence in low numbers in normal controls, suggesting a direct or 
indirect role in ovine pneumonia (Alley et al., 1975; Bakke, 1982; Buddie et al., 1984). 
Pathogenesis of Mycoplasmal Infection 
Assessment of Mycoplasma Pathogenicity 
Most mycoplasma diseases are multifactorial in which a variety of host, bacterial 
and environmental factors determine the final outcome of infection. Fulfillment of Koch's 
postulates, the usual accepted criterion for proof of etiological significance, has proved to 
be difficult to achieve even with M. mycoides, the most pathogenic of mycoplasmas 
(Gourlay and Howard, 1982, Stalheim, 1983; Cassell et al., 1985). The reasons for these 
difficulties are poorly understood. However, it is becoming more and more clear that some 
of the assumptions implicit in Koch's postulates are limited. For instance, complex 
requirements for in vitro growth of mycoplasmas renders fulfillment of Koch's postulates 
difficult to achieve. This delayed for many years the acceptance of M. mycoides subsp. 
mycoides as the etiological agent of contagious bovine pleuropneumonia (Gourlay and 
Howard, 1982). Mycobacterium leprae, the causative agent of leprosy, has not yet been 
cultured in laboratory medium (Salyers and Whitt, 1994). Other difficulties in achieving 
the criteria of Koch's postulates during the experimental production of disease include loss 
of virulence, strain variation and susceptibility of the experimental animal In addition. 
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mycoplasmas, in general, are not among the most highly pathogenic microorganisms. Also, 
because they primarily have predilection for mucosal surfaces and generally establish 
persistent superficial infections, their effects are less immediate and more subtle. 
Moreover, many of the diseases in which mycoplasmas are associated are diseases of 
complex etiology. Their effects may be heavily influenced by the presence of other 
bacteria, such as Pasteurella sp. which may be conmion inhabitants of mucosal surfaces of 
clinically normal animals (Gourlay and Howard, 1978). 
Apart firom animal models, various organ culture model systems have been 
extensively used to smdy the pathogenicity of mycoplasmas. These models have provided 
valuable information complementing that obtained from natural and experimental infections 
by mycoplasmas. In these model systems, subjective measurement of ciliary activity, light 
and electron microscopic observations, measurements of kinetics of oxygen uptake, ATP 
content, calmodulin levels, and dehydrogenase enzyme measurements have been used to 
assess explant epithelial cell damage (Gabridge, 1986; Bermudez et al., 1992). These 
systems appear to be easy to control and manipulate, and to accurately mimic the natural 
host tissue configuration (Gabridge, 1984). 
The differentiated epithelium lining mammalian mucosal surfaces comprises perhaps 
the single most important first line of defense against infectious agents including 
mycoplasmas. Mucus is made up mainly of acid glycoproteins and is thick, gel-like, 
viscous, and sticky. Mucosal ciliated cells contain cilia which beat in a coordinated 
manner, moving the mucus blanket upward toward the pharynx. These properties combine 
to protect the underlying mucosal surfaces against foreign invaders (Alder, 1986). 
Alteration of normal functions of the mucociliary blanket can lead to a deficiency of the 
host defense mechanisms and can be an important factor in the disease process. The 
pathogenesis of several mycoplasma respiratory pathogens seems to relate, at least in part, 
directly to loss of mucociliary clearance mechanisms. This deficiency may contribute to the 
establishment of secondary bacterial infections in the lung and its relevance in vivo has 
been proven beyond doubt (Araake, 1982; Gourlay and Howard, 1982; Almeida and 
Rosenbusch, 1994). Numerous mycoplasma respiratory pathogens including 
M. hyopneumoniae G^ebey and Ross, 1994), M. pneumoniae (Gabridge et al., 1974), 
M. gallisepticum (Levishon et al., 1986), M. dispar (Thomas et al., 1987), M. mycoides 
subsp. capri (Cherry and Taylor-Robison, 1970), M. pulmonis (Stadtlander et al., 1991), 
and M. ovipneumoniae (Jones et al., 1985) have been studied using tracheal organ cultures 
and, in all these studies, progressive ciliostasis and epithelial exfoliation were reported. 
Another in vitro model of mycoplasma infection is a monolayer cell culnire of 
ciliated epithelial cells (Gabridge, 1986). These ciliated cells in monolayer format can be 
infected with mycoplasmas and provide a unique perspective to examine the membrane-
membrane interactions between host and parasites (Gabridge, 1986). Moreover, 
monolayers of cell types other than the natural target cells such as lung fibroblasts have 
proven to be very useful for investigating mycoplasma-host cell interactions. The 
cytopathic effects of several mycoplasma species have been studied using this model. Also, 
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cell monolayers of Imig €n)roblasts have been used to study the adherence mechanism of 
several respiratory mycoplasmas (Razin, 1985). 
However, proper control of certain fectors is necessary when developing an in vitro 
organ culture system which accurately reflects pathogenic mechanisms operative in vivo. 
Culture conditions including variations of CO^ concentration in culture mediimi, type and 
content of serum, nature of the host cells including species and tissue of origin, and stams 
and passage history of the mycoplasma strain are factors that need to be controlled when 
assessing the pathogenicity of mycoplasmas in organ cultures (Debey, 1992). 
Alternatively, evaluation for evidence of certain components that may be of 
pathogenic potential such as a toxin, capsule, attachment molecules, or ability to 
manipulate or to affect the host immune defense systems may also be important in 
determining the etiological significance of an organism (Gourlay and Howard, 1978; 
Gourlay and Howard, 1982). 
Mechanism of Attachment to Host Tissues 
The success of surface parasitism by microorganisms such as mycoplasmas that 
colonize the mucosal surfaces requires an adequate attachment mechanism to resist and 
circumvent the flushing and cleaning mechanisms that protect these surfaces and to acquire 
nutrients from host cells. Those organisms that can effectively overcome these first lines of 
defense have a better chance of colonization and increased opportunity for induction of 
pathogenic changes. Hence, attachment of mycoplasmas to host cells is crucial for their 
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survival within a host (Razin, 1978) and is also a critical step in the initiation of tissue 
colonization and subsequent induction of cellular damage (Baseman et al., 1982). 
Mycoplasmas have been demonstrated to attach to inert surfaces as well as to a 
variety of cells or tissues including tracheal or fallopian-tube epithelial cells, erythrocytes, 
lymphocytes, phagocytic cells and various other cultured mammalian cells (Collier, 1979; 
Razin, 1985). The consequences of attachment of mycoplasmas are often injury to the host 
cells through biochemical alterations such as decreases in ATP, cyclic AMP, carbohydrate 
utilization, amino acid transport and oxidative metabolism (Cassell et al., 1985). However, 
adhesion per se should not be an indicator of pathogenicity since both pathogenic and non­
pathogenic mycoplasma species have the ability to attach to host cells, although loss of 
ability to attach may lead to avirulence (Gourlay and Howard, 1982). 
The general ability of mycoplasmas to attach to host cells has been studied most 
extensively with the respiratory pathogens. The most extensively studied is 
M. pneumoniae, the causative agent of atypical pneumonia in man. M. pneumoniae is 
known to attach to host cells by means of a specialized tip-structure which was described 
by Collier and Clyde Jr, (1969), and Collier and Baseman (1973). This specialized 
structure of M. pneumoniae is mostly concentrated at one site on the microorganism but 
also can be present on other areas of the membrane (Collier, 1979). In further studies it 
was demonstrated that trypsin treatment of M. pneumoniae could result in the loss of a 170 
kDa protein designated as PI. Removal of this PI protein correlated with loss of ability of 
the microorganism to attach to eucaryotic cells, while regeneration of the PI protein 
restored this activity, suggesting that this PI protein is associated with the adherence 
mechanism of the mycoplasma (Hu et al., 1977; Gorski and Bredt, 1977). Further support 
for the importance of the PI protein in the adherence mechanism of M. pneumoniae has 
been provided by morphologic and immunologic smdies. Monoclonal antibody against PI 
reacted with cultured mycoplasmas, and was found to be localized around the tip structure 
with a ferritin-labelled secondary antibody (Hu et al., 1982). Monoclonal antibodies against 
the PI blocked the adherence of virulent organisms to hamster tracheal organ cultures 
(Collier et al., 1983). 
However, the significance of the PI protein in vivo is not clear since avirulent 
strains of M. pneumoniae possess the PI protein but are unable to attach (Collier et al., 
1985). In addition, immunization of guinea pigs with purified PI protein did not protect 
these animals against virulent M. pneumoniae, even though there was a strong humoral 
response to the protein (Jacobs et al., 1988a; Jacobs et al., 1988b). Moreover, in organ 
cultures, Gabridge (1982) found that M. pneumoniae organisms that are located on 
nonciliated cells lie parallel to the plasma membrane of these cells while those on ciliated 
cells are oriented vertically. This finding suggested that the specialized tip-structure may 
not be mandatory for attachment. 
Strong evidence exists to suggest that expression of PI protein alone is not 
sufficient for adherence of M. pneumoniae to host cells. For instance, experiments with 
adherent and nonadherent mutants of M. pneumoniae indicated involvement of a P30 
protein in the adherence mechanism of the mycoplasma (Krause and Baseman, 1982; 
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Baseman et al., 1987). Like PI, this P30 protein is also clustered at the tip-structure of 
virulent Af. pneumoniae and antibodies against the protein blocked adherence of the 
mycoplasma to erythrocytes (Baseman et al., 1987). 
Another respiratory mycoplasma with specialized structures possibly involved in 
attachment is M. gallisepticum which attaches to the tracheal epithelium of chickens by 
means of its specialized adherence organelle or bleb (Uppal and Chu, 1977). The existence 
of cross reactions between epitopes of PI protein of Af. pneumoniae and a protein of 
similar size in M. gallisepticum was noted, but adherence-inhibiting monoclonal antibodies 
to PI did not react with that protein. 
There are many other respiratory mycoplasmas such as M. dispar, 
M. hyopneumoniae and Af. pulmonis that attach to a wide variety of host cells but 
apparently do not have any specialized attachment organelles. Adhesion to host cells in 
these mycoplasmas is mediated by a general interaction of the mycoplasma membrane with 
the host, implying a random distribution of adhesin molecules over the whole mycoplasmal 
surface. As will be discussed later in this review, the capsular material of these organisms 
has been suggested as a mediator in the attachment process to host cells (Rosendal, 1993; 
Minion and Rosenbusch, 1993). Several reports of morphological studies have suggested 
participation of mycoplasma capsules in the attachment process of mycoplasma species to 
host cells (Green and Hanson, 1973; Robertson and Smook, 1976; Wilson and Collier, 
1976; Taylor-Robmson et al., 1981; Tajima and Yagihashi, 1982; Rosenbusch, 1992), but 
the nature of this binding process is still unclear. 
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Adhesins expressed on the surface of bacteria including mycoplasmas are usually 
protein in nature. However, there are a few instances in which noiqjrotein molecules such 
as carbohydrate capsules can be used by the bacteria as adhesins. The capsule of many 
bacteria such as Pasteurella sp., Bacteroides sp. and Pseudomonas aeruginosa have been 
proposed as mediators of their adhesion to host cells (Marcus and Baker, 1985; Ramphal 
and Pier, 1985; Inzana, 1990; Pijoan and Trigo, 1990; Baselga et al., 1994). Moreover, 
the involvement of lipopolysaccharide in the adhesion of Actinobacillus pleuropneumoniae, 
a swine respiratory pathogen, to porcine epithelial cells has been reported (Belanger et al., 
1990 ). Binding of a streptococcus to human fibronectin via lipoteichoic acid has also been 
described (Stanislawski et al., 1985). 
Characteristics of the mycoplasma cell surface determine the capacity for adhesion 
(Gourlay and Howard, 1982) and adherence is probably a multifactorial event involving 
both nonspecific (hydrophobic interactions) and specific Qigand-receptor interactions) 
mechanisms. The chemical nature of receptors on animal cells for microbial pathogens 
including mycoplasmas are usually glycoconjugates. They can be either glycoproteins or 
glycolipids, in which the carbohydrate moieties serve as receptor epitopes. The receptors 
for several mycoplasmas including M. pneumonia, M. gallisepticum, M. genitalium, 
M. synoviae and M. bovis on host cells are neuraminidase sensitive, suggesting that 
glycoproteins containing sialic acid residues serve as receptors for these mycoplasmas 
(Razin, 1985). However, sialylated glycoconjugates are not the sole receptors on host cells 
for mycoplasmas. Another common type of receptor identified for mycoplasmas is sulfated 
glycolipid which is a common constituent of cell membranes. Mycoplasmas that are 
reported to utilize sulfated glycolipids on host cells as receptors include M. pneumoniae, 
M. hominis, M. genitalium, M. salivarium, M. orale, M. hyorhinis, M. arginini, 
M. pulmonis and Ureaplasma ureafyticum (Razin, 1985). More recently, Zhang et al. 
(1994) studied the mechanism of adherence of M. hyopneumoniae to swine ciliated cells 
and reported that sulfated glycolipids were the major native receptors for the organism on 
these cells. The aforementioned mechanisms of adherence can be considered as specific 
interactions between microbial surface molecules (adhesins) and complementary sugar 
moieties (receptors) on host cells. 
Other less specific but irreversible interactions such as hydrophobic interactions can 
also play a role in the adherence mechanism of microorganisms to host cells. High surface 
hydrophobicity was correlated with increased adherence properties in E. coli, in 
Streptococcus mutans, and in Salmonella typhimurium (Zielinski, 1991). The cell surface 
hydrophobicity of mycoplasmas has not been as well documented as for other bacteria. 
However, in a recent study, Zielinski and Ross (1992) presented evidence that the cell 
surface of M. hyopneumoniae is hydrophobic and may play in part in the adherence process 
of the mycoplasma to swine ciliated cells. Previously, Minion et al. (1984) proposed a 
multiphasic model of attachment for M. pulmonis which includes an initial recognition step 
mediated by long-range hydrophobic forces and followed by ligand-receptor specific 
interactions. These interactions also have been suggested in the adherence of several other 
pathogenic mycoplasmas to host cells (Kahane, 1984). The involvement of hydrophobic 
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interactions in the adherence process of several bacteria other than mycoplasmas has also 
been documented (Zielinsid, 1991). 
In regard to M. ovipneumoniae, morphologic studies have revealed its ability to 
attach to a variety of host cells including phagocytic cells (Al-Kaisi and Alley, 1983) and 
ovine ciliated cells (Jones et al., 1985) with profound effects on these cells. However, no 
information on mechanisms of adherence to host cells has been reported. 
Mechanism of Host Cell Injury 
Ciliostasis is a common result of infection of tracheal organ cultures with 
respiratory mycoplasmas including M. hyopneumoniae (Debey and Ross, 1994), 
M. gallisepticum (Levishon et al., 1986), Af. pneumoniae (Gabridge et al., 1974), 
M. pulmonis (Stadtlander et al., 1991), Af. dispar (Thomas et al., 1987), M. mycoides 
subsp. capri (Cherry and Taylor-Robinson, 1970) and M. ovipneumoniae (Jones et al., 
1985). 
There are reports that the basis for these cytopathic effects might be oxidative attack 
by hydrogen peroxide generated by many of the mycoplasmas. Cherry and Taylor-
Robinson (1970) reported that the cytopathic effects induced by M. mycoides subsp. capri 
in chicken tracheal organ cultures were related to hydrogen peroxide produced by the 
organism and that the addition of exogenous catalase could delay these cytopathic effects. 
Cytopathic effects on porcine and rat tracheal organ cultures by M. mobile 163 K was 
thought to be mediated by hydrogen peroxide generated by the organism (Stadtlander and 
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Kirchhoff, 1988). M. pneumoniae is known to actively generate superoxide and hydrogen 
peroxide, and these oxidants have been incriminated in cytopathological changes observed 
in a variety of M. pneumoniae-infectsd human cells including ciliated epithelial cells 
(Almagor et al., 1983; Almagor et al., 1984; Kahane, 1984). The role of hydrogen 
peroxide in the pathogenicity of M. mycoides subsp. mycoides was suggested by Nicholas 
and Bashiruddin (1995). Furthermore, M. equigenitalium produced damage and 
cytotoxicity to equine uterine tube epithelial cells; the effects could be reversed by addition 
of catalase (Bermudez et al., 1990; Rosendal, 1994), suggesting a role for hydrogen 
peroxide. Also, hydrogen peroxide produced by M. equigenitalium has been proposed as 
possible mediator of membrane leakage of calmodulin from infected equine uterine mbe 
epithelial cells (reported by Debey, 1992). Additionally, there are reports which indicated 
that both high and low concentrations of exogenous hydrogen peroxide alone disrupted 
airway epithelial cells and inhibited ciliary activity in sheep (Kobayashi et al., 1992) as 
well as in guinea pig (Khan et al., 1990) and rat (Burman and Martin, 1986) tracheal organ 
cultures. Hydrogen peroxide was the most damaging oxygen radical when lung fibroblasts 
were exposed to superoxide, hydrogen peroxide, hydroxyi radical or singlet oxygen (Simon 
et al., 1981). Moreover, hydrogen peroxide was demonstrated to be responsible for lysis of 
erythrocytes in vitro and also could potentially damage tissue of the respiratory tract 
(Clyde, 1963). 
Conversely, there are pathogenic mycoplasmas, like M. hyosynoviae, that do not 
produce hydrogen peroxide or nonpathogenic mycoplasmas, like A. ladlawii, that produce 
it (Razin, 1978). Also, comparative studies on in vivo effects of virulent and homologous 
attenuated strains of M. pneumoniae failed to show a consistent relationship between 
pathogenicity and peroxide production (Lipman and Clyde Jr, 1969). However, hydrogen 
peroxide produced by M. pneumoniae and other mycoplasmas is rapidly destroyed by host 
catalase activity. Therefore, for the hydrogen peroxide to exert its toxic effect, either host 
catalase must be depleted or mycoplasmas must adhere close enough to the host cell sinface 
to maintain a toxic, steady state concentration of hydrogen peroxide sufficient to cause 
direct damage to the cell membrane (Cohen and Somerson, 1969). Cohen and Somerson 
(1969) also reported the presence of peroxidase-like activity in M. pneumoniae and 
suggested that this may account for a lack of accumulation of hydrogen peroxide in growth 
media. Kahane (1984) and Almagor et al. (1984) presented evidence that the effectiveness 
of hydrogen peroxide may depend on both the intimate contact of the organism with the 
host cell membrane and production of superoxide anions which inactivate host cell catalase; 
this could permit the oxidative action of hydrogen peroxide produced by both the organism 
and the host cells. Furthermore, catalase deficient mice were more likely to develop 
pneumonia after infection with M. pulmonis than normal mice, providing circumstantial 
evidence that in vivo production of hydrogen peroxide by the organism contributes to its 
virulence (Brennan and Finsten, 1969). 
Some mycoplasmas cause cytopathic effects in cell cultures. This may be due to 
metabolic competition for essential nutrients. Arginine-requiring mycoplasmas may deplete 
arginine to such an extent that cell damage results. Alternatively, ammonia or urea, die end 
products of arginine-requiring mycoplasmas and ureaplasma, respectively, as well as acid 
production by glucose fermenting mycoplasmas may cause cell damage (Gourlay and 
Howard, 1982). 
Very little work on mycoplasmal toxins has been reported in the literature. A 
neurotoxin produced by M. neurolyticwn, the causative agent of rolling disease in mice and 
rats, has been described since the work of Sabin (1938). Neurotoxic properties of three 
other mycoplasmas species, including M. arthritidis, M. pulmonis and M. gallisepticum, 
were described by Thomas (1969) who demonstrated that the organisms must be alive to 
produce toxin and larger doses were necessary to produce toxicity. A toxin capable of 
eliciting an inflammatory response in the skin of guinea pigs and the mammary gland of 
cows was produced by M. bovis (Geary et al., 1981); however, the relevance to the 
cytopathic effects of this organism for organ cultures could not be demonstrated (Thomas et 
al., 1987). There are studies which suggest that proteins associated with the mycoplasma 
cell membrane are the toxic factors responsible for the cell damage caused by the 
mycoplasmas. Both M. pneumoniae live organisms and membrane-associated preparations 
induced ciliostasis in organ culmres of adult hamster trachea (Gabridge et al., 1974). 
Similarly, whole cells and purified membranes of M. hyopneumoniae were reported to be 
cytotoxic for porcine lung fibroblasts (Geary and Walczak, 1983). In both cases, membrane 
associated proteins were implicated in these cytopathic effects. In contrast to these reports, 
however, Hu et al. (1976) were unable to induce ciliostasis or necrosis in tracheal organ 
cultures treated with M. pneumoniae membranes. 
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Other potential mediators of toxicity in mycoplasma infections are capsular 
galactan, a phenol-water extract of M. mycoides subsp. mycoides, and a lipoglycan 
extracted from several acholeplasma species. Evidence that these products may play a 
pathological role similar to the endotoxin of gram negative bacteria has been suggested by 
several authors, although biochemically they are different from classical 
lipopolysaccharides (Gourlay and Howard, 1982; Rosendal, 1993; Nicholas and 
Bashiruddin, 1995). 
Numerous enzymatic activities have been described and suggested to play a role in 
mycoplasma pathogenicity. Proteases specific for IgA have been found in U. urealyticum 
(Robertson et al., 1984; Kapatais-Zoumbos et al., 1985). Liquefaction of gelatin by 
cultures of M. mycoides subsp. mycoides and subsp. capri was described by Freundt 
(1958). Liquefaction of coagulated serum by M. capricolum and M. mycoides subsp. 
mycoides has also been described (Gabridge et al., 1985). Increased collagenase activity of 
certain M. arthritidis strains have been reported to have some role in the development of 
arthritis in mice (Kluve et al., 1981). Phospholipase activities associated with membranes 
of M. hominis, M. mycoides and A. laidlawii have been observed to be responsible for lysis 
of red blood cells from various sources (Tryon and Baseman, 1992). 
Mycoplasma Capsules 
Mycoplasmas, unlike bacteria, lack a cell wall and cell-wall precursors. However, 
similar to many bacteria, capsules have been described in several mycoplasma species. 
The common techniques used for detection of bacterial capsules, based on light 
microscopy combined with India ink to enhance contrast, have not been useful with 
mycoplasmas because of their small size and complexity of the media or animal tissue 
environment in which capsule is being expressed (Rosenbusch and Minion, 1992). 
Demonstration of mycoplasma capsules has been achieved mainly by using positively 
charged electron dense compounds such as ruthenium red or polycationic ferritin which 
react with substances that are negatively charged including acidic sugars, phospholipids and 
fatty acids (Luft, 1971). Another technique that has been widely used for demonstration of 
mycoplasma capsules is lectin reactivity. Since lectins are known to exhibit carbohydrate 
specificity, this technique can also provide some basic information on the sugar 
composition of the capsule (Bayer, 1990; Minion and Rosenbusch, 1993). 
The presence of a capsule has been reported on several mycoplasma species that are 
proven respiratory pathogens including M. pneumonia, M. mycoides subsp. mycoides, 
M. dispar, M. hyopneumoniae, M. gallisepticum, M. pulmonis. Among the ureaplasmas, 
U. urealyticum has been reported to express a capsule. Capsules have not been reported 
among the acholeplasmas, anaeroplasmas, or asteroleplasmas, but lipoglycans have been 
found in the members of these species (Razin, 1978; Rosenbusch and Minion, 1992; 
Minion and Rosenbusch, 1993). In contrast to capsules, lipoglycans are considered integral 
to the mycoplasma membrane. Moreover, lipoglycans do not provide significant staining 
with rutheniimi red and have lower molecular weight than capsules (Rosenbusch and 
Minion, 1992). 
Little is known concerning the effects of enviroiunental factors on capsule 
production and the nature of the interaction occurring between eucaryotic cells and the 
mycoplasmas. Some mycoplasma species seem to synthesize their capsule constimtively, 
while others sjoithesize the capsule in a considerable amount only during in vivo growth or 
when co-cultured in vitro with eucaryotic cells. M. dispar produces a higher percentage of 
encapsulated cells and thicker capsule when grown in vivo or co-cultured with fetal bovine 
limg cells than when grown in vitro (Almeida and Rosenbusch, 1991), implying that 
capsule synthesis was induced in this mycoplasma. Similarly, synthesis of capsular material 
in M. penetrans has been shown to be a regulated process (NeyroUes et al., 1996). 
Increases in the capsular thickness have also been observed to occur with co-cultured M. 
hyopneumoniae (Tajima and Yagihashi, 1982), M. pulmonis (Taylor-Robinson et al., 1981) 
and M. gallisepticum (Tajima et al., 1982; Yagihashi et al., 1987). 
Several techniques have been used for capsule extraction and purification. Hot 
phenol extraction procedures followed by ion-exchange chromatography have been used 
extensively (Rosenbusch and Minion, 1992). However, capsular material that has been 
isolated by the use of hot phenol extraction procedures may contain lipoglycans; these are 
integral membrane components and therefore can be a source of contamination. Capsular 
material can also be extracted by prolonged exposure of the whole mycoplasma cells to 
buffered saline at 37°C (Almeida et al., 1992). The capsular material of M. hyopneumoniae 
was also extracted by boiling the organisms (Young et al., 1996). These observations may 
relate to the supposition that capsule may be loosely attached to the mycoplasma 
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membrane. There are also reports of releasing carbohydrates from mycoplasma cells by 
mild sonication (Minion and Rosenbusch, 1993). The ability of lectins to exhibit 
carbohydrate specificity has also been explored as a component of capsular marprial 
purification protocols. Alemeida and Rosenbusch (1991) purified the capsule of M. dispar 
based on its specific reactivity to Ricinus communis lectin. The capsule of U. urelyticum 
which binds to concanavalin A lectin (Whitescarver et al., 1975; Robertson and Smook, 
1976) has also been purified in this way for further smdy. 
Information regarding the chemical composition of mycoplasma capsules is lacking 
and is mostly derived from indirect evidence provided by electron microscopic observations 
of preparations stained with positively charged electron dense compoimds such as 
ruthenium red or polycationic ferritin, and also the ability of specific lectins to react with 
different mycoplasmas. The results obtained from such studies suggest that mycoplasma 
capsules are composed at least in part of acidic sugars (Rosenbusch and Minion, 1992). 
Few mycoplasma capsules have been chemically analyzed. The capsular galactan of 
M. mycoides subsp. mycoides is reported to be composed of polymers of galactose which 
are linked in a beta (1-6) configuration (Rosenbusch and Minion, 1992). The composition 
of a polysaccharide isolated from mycoplasma CF-38 strain), die etiological agent of 
contagious caprine pleuropneumonia in goats, was determined to be of equal quantities of 
glucose, galactose, mannose, fiicose, glucosamine and galactosamine (Rurangirwa et al., 
1987). The chemical composition of the capsular polysaccharide of M. dispar was a 
polymer of galactose and galacturonic acid (Bansal, 1995). More recently, the sugar 
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composition of the capsular material of M. penetrans was determined by gas liquid 
chromatography and was found to be mannose:glucose:N-acetylglucosamine:N-
acetylgalactosamine in the proportion of 1:6:1:2 (NeyroUes et al., 1996). 
Pathogenic roles of mycoplasma capsules. Capsules have long been associated 
with virulence properties of bacteria including mycoplasmas. Since they are composed of 
99% water, these highly hydrated polysaccharide capsules may protect the organisms from 
desiccation thereby enhancing their survival and facilitate their spread from one host to 
another (Dudman, 1977; Whitfield, 1988). This observation is quite interesting at least for 
the mycoplasma respiratory pathogens which are in most cases encapsulated and spread 
from one host to another by means of aerosols. A capsule may also significantly affect 
access of molecules to the bacterial cell envelope and cytoplasmic membrane in a way that 
they are not accessible to antibacterial agents such as antibiotics (Costerton et al., 1987). 
Capsules may mediate adherence of organisms including mycoplasmas to host 
tissues. Direct evidence that mycoplasma capsules may promote adherence of the 
organisms to host cells is lacking and derived mostly from morphological observations 
(Green and Hanson, 1973; Wilson and Collier, 1976; Robertson and Smock, 1976; Taylor-
Robinson, 1981; Tajima and Yagihashi, 1982; Rosenbusch, 1992). Recently, however, 
Yoimg et al. (1996), using a microtiter adherence assay, reported that Af. hyopneumoniae 
purified capsular polysaccharide possessed an inhibition effect on the adhesion of the 
organism to swine cilia. This demonstrated, perhaps for the first time, evidence of direct 
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involvement of polysaccharide capsules in the interaction of mycoplasmas and their host 
cells. 
Participation of capsules in microbial adhesion is relatively controversial because of 
their composition. Capsules are negatively charged, and are best known for their repulsive 
properties, therefore contributing to antiphagocytic activity. Possible explanations as to 
how negatively charged bacterial capsules can mediate adherence include the formation of a 
latch effect provided by multiple binding sites as a result of repeating structural entities of 
polysaccharides. In addition, enzymes or proteins, supposedly bound to or buried in the 
membranes may extend across the extracellular capsule and neutralize the negative charges 
of the capsule or provide important binding sites in negative to negative-charged surface 
attachment (reviewed by Almeida, 1988). Based on the presence of lectins in mammalian 
host cells (Roberson et al., 1981; McArthur and Ceri, 1983), there has been speculation 
that capsules may promote adhesion through specific interaction between host cell lectins 
and capsular sugar moieties (Marcus and Baker, 1985). Perhaps the best indication that 
bacterial capsules can act as adhesion molecules is lectinophagocytosis, a nonspecific 
phagocytosis of bacteria in the absence of serum opsonins mediated by lectins on the 
phagocytic cell membrane that bind specifically to carbohydrate on the bacterial surface. 
For instance, Klebsiella pneumoniae undergoes phagocytosis mediated by capsular 
exopolysaccharides which are recognized by a specific lectin of macrophages (Athamna et 
al., 1991). This also would not be inconsistent with the ability of many mycoplasma 
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species to adhere to the surface of phagocytic cells, although xjptake occurs only in the 
presence of specific antibodies (Howard and Taylor, 1985). 
A common theme in bacteriology regarding the role of polysaccharide capsules is 
their antiphagocytic effect associated with their electronegative charges and with their 
capacity to nonspecifically interfere with complement activation. It has been shown that 
capsular polysaccharides inactivate the amplification loop of the complement system either 
by binding to factor H or decreasing the affinity of factor B for C3b, resulting in the 
blockage of the alternative pathway (Kasper, 1986). This strategy of limiting complement 
activation has been described for capsules containing sialic acid such as group B 
streptococci (Edwards et al., 1982) and K1-encapsulated E. coli (Stevens et al., 1978), and 
those that do not contain sialic acid such as type 7 and type 12 pneumococci (Joiner et al., 
1984). Other mechanisms by which the capsule has been reported to protect against 
phagocytosis include formation of microcolonies immersed in a glycocalix of joined 
individual exopolysaccharides which creates a protective niche against host enzymatic 
degradation (Isenberg, 1988), and masking binding receptors on the bacteria for opsonic 
factors such as specific antibodies and complement components (Absolom, 1988). 
Mycoplasmas, in general, are known to resist phagocytosis. For instance, many in vitro 
studies have shown that in the absence of specific antibodies several mycoplasma species 
can colonize the surface of phagocytic cells without stimulating phagocytosis (Howard and 
Taylor, 1985). This phenomenon has been described for both encapsulated and 
unencapsulated organisms of M. dispar (Almeida et al., 1992), and for the unencapsulated 
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M. bovis (Howard, 1980). Thus, it appears that with mycoplasmas, production of a capsule 
per se is not necessarily a prerequisite for restricting phagocytosis, at least for the 
organisms themselves. Yet, mycoplasma capsules have been reported to interfere with the 
phagocytosis and the killing of a second bacterial target by phagocytic cells. For example, 
both encapsulated M. dispar and its purified capsule reduce bovine alveolar macrophage 
metabolism and suppress phagocytosis of a second bacterial target (Almeida et al., 1992). 
Mycoplasma capsules may have toxic effects. The capsular galactan of M. mycoides 
subsp. mycoides has detrimental effects on host cells; these effects are expressed as 
lymphatic and capillary thrombosis, pulmonary edema and infiltration of lymphatic spaces 
of the affected lobules (Nicholas and Bashiruddin, 1995). Such changes were reproduced in 
calves following intravenous injection of purified galactan into cattle (Buttery et al., 
1976). Capsular galactan induced lethal effects for chicken embryos when inoculated in the 
chorioallantoic cavity (Gourlay and Howard, 1982). Another toxic effect associated with 
capsular galactan of M. mycoides subsp. mycoides is the deposition of fibrin in chronic lung 
lesions of cattle, thus promoting lung lesions and persistent mycoplasmemia (Gourlay and 
Howard, 1982). 
In general, bacterial polysaccharide capsules are poorly immunogenic, are T cell 
independent antigens, fail to induce development of memory cells and immune responses 
may not develop in the very young (Stein, 1985; Maxon and Kroll, 1990). Also, capsules 
may express immunosuppressive activity by preventing an appropriate immune response. 
All of these features have also been described for immune responses against some of the 
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mycoplasma capsules (Hudson et al., 1967; Howard and Gourlay, 1983; Bansal et al., 
1995). Paradoxically, however, convalescent animals may have titers of anticapsular 
antibodies in their serums (Buttery, 1970; Rurangirwa et al., 1987). There are several 
reasons why polysaccharide capsules are poor immimogens. The majority of bacterial 
polysaccharide capsules lack complexity and are made up of repeating single (linear 
homopolymers) or a few (linear heteropolymers) monosaccharide types. This property may 
also explain their T cell independency. The repeating antigenic determinants should 
contribute to an efficient cross-linking to the surface immunoglobulin receptors on B cells 
and provide activation signals to B cells (reviewed by Bansal, 1994). Polysaccharide 
capsules are also generally high molecular weight and are slowly metabolized since the 
animal may lack the appropriate catabolic enzymes. This could contribute to the ability to 
induce immunological tolerance. In many situations, there is structural mimicry between 
polysaccharide capsules and host cell constiments and it is believed that this relationship is 
responsible for establishing an initial inmiunological tolerance. A well known example of 
this mimicry is the capsular galactan of M. mycoides subsp. mycoides which has been 
shown to possess a serological similarity to pneumogalactan, a product of normal lung 
epithelial cells (Bashiruddin and Nicholas, 1995). Structural mimicry has also been 
described in other bacterial capsules including K1 and K5 polysaccharides of E. coli 
(Finne, 1982; Navia et al., 1983). 
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Interaction of Mycoplasmas with the Host Immune System 
The interaction of mycoplasmas with the imTnnnp. system has been thoroughly 
reviewed elsewhere (Messier, 1986; Almeida, 1991; Niang, 1992); therefore, only 
pertinent aspects wiU be cited. 
One of the main features of mycoplasma species is their ability to survive and even 
multiply in cultures of phagocytic cells in the absence of specific antibodies. This 
phenomenon has been observed with several respiratory mycoplasmas including 
M. pneumoniae, M. pulmonis, M. dispar and Af. bovis (Howard and Taylor, 1985), and 
M. ovipneumoniae (Al-BCaisi and Alley, 1983). Mycoplasmas are also recognized for their 
ability to suppress the ability of phagocytic cells to ingest and kill a second bacterial target. 
Examples include M. hominis, M. anhritidis (Simberkoff et al., 1971; Thomsen and 
Heron, 1979), M. bovis (Howard and Taylor, 1983), M. dispar (Almeida et al., 1992), and 
M. hyopneumoniae (Carusso and Ross, 1990). Our previous in vitro studies have also 
demonstrated decreased uptake of a second bacterial agent by sheep alveolar macrophages 
when these macrophages were pretreated with M. ovipneumoniae (Niang, 1992). The 
mechanism by which mycoplasmas inhibit the phagocytic capacity of phagocytes is still 
unclear. However, a role for polysaccharide capsules has been demonstrated (Almeida et 
al., 1991). Also, it has been speculated that the ability of mycoplasmas to inhibit 
phagocytosis is due to their ability to bind firmly to the cell membranes of these phagocytic 
cells. Thus, this action may mask or prevent stimulation of appropriate receptors (Howard 
and Taylor, 1985). 
Another in^)ortant characteristic of mycoplasmas is their ability to interact 
nonspecifically with lymphocytes as first demonstrated by Ginsbm-g and Nicolet (1973) 
with M. pulmonis. Following this report, many other mycoplasma species were reported to 
possess mitogenic activity for either T or B cells or both (Cole et al., 1985; Messier et al., 
1990). This mitogenic activity has been demonstrated with whole organisms, culture 
supematants, and membrane preparations but the nature of mycoplasmal mitogens has not 
been well characterized (Cole et al., 1985). In the case of M. arthritidis, a factor 
characterized as a superantigen has been implicated in the T cell-mitogenic activity of the 
organism (Cole, 1991). Mitogenic activity of mycoplasmas and their products has also been 
observed with in vivo experimentation (Cole et al., 1985; Messier et al., 1990) and has led 
to speculation that this activity may contribute to disease pathogenesis . 
While mycoplasma species have been reported to activate lymphocytes, suppressive 
effects on these cells have also been reported. Both viable and killed nonfermenting 
mycoplasmas have been reported to suppress lymphocyte blastogenic responses to 
phytohaemagglutinin (PHA) lectin. Barile and Leventhal (1968) suggested that the 
suppressive factor in these arginine requiring mycoplasmas was depletion of arginine 
required for the nutrition of cells. More recently, arginine deiminase was characterized as 
the factor responsible for inhibition of lymphocyte blastogenesis by these mycoplasmas 
(Sugimura et al., 1989). In addition, other experiments with glucose fermenting 
mycoplasma species including M. mycoides subsp. mycoides, M. hyopneumoniae, M. bovis 
and M. gallisepticum (Thomas et al., 1990), and M. dispar (Finch and Howard, 1990) and 
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M. hyopneumoniae (Kishima and Ross, 1985) also demonstrated suppression of lymphocyte 
blastogenic responses to lectins. These suppressive effects have also been demonstrated by 
in vitro culture and lectin stimulation of lymphocytes from infected animals. 
Suppressive effects on both himioral and cell-mediated responses by mycoplasma 
species have been reported. Kaklamanis and Pavlatos (1972) reported that simultaneous 
injections of Af. arthritidis and viral antigens resulted in complete or partial suppression of 
humoral responses against the antigens. Similarly, Af. dispar has also been shown to induce 
immimosuppression when injected in combination with other antigens (Howard and 
Gourlay, 1983). Impaired development of delayed type hypersensitivity has been reported 
with M. hyopneumoniae (Adegboye, 1978), Af. pneumoniae (Biberfeld and Sterner, 1976) 
and Af. pulmonis (Lai et al., 1989). Suppression of both humoral and cell-mediated 
responses were reported with Af. bovis in calves (Bennett and Jaspar, 1977) and 
M. pneumoniae in humans (Sabato et al., 1981). Evidence of mycoplasma induced-
immunosuppression can also be implied by their ability to potentiate bacterial infections. 
For example, the potentiating effect of M. pneumoniae on the development of 
pneumococcal septicemia in hamsters by Diplococcus pneumoniae was demonstrated by 
Lui et al. (1972). 
Concerning M. ovipneumoniae, studies conducted in this laboratory showed that 
responses of sheep peripheral blood lymphocytes to various antigen preparations of the 
organism were inconsistent. These inconsistent responses in blastogenic assays were noted 
between animals and even in the same animal at different times. Also, lymphocytes from 
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normal lambs gave moderate responses in these assays (unpublished data). This suggests 
that Af. ovipnewnoniae or its product could elicit regulatory influences on immune 
responses of sheep. 
Role of the Host Immune Responses in the Pathogenesis of Mycoplasma Diseases 
The activation of cells of the immune system is not always beneficial for the 
host, and the concept that the pathologic lesions seen in mycoplasma diseases are host-
mediated immune responses is plausible. Indeed, a feature common to many mycoplasmas-
induced respiratory and arthritic diseases is the marked lymphoid-cell infiltration at the site 
of primary involvement. Many of the respiratory mycoplasmas mainly colonize the ciliated 
epithelial cells lining the respiratory tract and induce characteristic lesions, partly 
comprised of a lymphocyte infiltration in a form of marked peribronchial and perivascular 
accumulations (Gourlay and Howard, 1982; Howard and Taylor, 1985; Howard et al., 
1987). Many of the lymphocytes observed in these lesions are lymphocytes producing 
immunoglobulins that were, in some cases, specific for the invading mycoplasmas (Gourlay 
and Howard, 1982; Howard and Taylor, 1985). Additional support for this view was 
provided by the studies of Denny et al. (1972) in mice infected with M. pulmonis and 
Taylor et al. (1974) in hamsters infected withM. pneumoniae who showed that treatments 
which suppressed the immune response, such as thymectomy, irradiation, antilymphocyte 
serum treatment, and cyclophosphamide injections, reduced the extent of the lesions 
formed in the lungs of these animals. Furthermore, athymic mice were found to develop 
less lung lesions and less specific immunoglobulins than normal mice when both were 
infected with M. pulmonis (Cassell and McGhee, 1975). However, experimental studies in 
gnotobiotic calves with M. dispar failed to demonstrate the characteristic lymphoc)rtic 
accumulations observed with other respiratory mycoplasmas. A possible explanation was 
that this species is poorly immunogenic and has an innnunosuppressive effect in young 
calves (Howard et al., 1987). 
Evidence regarding the mechanisms involved in the formation of these lymphoid 
lesions varies. A local specific humoral immune response to persistent mycoplasmal 
antigen stimulation on the surface mucosa appears to play a major role in the development 
of these lesions. Cassell et al. (1974) examined the nature of the lymphocyte infiltration in 
mouse lungs after infection with M. pulmonis and observed that one week after infection 
the majority of the lymphocytes were IgM producing cells and a few IgA producing cells 
were also present. By 3 weeks post-infection, the accumulated lymphocj^es were 
predominantly IgA producing cells but large numbers of IgGl and IgG2 producing cells 
were also present. Similar observations, but with a different antibody isotype 
predominating, were made on lungs of M. hyopneumoniae-mSs.ctt6. pigs (Messier, 1990), 
Af. pneumoniae-witc\&i. hamsters (Femald et al., 1972), and M. dispar- and M. bovis-
infected calves (Howard et al., 1987). Evidence for a direct role of host specific immunity 
in the pathogenesis of respiratory mycoplasmas remains an open question, since evidence 
of cross-reactivity of these specific mycoplasma antibodies with host cells is lacking. 
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However, indirect evidence, such as progressive and persistent lymphoid hyperplasia 
causing occlusion of airways and alveolar collapse, is overwhelming. 
The mitogenic activity for lymphocytes exhibited by numerous respiratory 
mycoplasmas is an alternative explanation for lymphoid responses seen in mycoplasma 
respiratory lesions. This nonspecific stimulation of lymphocytes by the mycoplasmas also 
may contribute to disease pathogenesis by induction of antibodies with various specificities. 
Support for the idea that mycoplasma mitogenicity plays a role in disease pathogenesis 
comes from evidence that mitogenicity of certain mycoplasmas is not only an in vitro 
phenomenon but is also expressed in vivo. Inoculation of mycoplasmal membranes into the 
respiratory tract of experimental animals led to significant lymphocyte infiltration and lung 
lesions that were indistinguishable from that produced by viable mycoplasmas (Cole et al., 
1985; Messier et al., 1990). Furthermore, the release of a variety of soluble products 
including interferons and interieukins by mycoplasma mitogen-activated lymphocytes could 
induce damage to host cells by recruiting and stimulating differentiation or activation of 
other cells (Cole et al., 1985). 
Other evidence suggests that some type of activation of the host immune system 
plays a role in pathogenicity of mycoplasmas, eventually leading to an autoimmune 
response and thereby to immunopathological damage. An autoimmune response to various 
tissue antigens associated with mycoplasmal infection has been described in humans 
(Biberfeld, 1985), in catde (Cassell et al., 1985, Nicholas and Bashiruddin, 1995), in pigs 
(Suter et al., 1985, Baumgarter and Nicolet, 1984; Roberts and Little, 1970) and in rats 
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(Runge et al., 1990; Kirtchoff et al., 1989). In addition to nonspecific lymphocyte 
activation, reviewed above, molecular mimicry was proposed to explain the occurrence of 
these immunopathological responses during microbial infections. The capsular galactan of 
M. mycoides subsp. mycoides is antigenically related to pneumogalactan, a product of 
normal lung epithelial cells (Nicholas and Bashiruddin, 1995). This suggests that an 
immune response to the mycoplasma galactan could induce autoreactive antibodies with 
consequential formation of immune complexes in the lymph nodes leading to lymphatic and 
capillary thrombosis, edema and infiltration of lymphatic spaces of the affected lobes 
(Nicholas and Bashiruddin, 1995). Antigenic mimicry has also been associated with the 
occurrence of autoantibodies in himians infected with M. pneumoniae (Biberfeld, 1985) and 
M. genitalium (Bisset, 1994). Possible induction of an autoimmune response as a 
consequence of aberrant expression of MHC molecules on recognized antigen presenting 
ceils, or on cells that normally do not present antigen is another proposed mechanism by 
which microorganisms can elicit autoantibodies. In this regard, the in vitro upregulation of 
MHC molecules on antigen presenting cells by several mycoplasma species has recently 
been demonstrated and proposed to be responsible of the generation of autoimmime 
pathology (Stuart et al., 1989; Stuart et al., 1990). The relevance of this is indicated by 
several autoimmune conditions in which abnormal expression of HLA class n molecules by 
specific cells of the target organs has been demonstrated (Bottazzo et., 1986; Smith and 
Allen, 1992). 
A possible role for mycoplasmas in the pathogenesis of asthma and allergic airway 
hypersensitivity is beginning to emerge. Serological studies on asthmatic patients infected 
with M. pneumoniae indicated a high level of serum IgE specific for the organism, 
suggesting involvement of IgE-mediated hypersensitivity (Tipimeni et al., 1980; Yano et 
al., 1994). Yano et al. (1994) speculated on the possibility that the production of this M. 
pneumoniae-s^ciSic IgE may arise from epitopes that are cross-reactive with components 
of the airway. Nagayama et al. (1987) also demonstrated a correlation with infection by 
observing decreased levels of plasma IgE in 78.4% of children with M. pneumoniae 
infection between the acute and convalescent phases. Mycoplasmal infection was also a 
predisposing factor for IgE production to other allergens (Yano et al., 1994). This effect 
could be due to destruction of respiratory mucosal cells facilitating allergen penetration of 
the mucosa and also to influences on regulatory mechanisms leading to IgE synthesis 
(Frick, 1986). 
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CHAPTER 3. DEMONSTRATION OF A CAPSULE ON 
MYCOPLASMA OVIPNEUMONIAE 
A paper to be submitted to the Am J Vet Res 
Mamadou Niang,' MS; Ricardo F. Rosenbusch,^ DVM, PhD; John J. Andrews,^ DVM, 
Ph.D; Merlin L. Kaeberle/ DVM, PhD. 
Objective 
To examine Mycoplasma ovipneumoniae for the presence of a capsule and the 
potential role of the capsule as a virulence factor. 
Samples 
Seventeen isolates of M. ovipneumoniae and two isolates of M. arginini, isolated 
from respiratory tracts of sheep with respiratory disease, were used. The smdy also 
included a reference strain and a high passage level isolate of M. ovipneumoniae. 
Procedure 
Mycoplasmas were cultured in modified Friis broth mediirai, ovine fetal lung cells 
or ovine tracheal ring explants. Pelleted mycoplasmas or mycoplasma-infected ring cultures 
^ Department of Microbiology, Immunology and Preventive Medicine, Iowa State 
University, Ames, lA 50011. 
^ Veterinary Research Instimte, College of Veterinary Medicine, Iowa State 
University, Ames, lA 50011. 
^ Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Iowa State 
University, Ames, LA 50011. 
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were treated with rutheniuin red or polycationic ferritin and visualized by transmission 
electron microscopy. Also, the reactivity of several lectins with the mycoplasmas was 
studied by a microtiter agglutination test. 
Results 
Electron microscopic analysis revealed a large number of M. ovipneumoniae cells 
covered with an electron dense-stained amorphous material. This dense-staining material 
was absent when unlabeled mycoplasma preparations were examined, suggesting that it was 
a capsule. Marked variations in the thickness of the capsule were observed for a single M. 
ovipneumoniae isolate grown under the different culture conditions. Multiple passages of 
the microorganisms in modified Friis broth medium decreased the thickness of the capsule 
but not the percentage of cells encapsulated. When the different Af. ovipneumoniae isolates 
grown in modified Friis broth medium or co-cultured with ovine fetal lung cells were 
compared for capsular thickness or for percentage of encapsulation, marked differences 
were observed among them. However, no apparent differences in the percentage of 
encapsulation were observed for any of these isolates when growth in modified Friis broth 
mediimi was compared with co-culturing in ovine fetal lung cells, but there were 
differences in the capsular thickness. In thin sections of ruthenium red-stained tracheal ring 
cultures, the mycoplasmas appeared to be in close contact with cilia through their capsule. 
All isolates of M. ovipneumoniae reacted strongly with wheat germ agglutinin lectin. 
Variable reactivity of the M. ovipneumoniae isolates with the other lectins was observed. 
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Conclusions 
M. ovipneumoniae expresses a polysaccharide capsule with variable size expression 
in different cultures. Strain heterogeneity could be further indicated by variable reactivity 
of this capsular material with several different lectins. Morphological observations suggest 
that this capsule facilitates adherence of the organism to ciliated epithelium. 
Clinical Relevance 
Strain variation associated with this capsule and its possible association with 
attachment to cilia may provide a versatile interaction of M. ovipneumoniae with its 
environment; thus, a long term colonization of the host by the organism. 
Introduction 
M. ovipneumoniae is the most commonly isolated mycoplasma from sheep with 
respiratory disease. However, the potential pathogenic role of this agent still remains 
unresolved. Experimental transmission of the organism has yielded inconsistent evidence of 
pathogenicity. There is lack of evidence relative to its ability to produce certain factors that 
may be suggestive of pathogenic potential such as a toxin, adhesion molecules, or a 
capsule. A capsule may be an important factor that enables pathogenic microbes including 
mycoplasmas to colonize the host respiratory tract. The presence of a capsule has been 
reported on several mycoplasma species that are proven respiratory tract pathogens 
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including M. pneumoniae, M. mycoides subsp. mycoides, M. dispar, M. hyopneumoniae, 
M. gallisepticum, and M. pulmonis. 
With many other mycoplasma species causing respiratory diseases (e.g., 
M. pneumoniae* M. dispar,^ M. hyopneumoniae,^'^ M. gallisepticum,^ andM. 
pulmonis^, a positive correlation between increased capsule production and the ability to 
colonize the host's respiratory tract has been suggested. More recently, the capsule of 
M. dispar has been reported to induce a poor immune response in calves and mice.'° This 
association of mycoplasma capsules with failure of an immune response that might inhibit 
attachment and colonization of host respiratory cells suggests that the capsule may be an 
important virulence factor. Based on these observations, it was of interest to examine 
M. ovipneunwniae for the presence of a capsule since the agent has also been observed to 
attach to cilia, to colonize the upper respiratory tract of sheep,' and to induce a poor 
immune response in naturally infected lambs.'' 
Materials and Methods 
Mycoplasma isolates. Nineteen isolates of M. ovipneumoniae including a reference 
strain, a high passage level isolate, and two isolates of M. arginini were used in this study. 
All the mycoplasma isolates, except the reference strain which was provided by the second 
author, were isolated in this laboratory from lung tissues or nasal swabs of sheep with 
respiratory disease and identified as either M. ovipneumoniae or M. arginini.^ All the 
mycoplasma isolates, except the high passage level one, were utilized below the 11th 
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passage level. The high passage isolate was originally derived from a low passage isolate 
by successive in vitro growth in modified Friis broth medium (MFBM). For investigation 
of in vitro passage effects on capsule production, both the high passage and its parent low 
passage isolate were included in various experiments. A stock culture of each of the 
mycoplasma isolates was prepared by growing the organisms in MFBM. Cultures were 
harvested and washed once in phosphate buffered saline solution (PBS, pH 7.4) by 
centrifligation at 10,000 g for 30 minutes. Washed cells were resuspended and concentrated 
in PBS and aliquots were stored at -70PC. 
Growth conditions. Mycoplasmas were cultured for various experiments in 
MFBM, ovine tracheal ring explants or ovine fetal lung (OFL) cells. For growth in 
MFBM, organisms from a stock aliquot were inoculated into MFBM, cultures were 
incubated at 37°C in 0.5% CO2 in air. On attaining optimal growth, organisms were 
harvested by centrifugation at 10,000 g for 30 minutes at 4®C. 
Ovine tracheal ring cultures were prepared from the trachea of Iambs obtained by 
caesarean section. The trachea was removed, stripped of extraneous tissues and sliced into 
rings which were placed in 12-well tissue culture platesP containing 0.4 ml of Medium 199 
(M199),'' supplemented with 5% fetal bovine serum'' and 200 /ig/ml of bacitracin''. Tracheal 
rings were infected with M. ovipneumoniae (isolate R19) at 105 CFU/ml and plates were 
incubated at 37°C in 0.5% COj. Spent medium was removed every other day and replaced 
with fresh M199 medium until the experiment was terminated. 
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Ovine fetal lung (OFL) cells,® used below flie 15th passage level, were cultured in 
Dulbecco's modified Eagle's medium'' (DMEM) supplemented with 10% fetal bovine 
serum in 25 cra^ tissue culture flasks."^ Cell monolayers were infected with selected isolates 
of M. ovipneumoniae at approximately 25 mycoplasmas per cell and flasks were incubated 
at 3>TC in 0.5% COj for 30 hours. Thereafter, the flasks were rinsed with cold PBS and 
supematants were saved. The monolayer cells were scraped from the flasks and added to 
the corresponding supematants. The suspensions were centrifiiged into pellets. 
Fixation and labelling. Seven M. ovipneumoniae isolates cultured in MFBM were 
pelleted by centrifiigation. The pellets were fixed with equal parts of 3 % glutaraldehyde in 
0.1 M sodium cacodylate buffer (pH 7.2) with and without 1% rutheniimi reef for 2 hours 
on ice and washed 3 times (15 miDutes each) with 0.1 M sodium cacodylate buffer. Pelleted 
cells co-cultured in OFL were also fixed with and without ruthenium red. 
Only isolate R19 grown in MFBM was labelled with polycationic ferritin. 
Organisms were fixed with 3% glutaraldehyde in 0.1 M sodium cacodylate buffer and 
labelled with polycationic ferritin^ as previously described." Fixed mycoplasmas were 
resuspended in 0.1 M of sodium cacodylate buffer with polycationic ferritin (1 mg/ml) for 
30 minutes at 4°C and the reaction was stopped by ten-fold dilution with cold PBS. 
Mycoplasmas were resuspended in 4% agar and washed 3 times in cold PBS by 
centrifiigation. 
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Freshly collected tracheal rings infected with isolate R19 at two and six days post­
infection were fixed with and without ruthenium red. 
Transmission electron microscopy. Samples were postfixed with 1 % osmiimi 
tetroxide in 0.1 M sodium cacodylate buffer for 2 hours at room temperature, washed with 
distilled water, dehydrated in a graded series of 50, 75, 95 and 100% acetone and then 
embedded at 60°C in Epon 812 resin. Thin sections cut at 70-90 mn using a diamond knife 
were stained with 2% uranyl acetate in 50% methanol followed by Reynold's lead citrate, 
and then examined with an electron microscope (Hitachi H500) at 75 kv. 
For estimation of the percentage of encapsulation, a total of 100 mycoplasma cells 
were coimted randomly under the transmission electron microscope for each of the seven 
mycoplasma isolates grown either in MFBM or co-cultured with OFL cells." 
Capsular thickness of the mycoplasma isolates, grown under the different culture 
conditions, was estimated by using a photomicrograph scale marker® on enlarged 
photomicrograph prints following manufacturer's instructions. 
Lectin agglutination. The reactivity of several lectins with the nineteen 
M. ovipneumoniae isolates and the two M. arginini isolates grown in MFBM was smdied 
by a microtiter agglutination test as previously described" with some modifications. 
Briefly, serial two-fold dilutions of the lectins'* (starting concentration of 1 mg/ml) in 25 /zl 
saline were made in 96-well microtiter plates with U-shaped bottoms (Inomulon 1 
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microplates,).' Twenty five fil of a constant amount of each washed mycoplasma suspension 
in saline was added to each well. After mixing, plates were incubated overnight or up to 24 
hours at room temperature. Agglutination was detected visually and the agglutination titer 
of each lectin was recorded as the last dilution causing agglutination. For determination of 
lectin specificity, inhibition of agglutination with various carbohydrates' was assayed by 
mixing 25 fil of a two fold dilution series of 1 % stock sugar solutions with an equal volimie 
of each lectin solution (containing at least 2 agglutinating units). After 15 minutes 
mcubation at 37°C, an equal volume of the mycoplasma suspension was added and the 
reaction was incubated and read. 
Statistical analysis. Estimates of the percentage of encapsulation and those of the 
capsular thickness were analyzed using analysis of variance and differences were 
considered significant when p values < 0.05 were obtained. 
Results 
Electron microscopic evaluation of MFBM-grown M. ovipneumoniae isolate R19 
fixed with glutaraldehyde showed a thin fuzzy layer of material on the surface of all 
mycoplasma cells (Figure 1). In thin sections of the same mycoplasma preparation fixed in 
the presence of ruthenium red or labelled with polycationic ferritin, a large niraiber of 
mycoplasma cells could be observed covered with a dense-staining capsular material 
(Figures 2, 3, 4). Variations in the thickness of the capsule were observed for organisms 
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grown under different culture conditions. Isolate R19 organisms cultured in ovine tracheal 
ring explants had a much thicker capsule when compared to organisms grown either in 
MFMB or co-cultured with OFL cells. At the same time, mycoplasma organisms co-
cultured with OFL cells had a thicker capsule than those grown in MFBM (Table 1, 
Figures 2, 3 and 5). Also, when the different mycoplasma isolates grown in MFBM or co-
cultured with OFL cells were compared, marked differences in capsular thickness were 
observed among them (Table 2). There was no apparent differences in the percentage of 
encapsulation for any isolate when grown either in MFBM or co-cultured with OFL cells. 
However, significant differences in the percentage of encapsulation were observed between 
different isolates when grown ui MFBM or co-cultured with OFL cells (Table 3). 
Following multiple in vitro passages of M. ovipneumomae R19 in MFBM, a marked 
decrease in capsular thickness but not in the percentage of encapsulation was also noted 
(Figure 6 and Tables 2, 3). 
In thin sections of rutheniimi red-stained ovine tracheal ring ciiltures and OFL cells, 
the mycoplasmas appeared to be in close contact with the cilia or the membrane of the lung 
epithelial cells through their capsule (Figure 7). This was in contrast with thin sections 
fixed without ruthenium red where the organisms appeared to be separated from the cells 
(Figure 8). 
Variable reactivity of the M. ovipneumoniae isolates with different lectins was 
observed (Table 4). However, all the isolates reacted strongly with wheat germ agglutinin 
lectin which has specificity for N-acetyl-D-glucosamine residues. Most of these isolates 
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reacted also to a lesser degree with concanavalin-A which binds specifically to D-glucose 
or D-mannose. A few isolates showed low reactivity with phytohemagglutinin 
erythroagglutinin, Pissium sativum agglutinin, Ricinus communis-l agglutinin. Lens 
culimris agglutinin or soybean agglutinin lectins. There was no reactivity with Dolichos 
biflorus agglutinin, peanut agglutinin or phytohemagglutinin leukoagglutinin lectins. 
Neither of the M. arginim isolates was agglutinated by the lectins. Inhibition of 
M ovipneumoniae agglutination was observed with N-acetyl-D-glucosamine, D-glucose and 
D-mannose. Decreased agglutinability of M. ovipneumoniae was observed following 
multiple in vitro passages of the organism in MFBM; however, the lectin specificity was 
not affected. 
Discussion 
To the best of our knowledge, this is the first report of a capsule associated with M. 
ovipneumoniae and the first study that describes strain variation of a mycoplasma species 
based on capsule characteristics. Among the mycoplasma species, several well known 
human and animal respiratory tract pathogens have been reported to produce a capsule. 
These include M. pneumoniae, M. hyopneumoniae, M. dispar, M. gallisepticum, 
M. pulmonis, M. mycoides subps. mycoides and M. pulmonis}'^ As in these previous 
studies, we used positively charged electron dense components such as rutheniimi red and 
polycationic ferritin, which react to acidic polysaccharides on the surface of the organism, 
to demonstrate presence of a capsule on M. ovipneumoniae. The methods gave similar 
49 
resiilts and additional evidence for the expression of a capsule on M. ovipneumoniae was 
obtained by lectin reactivity. 
Multiple in vitro passages of the organism in MFBM decreased significantly the 
thickness of the capsule. In addition, when various isolates were grown in the same culture 
conditions, the resultant capsule was not always equal in thickness, indicating that the 
binding of ruthenium red to the cell surface is unlikely to be mediated by nonspecific 
adsorption of culture medium components on the surface of the organism. These 
observations are in agreement with similar studies conducted on several other mycoplasma 
species.'" 
Growing M. ovipneumoniae under different culture conditions affected the thickness 
of the capsule but not the percentage of encapsulation. For instance, co-culturing the 
organism with OFL cells increased the thickness of the capsule from 13 nm (when grown 
in MFBM) to 26 nm. Likewise, growth in tracheal organ cultures increased the size of the 
capsule to 45 nm. This increase in the capsular thickaess is unlikely due to deposition of 
host cellular components on the surface of the organisms since in the same mycoplasma 
preparations many unencapsulated mycoplasma cells were observed. This variable size 
expression of the capsule imder different culture conditions could be explained, at least in 
part, by the fact that tracheal ring explants mimic the natural environment and the in vivo 
growth of the mycoplasmas more than OFL cells or MFBM. Likewise, OFL cells mimic 
the in vivo conditions more than MFBM. Other workers have reported effects of culture 
conditions on capsule production. Variations in the thickness of the capsule of 
M. hyopneumoniae^ and M. gallisepticim^'^^ have been reported. From their studies, 
Tajima and Yagihashi® reported decreases in the thickness and poor staining of the capsule 
of an in vitro-passaged strain of M. hyopneumoniae. Similar results have also been reported 
for M. pulmonis.^ Cytoadsorptive virulent strains of M. pulmonis have more capsular 
material than strains that have been passaged in vitro until they are no longer virulent. 
These observations have also been described for certain capsule producing bacteria other 
than mycoplasmas.^^ While these observations seem consistent with our findings, we also, 
however, observed that the percentage of encapsulation was not affected by multiple in 
vitro passage and culture conditions. Ahneida and Rosenbusch" reported that the 
percentage of encapsulated M. dispar co-cultured with bovine lung fibroblasts was 
significantly higher than that of MFBM-grown mycoplasmas. These results differ from our 
findings but could be explained by species variation. 
Lectins have been used for detection of carbohydrate residues on the membrane 
surfaces of many microorganisms including mycoplasma species.^ This specific interaction 
of lectins and carbohydrates can also provide some basic information on the sugar 
composition of the capsular exopolysaccharides. In the present smdy, the strong 
agglutination of the M. ovipneumoniae organisms with wheat germ agglutinin lectin 
indicates that carbohydrates containing N-acetyl-D-glucosamine and/or D-glucose and/or 
D-mannose constitute the main sugar residues of M. ovipneumoniae capsule. Despite the 
fact that all the strains that were tested reacted strongly with wheat germ agglutinin, 
marked variable reactivity with other lectins was evident, possibly indicating strain 
variation among the different M. ovipneumoniae isolates. Another possible explanation 
could be the failure of agglutination despite binding of the lectin to cell surfaces. Binding 
of lectins to cell surfaces without agglutination is a well known phenomenon.^' However, if 
that was the case here, the agglutination titers would be expected to be about equally low or 
high for all the lectins when reacted with a single mycoplasma isolate. Consistent with this 
idea is the fact that both the high passage isolate and its parent low passage isolate had the 
same lectin specificity. Strain variation among M. ovipneumoniae isolates has been 
reported previously on the basis of antigenic and DNA analyses Strain variation has 
been predominantly recognized as a mechanism for evasion of the host inmiune response. 
This would not be inconsistent with our earlier findings that lambs namrally infected with 
M. ovipneumoniae had low antibody titers against capsule of the organism (Chapter 5 in 
this dissertation). 
The present experiments suggest that the capsule may have a role in adherence of 
the organism to host cells. In ruthenium red-stained thin sections, the organisms were 
observed in close association with either the cilia or the lung cells through their capsule, 
but when non-stained sections were examined, a gap seemed to separate the organisms 
from the host cells. Direct experimental proof of the role of capsule in the adherence of 
mycoplasmas to host cells has yet to be provided. However, as in the present study, several 
reports of morphological observations have suggested participation of capsule in the 
attachment process of mycoplasma species to host cells.^ "'"® ''' '^ More recently, Young^ et 
al. demonstrated that purified M. hyopneumoniae capsular polysaccharides possess an 
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inhibitory effect on the binding of the organism to swine cilia. In addition, the capsules of 
certain bacteria other than mycoplasmas have also been proposed to mediate their adhesion 
to host cells. 
Participation of capsules in microbial adhesion is relatively controversial because 
they are commonly composed of carbohydrates. Being negatively charged, capsules are 
best known for their repulsive properties, and therefore antiphagocytic activity. Adherence 
is probably a multifactorial event involving both specific and nonspecific mechanisms. 
Specific microbial adhesion is most commonly described as interaction between microbial 
surface proteins (adhesins) and complementary sugar moieties (receptors) on host cells. 
However, in some instances, proteins on the host cells can act as specific receptors for 
other microbial surface components including capsules. The involvement of 
lipopolysaccharide in the adhesion of Actinobacillus pleuropneumoniae to porcine tracheal 
rings has been reported.'^ Human plasma fibronectin has also been shown to bind 
Streptococcus pyogenes via lipoteichoic acid.^° Exopolysaccharide capsules of Pasteurella 
Pseudomonas aeruginoscr^-^ and Streptococcus sui^ have been described as 
imponant components in the adhesion of these bacteria to host cells. There have been 
reports of the presence of a lectin-like material in the lungs of rats.^''-" Based on that, 
Marcus and Baker^' speculated about specific Interactions between host cell lectins and 
P. aeruginosa capsular sugar residues. 
Perhaps the best example that bacterial capsules can act as adhesion molecules is the 
lectinophagocytosis process in which there is phagocytosis of bacteria in the absence of 
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specific serum opsonins. Adherence is mediated by lectins on the phagocytic cell membrane 
that bind specifically to carbohydrate on the bacterial surface. Klebsiella pneumoniae 
undergoes phagocytosis mediated by capsular expolysaccharides which are recognized by a 
specific lectin of macrophages.^^ This would not be inconsistent with the ability of many 
mycoplasma species to adhere to the surface of phagocytic cells, although uptake occurs 
only in the presence of specific antibodies. 
Possible explanations as to how a negatively charged mycoplasma capsule can 
mediate adhesion include the formation of latch effect provided by the multiple binding 
sites as a result of repeating structural components of polysaccharides. In addition, 
enzymes or proteins supposedly bound to or buried in the membranes and arising across the 
extracellular capsule may neutralize the negative charges of the capsule or provide 
important binding sites in negative to negative-charged surface attachment.' It could also be 
speculated, on the basis of the afformentioned lectin reports, that another possible 
explanation would be through specific interaction between capsular sugar moieties and host 
cell proteins (lectins). 
Another suggested role for mycoplasma capsules in pathogenesis is their modulating 
activity on phagocytic cells. Encapsulated M. dispar or its purified capsule was shown to 
depress bovine alveolar macrophage metabolism and suppress phagocytosis of a second 
bacterial target."' Our previous in vitro smdies have demonstrated that M. ovipneumoniae 
organisms have marked effects on characteristics and functions of ovine alveolar 
macrophages."' Whether or not the capsule of the organism has something to do with these 
54 
effects was not investigated at that time but an analogy with M. dispar capsule could be 
implied. 
Results of the present smdy clearly indicate that M. ovipneumoniae produces a 
capsule in which N-acetyl-D glucosamine and probably D-glucose and D-mannose are the 
predominant sugar residues. Although the exact functions of this capsule have yet to be 
clearly defined, the morphological observations suggest its possible association with 
attachment of the organism to the host cells. In addition, variable reactivity of this capsule 
with different lectins may be suggestive of strain variation associated with its expression. 
This may provide a versatile interaction of the organism with its environment as well as a 
means to evade host immune responses. The consequences of all these effects would be 
long term colonization of the host by the organism. It thus appears that expression of 
capsule by M. ovipneumoniae may be related to its pathogenicity. 
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Figure 1. Electron micrograph of Mycoplasma ovipneumoniae grown in modified Friis 
broth medium, unstained. A thin layer of amorphous material is seen on the surface of all 
mycoplasma cells. Bar = 0.5 fim. 

Figure 2. Electron micrograph of Mycoplasma ovipneumoniae grown in modified Friis 
broth medium as for Fig. 1, stained with rutheniimi red. A large number of mycoplasma 
cells are covered with a dense ruthenium red-stained capsular material (C). Bar = 0.5 ^m. 

Figure 3. Electron micrograph of Mycoplasma ovipneumoniae co-cultured with fetal ovine 
lung cells, stained with ruthenium red. A dense ruthenium red-stained capsular material (C) 
is evident outside the limiting cj^oplasmic membrane (CM) of the mycoplasma. Bar = 0.1 
fxni. 

Figure 4. Electron micrograph of Mycoplasma ovipneumoniae grown in modified Friis 
broth medium, labelled with polycationic ferritin. A large number of mycoplasma cells are 
covered with a dense-stained capsular material. Bar = 0.5 (im. 
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Table 1. Estimates of capsular thickness of Mycoplasma ovipneumoniae isolate (R19) 
when grown in modified Friis broth medium (MraM), on ovine tracheal ring explants 
(OTR) or co-cultured in fetal ovine lung cells (FOLC). 
Growth Conditions Mean-Thickness^+.SEM 
MFBM^ 17±2.185 
FOLC^ 30+2.333 
OTR^ 43jil.0{)0 
^Statistically different (p<0.05) from each other. 
Vverage of 3 capsular thickness measurements in nanometers from 3 separate 
experiments. 
Figure 5. Electron micrograph of Mycoplasma ovipneumoniae organisms cultured in ovine 
tracheal ring explants, stained with ruthenium red. Mycoplasma cells are covered with a 
very dense ruthenium red-stained capsular material (C). Bar = 0.1 /zm. 
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Table 2. Estimates of capsular thickness of several Mycoplasma ovipnewnomae isolates 
when grown in modified Friis broth medium (MFBM) or co-cultured with fetal ovine 
lung cells (FOLC). 
Mean-Thickness'^'^+SEM 
Isolates MFBM FOLC 
1-Lomax^ 19+1.000^^* 24-h3.500^* 
2-R19 19-t-0.500^^ 31-f-2.500^'^'^ 
3-R19^ 04+1.000^^^^^ 10+1.500^^^"^ 
4-MLA2 13-1-1.500^^^^ 18±2.000^® 
5-P21 26+3.000^^''^^ 31 + 1.000^"^ 
6-Hill 17+0.500^^ 29-1-0.500^'^ 
7-S6 19Jil.000^^ 20+3.500^^^ 
^Reference strain. 
''Multiple passages in MFBM. 
Values represent average of 3 capsular thickness measurements in nanometers from 
2 separate experiments. 
Significant differences (p < 0.05) between growth in MFBM and co-culturing with 
FOLC for Hill and R19 isolates. 
*Superscript numbers in each column represent differences (p<0.05) among isolates 
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Table 3. Percentage of encapsulated Mycoplasma ovipneumoniae organisms of several 
isolates when grown in modified Friis broth medium (MFBM) or co-cultured with fetal 
ovine lung cells (FOLC). 
Percent Encapsulation 
Isolates MFBM FOLC 
1-Lomax^ 25±1.000^'^^®''* 23 +3.000^'^^^''* 
2-R19 36±0.500^^^ 40±3.500^^^ 
3-RI9'' 28±1.500^^'' 29ii3.500^'^^ 
4-MLA2 39 + 1.000^^^ 37±0.000^^^ 
5-P21 54±3.500^^^'^ 52^0.500^^^"^ 
6-HILL 35±3.500^^ 36±.0.000^^ 
7-S6 33±2.000^^ 36ii0.000^^ 
Values represent mean percentages C+.SEM) of 2 separate experiments. 
^Reference strain. 
'Multiple passages in MFBM. 
•Superscript numbers in each column represent differences (p<0.05) among isolates. 
Figure 6. Electron micrograph of high passage of Mycoplasma ovipneumoniae grown in 
modified Friis broth medium, stained with ruthenium red. A marked decreased in capsular 
(C) thickness is noted when compared with the parent low passage as shown in Fig. 2. Bar 
= 0.5 nm. 

Figure 7. Electron micrograph of a fetal ovine tracheal ring explant infected with 
Mycoplasma ovipneumoniae for 2 days, unstained. Mycoplasama organisms (M) are not in 
close contact with the cilia (CI) and a gap between both membranes are clearly discemable 
(arrow). Bar = 0.5 /tm. 

Figure 8. Electron micrograph of a fetal ovine tracheal ring explant infected with 
Mycoplasma ovipneumoniae as for in Fig. 7, stained with ruthenimn red. The capsular 
material appears to bridge the gap between the mycoplasmas (M) and the cilia (CI). 
Bar = 0.5 ixm. 
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Table 4. Microtiter agglutination of Mycoplasma ovipneumoniae and M. arginini isolates with 
weat germ agglutinin (WGA), concanavalin-A (CONA), phytohemagglutinin erythoagglutinin 
(PHAE), Pissium sativam agglutinin (PSA), Ricinus communis-l agglutinin (RCAI), Lens 
cuUnaris agglutinin (LCA), soybean agglutinin (SBA), Dolichos b^orus agglutinin (DBA), 
peanut agglutinin (PNA), or phytohemagglutinin leukoagglutinin (PHAL) lectins. 
Titers of Agglutination with Different Lectins 
Isolates WGA" CONA' PHAE PSA RCAI LCA SBA DBA PNA PHAL 
LOMAX* 128 128 32 8 0 0 0 0 0 ND' 
R19 >256 64 32 8 4 8 0 0 0 0 
RIQ" 128 32 16 4 4 4 0 0 0 ND 
27 >256 >256 64 16 64 16 0 0 0 ND 
P21 >256 >256 64 32 128 32 0 0 0 ND 
HILL-N >256 >256 >256 16 8 8 0 0 0 ND 
ENESS >256 64 64 8 128 128 2 0 0 ND 
53 >256 64 32 16 32 2 0 0 0 ND 
WL >256 >256 32 8 2 32 0 0 0 ND 
HILL-L >256 64 16 8 128 64 128 0 0 0 
64 >256 128 128 8 0 0 0 0 0 0 
219 128 128 128 8 16 4 0 0 0 0 
764 128 128 16 4 0 0 0 0 0 0 
S6 128 128 4 4 8 0 0 0 0 0 
50 >256 0 0 0 0 0 0 0 0 0 
47 128 >256 32 4 8 8 0 0 0 ND 
288 128 128 32 4 0 0 0 0 0 ND 
2033 128 >256 32 16 32 16 0 0 0 ND 
126 >256 64 64 8 64 2 0 0 0 ND 
221' 0 0 0 0 0 0 0 0 0 0 
WNS' 2 0 0 0 0 0 0 0 0 0 
'Reference strain. 
""Multiple passages in modified Friis broth medium. 
"M. arginini isolates. 
Agglutination was inhibited by N-acetyl-D-glucosamine (1%). 
'Agglutination was inhibited by D-glucose (1%), D-mannose (1 %). 
•Not done. 
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CHAPTER 4. CYTOPATmC EFFECTS OF MYCOPLASMA OVIPNEUMONIAE 
FIELD ISOLATES IN OVINE TRACHEAL ORGAN CULTURES 
A paper to be submitted to the Am J Vet Res 
Mamadou Niang,' MS; Mary C. Debey, DVM, Ph.E)^; Yosiya Niyo,^ DVM, PhD; John 
J. Andrews,^ DVM, Ph.D; Merlin L. Kaeberle,^ DVM, PhD. 
Objective 
To investigate the cytopathic potential of different isolates of Mycoplasma 
ovipneumoniae on ovine tracheal ring explants and factors that contribute to in vitro 
cytopathic effects. 
'Department of Microbiology, Immunology and Preventive Medicine, College of 
Veterinary Medicine, Iowa State University, Ames, lA 50011. 
^USDA, National Animal Disease Center, Ames, lA 50010. 
^Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State 
University, Ames, LA 50011. 
^Veterinary Diagnostic Laboratory, College of Veterinary Medicine, Iowa State 
University, Ames, lA 50011. 
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Samples 
Four isolates of M. ovipneumoniae including a high passaged isolate, and one 
isolate of Mycoplasma arginini were used in this study. 
Procedure 
Ovine tracheal rings were prepared from tracheas of unborn lambs obtained from 
sheep by caesarean section. Tracheal rings were randomly placed in a 12-well tissue culture 
plate (one ring/well) and wells were inoculated with each of the mycoplasmas in M199 
supplemented with 5% fetal calf serum and bacitracin. Tracheal rings were examined every 
over day under an inverted microscope for evaluation of ciliary activity. Infected and 
noninfected tracheal rings were randomly selected at various incubation times for light and 
electron microscopic examinations. Also, samples of spent mediimi from infected and 
noninfected rings were collected at various incubation times for determination of 
extracellular calmodulin content and for presence of hydrogen peroxide. 
Results 
Infected tracheal rings showed significantly decreased ciliary activity as compared 
to the noninfected control rings. There were, however, marked differences between isolates 
in the onset and severity of the effects which correlated with their ability to produce 
hydrogen peroxide. Infected tracheal rings released more calmodulin than the noninfected 
controls. The amount of calmodulin released also varied between isolates and somewhat 
reflected the degree of loss of ciliary activity in the corresponding rings induced by the 
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different isolates. Light and electron microscopic examinations of infected tracheal rings 
revealed disorganization and sloughing of the epithelium, and association of mycoplasmas 
only with the cilia. Following repeated in vitro passages, the organisms had reduced ability 
to inhibit ciliary activity which correlated with decreased hydrogen peroxide production. 
Addition of catalase to the organ cultures delayed loss of ciliary activity. 
Conclusions 
M. ovipneumoniae induced ciliostasis in ovine tracheal ring explants which 
correlated with hydrogen peroxide production. M. ovipneumoniae is an extracellular 
pathogen that colonizes the ciliated epithelium. 
Clinical relevance 
M. ovipneumoniae colonization of respiratory epithelial cells contributes to the 
pathogenesis of sheep respiratory disease. 
Introduction 
M. ovipneumoniae has been routinely recovered from the respiratory tract of sheep 
with respiratory disease worldwide.' Recently, Khan® consistently isolated both M. 
ovipneumoniae and M. arginini from Iambs exhibiting a clinical coughing syndrome. This 
respiratory disease is a major problem in the midwestem states of the United States of 
America due to widespread occurrence in young lambs with resultant predisposition to 
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rectal prolapses, to secondary bacterial pneumonias, and reduction in the rate of gain. 
M. ovipneumoruae can be consistently demonstrated in association with the cilia of the 
upper respirator>' tract of the affected lambs. 
The pathogenicity of M. ovipneimoniae has been extensively studied by 
experimental infection of sheep; these smdies have yielded conflicting results.^ It is 
generally assimied that this may be due to variations in pathogenicity of different strains, 
attenuation during isolation and cloning on artificial medium, and nature of the 
experimental animals. 
Evaluation of the effects of mycoplasma species on tracheal organ cultures is 
another approach to study their pathogenicity since interference with the mucociliary 
clearance mechanism is an important consideration in the induction of respiratory disease.®" 
" In these instances, subjective measurement of ciliary activity, light and electron 
microscopic observations, and measurement of metabolic activities (e.g., calmodulin 
levels, dehydrogenase enzymes, ATP content, and oxygen utilization*-^) have been used to 
assess epithelial cell damage. 
The possibility of hydrogen peroxide (HjOj) or hemolysin produced by several 
mycoplasma species as cytotoxic factors responsible for cellular injiuies is controversial 
because of conflicting reports in the literature. However, there are several lines of evidence 
that suggest correlation between H2O2 production and ciliostasis induced by mycoplasma 
species.'^  " Also, recently published data indicated that both high and low concentrations of 
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exogenous H2O2 alone disrupt airway epithelial cells and inhibit ciliary activity in sheep"* 
as well as in guinea pig** and rat'^  tracheal organ cultures. 
Previous work has demonstrated ciliostasis and loss of cilia caused by 
M. ovipneumoniae and M. arginini in ovine tracheal explants,'® but possible factors and 
variability in pathogenicity related to these cytopathic changes were not reported. The 
purpose of the present smdy was to investigate die cytopathic potential of different isolates 
of Af. ovipneumoniae on ovine tracheal explants for determination of variability in 
pathogenicity among the different isolates of the organism. Factors that could potentially 
contribute to the in vitro cytopathic effects caused by the organisms were also evaluated. 
Materials and Methods 
Mycoplasma isolates. M. ovipneumoniae isolates R19, Hill and MLA2, and M. 
arginini isolate WNS Gow passage) were isolated from pneumonic sheep lungs in this 
laboratory. M. ovipneumoniae R94 (a high passage strain) was derived from the R19 isolate 
by 94 in vitro passages in modified Friis broth medium (MFBM). 
The mycoplasmas were grown in MFBM. Cultures were harvested and washed once 
in phosphate buffered saline (PBS, pH 7.4) by centrifiigation at 10,000 g for 30 minutes at 
4°C. Washed cells were resuspended in PBS, the number of organisms/ml was determined 
by the plate count method and aliquots were stored at -70PC until used. The viability of the 
stock preparation was determined at the time of use in each experiment. 
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Organ cultures. The method of preparation of the organ explants has been fully 
described elsewhere.® Unborn lambs were obtained from sheep by caesarean section. The 
trachea was removed aseptically and placed in sterile M199 medium (M199).'' Comiective 
tissues were trimmed from the outer surface of the trachea and the organ washed with 
M199. The trachea was cut into separate rings and each ring was randomly placed in a well 
in a 12-well tissue culture plates'* containing 0.4 ml of M199s (M199 supplemented with 
5% fetal bovine serum® and 200 /xg/ml of bacitracin). After incubation for 12 hours at 37C 
in 0.5% COj in air, wells were either inoculated with 50 /nl of 1 x l(f colony forming units 
(CFU) per ml of each of the mycoplasma in M199s or M199s alone. Spent medium was 
removed every other day and replaced with fresh M199s until the experiment was 
terminated. The spent medium from each well was cultured for mycoplasmas and other 
bacteria, and was either used immediately for specific assays or frozen at -70'C until 
further usage. 
Evaluation of ciliary activity. Tracheal rings were examined after 12 hours in 
cultures (just prior to inoculation) and every other day after inoculation by using an 
inverted microscope (lOOX or 800X magnification). Treatment ring identity was obscured 
to avoid bias. Quantitation of ciliary activity was determined as previously described.' 
Briefly, the proportion of the ring surface bearing motile cilia (0 to 100%) was multiplied 
by the vigor of ciliary movement (0 to 3+) and these results were expressed as relative 
ciliary activity. 
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Light and electron microscopy. Light and electron microscopic examinations 
were conducted on tracheal rings infected with the M. ovipneumoniae isolate R19 and 
uninfected control rings. Infected and noninfected tracheal rings were randomly selected at 
various incubation times. For light microscopy, rings were fixed in 10% buffered neutral 
formalin, processed by routine paraffin embedding, microsectioned and stained with 
hematoxylin and eosin. Formalin-fixed tissue sections were also examined for the presence 
of M. ovipneumoniae antigen using an indirect immunohistochemical staining procedure 
described elsewhere®. For electron microscopy, rings were fixed with or without ruthenium 
red® at 4°C in 3% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2), processed as 
previously described,® and thin sections were examined by transmission electron 
microscopy (TEM) using a Hitachi H500 TEM at 75 kV. 
Determination of extracellular calmodulin content. Samples of spent mediimi 
firom infected and noninfected rings (in triplicate) collected at various incubation times 
were homogenized in an equal volume of homogenizing buffer (0.25 M sucrose, 0.3 mM 
EDTA, 1 mM 2-mercaptoethanol, pH 7.2).^ The homogenates were centrifiiged at 105,000 
X g for 15 minutes and designated as tissue culture medium (TCM). Prior to calmodulin 
assay, prepared TCM samples were heated at lOCyC for 2 minutes and their protein content 
was determined with a Bio-Rad Protein Assa/ following the manufacturer's instructions. 
The calmodulin content of test samples was assayed by measuring inorganic 
phosphate release from AMP in a calmodulin-activated enzyme cascade described by 
Sharma and Wang" except that, instead of reading the assay tubes in a spectrophotometer, 
a total volume of 200 fd from each tube was transferred in duplicate to individual wells of 
96-well, microtiter flat bottom plates (Immulon)® and read in a microtiter plate reader*" at 
650 nm. The estimation of calmodulin content was made by plotting the absorbance values 
of test samples against a standard curve of known amoimts of purified calmodulin. 
Calmodulin concentrations in fig were calculated with reference to mg protein content. 
Detection of hydrogen peroxide in tracheal ring cultures. The presence of 1^02 
in tracheal ring cultures was determined with the benzidine test of Cherry and Taylor-
Robinson" with some modifications. Benzidine-blood-agar (BBA) plates were prepared 
aseptically by mixing mycoplasma agar base mediirai' with 4% washed sterile sheep red 
blood cells, 100 U/ml of bacitracin and 0.1% benzidine hydrochloride.' 
Spent medium from infected and noninfected rings (in triplicate) collected at 2, 4, 6 
and 8 days postinfection was centrifiiged at low speed for 4 minutes and 100 fil of 
supernatant fluid was placed in wells cut into the BBA plates. Plates were incubated 2 to 4 
days aerobically at 37°C in a humidified container, if necessary overnight at 4°C, and 
examined for presence of black coloration around wells as an indicator of the presence of 
HjOo. 
To determine whether mycoplasma isolates used in this experiment produced HjO,, 
the organisms were actively grown in MFBM, centrifiiged at low speed for 4 minutes and 
100 ^1 of the supernatant fluid was placed in wells cut into the BBA plates. A 30% 
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solution of H2O2' and fresh MFBM were included as positive and negative controls, 
respectively. 
Effect of catalase on benzidine reaction. Actively growing mycoplasma cultures 
in MFBM, a 30 % solution of HjOj or fresh MFBM were placed in wells cut into either 
BBA plates or BBA plates supplemented with 2,000 U/ml of catalas^. The plates were 
incubated and examined for presence of H2O2. 
Effect of catalase on cytotoxicity induced by mycoplasmas. M. ovipneumoniae 
isolate, R19, which caused the most ciliostasis, was chosen for this experiment. Tracheal 
ring explants prepared as before were inoculated with 50 /xl of 1 x IC? of the mycoplasma 
preparation or M199s. To some inoculated rings (triplicate), catalase was added. Ciliary 
activity and HjOj production were determined. 
Results 
Tracheal ring cultures were examined 12 hours after establishment and only those 
rings showing strong ciliary activity were used. All mycoplasma isolates readily grew in 
the tracheal ring cultures and a large number of the organisms could be recovered from the 
spent medium throughout the experimentation (data not shown). Ciliostasis, expressed as 
percent ciliary activity, of infected and noninfected tracheal ring explants is reported in 
Figure 1. Tracheal rings infected with the different mycoplasma isolates showed a 
significant decrease ^<0.05) in ciliary activity at all times postinfection as compared to 
control rings. However, isolates showed marked differences in the rapidity and severity of 
the effects. Tracheal rings infected with isolates R19 or Hill showed a drastic drop in 
ciliary activity within 2 days postinfection which persisted until day 8, when there was 
almost no detectable ciliary activity. In contrast, in tracheal rings infected with isolates 
MLA2, WNS or P94, this decrease was moderate and there appeared to be a small 
recovery at day 6 postinfection, particularly in rings infected with WNS, which is a 
Af. arginini isolate. Rings infected with isolates R19 or Hill had significantiy (p<0.05) 
less ciliary activity at all times postinfection than did rings infected with isolates MLA2, 
WNS or the high passage isolate, exclusive of isolate WNS at day 2. 
The potential for HjOj to be a cause of ciliary damage was the basis for testing for 
this material in the tracheal explant cultures. HjOj was detectable in ring cultures infected 
with isolates R19 or Hill but not in those infected with isolates MLA2, WNS or P94 and 
noninfected control rings. The ability of the different mycoplasma isolates to produce ItO, 
was also tested and only isolates R19 and Hill produced detectable quantities in the assay 
utilized (Figure 2a). Further association between H2O2 production by the mycoplasma 
isolates and their ability to induce loss of ciliary activity was investigated. Extensive in 
vitro passage caused a significant loss of HjO, production associated with a significant 
decrease in the ability of this isolate to induce ciliostasis (Figure 1). Addition of catalase to 
the BBA plate inhibited the benzidine reaction (Figure 2b). Also, addition of catalase to the 
organ cultures delayed significantly the loss of ciliary activity (Figure 3). 
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When infected tracheal ring sections with isolate R19 were observed by light 
microscopy, cellular damage consisting of disorganization and sloughing of the ciliated 
epithelium from the basement membrane was evident by day 2 postinfection. Often, a new 
single layer of low cuboidal to flat epithelial cells with no cilia was observed replacing the 
damaged epithelium at day 8 postinfection. However, this change was not apparent during 
evaluation of ciliary activity. Conversely, control noninfected tracheal ring sections usually 
appeared normal with intact and organized epithelium (data not shown). 
Indirect immimohistochemical staining detected M. ovipneumoniae antigen on the 
ciliated epithelium of infected tracheal ring sections. Positive staining was not observed in 
any other areas of the sections or on noninfected tracheal ring sections. Examination of 
tracheal ring sections using TEM (Figures 4, 5, 6) confirmed the cellular damage in the 
form of loss of epithelium and ftirthermore revealed close association of mycoplasma 
organisms only with the remaining cilia. However, at later stages of the infection, a few 
organisms were observed near the microvilli (Figure 5). No mycoplasmas were found in 
association with the basement membrane, within epithelial cells, or within the lamina 
propria. In addition, attachment of the organisms to the cilia was never observed as being 
mediated by a terminal structure. When stained with ruthenium red, a dense thick layer of 
capsular material was seen not only bridging the mycoplasmas and the cilia but also 
adjacent mycoplasmas in the form of microcolonies (Figure 4). 
Metabolic changes as measured by intracellular calmodulin release are indicated in 
Table 1. With few exceptions, the mean calmodulin concentrations detected in samples of 
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spent medium of the infected tracheal rings were significantly higher (p<0.05) than in the 
medium firom noninfected explants, especially at days 6 and 8 postinfection. Overall, these 
values varied significantly from one isolate to another and reflected the degree of ciliostasis 
induced by each isolate. 
Discussion 
The present study confirmed an earlier report that M. ovipneumoniae induces 
ciliostasis in ovine tracheal ring explants'® and extended our understanding of the in vitro 
colonization process of respiratory epithelium by the organism. We also investigated 
factors that might contribute to pathogenicity and attempted to compare these in vitro 
cytopathic effects on tracheal ring explants with variability in pathogenicity among the 
different isolates of the organism. 
When tracheal rings infected with isolate R19 were examined for histopathological 
changes, cellular damage consisting mainly of disorganization and sloughing of ciliated 
epithelium firom the basement membrane was evident at day 4 postinfection. A new single 
layer of flat epithelial cells without cilia was present replacing the damaged epitheliimi at 
day 8 postinfection. Similar observations have been reported for M. hyopneumoniae-
infected porcine tracheal organ cultures.® While not investigated here, these changes may 
indicate a healing process and suggest that the effects of the HjO, or other toxic factor 
produced by the organism may be reversible. This is supported by the observations of 
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Kobayashi et al." who reported that a low concentratioii of HjOj induced reversible 
damage on ovine tracheal organ cultures. 
Immtmohistochemical staining demonstrated M. ompneumoniae antigens associated 
only with the ciliated epithelium of the infected tracheal rings. Positive staining was not 
observed in any other areas, suggesting that M. ovipneumoniae colonizes only the ciliated 
epithelium. This is in agreement with the observations made by Khan," but contrasts with 
those made by Haziroglu et al.'® who demonstrated the presence of M. ovipneumoniae 
antigens within the epithelial cells with an inmmnoperoxidase technique in pneumonic 
ovine lungs. Further evidence corroborating our findings were observations by TEM which 
showed close association of mycoplasma organisms only with the cilia. No mycoplasmas 
could be seen near or below the basement membrane, although at late stages of the 
infection, a few organisms were noted close to the microvilli. These observations suggest 
that M. ovipneumoniae, like most other mycoplasmas, is not invasive. In addition, when 
tracheal ring sections were stained with ruthenium red, a dense thick layer of capsular 
material was observed bridging the mycoplasma organisms and the cilia, as well as adjacent 
mycoplasmas in the form of microcolonies. Although the exact fimction of mycoplasma 
capsules is not ftiUy known, a role in adhesion of mycoplasma to host cells has been 
suggested.''- '^ 
All mycoplasma isolates induced ciliostasis; however, the various isolates showed 
marked differences in the rapidity and severity of the effects. These differences between the 
isolates was probably not a result of organism concentrations since all the isolates were 
recovered in about equal numbers from the corresponding tracheal ring cultures. 
Differences in ciliostatic activity correlated with the presence of HjOj in the tracheal ring 
cultures suggesting that this material might contribute to pathogenic effects. Since no ftOz 
was detected in noninfected control tracheal ring cultures, it is likely that this ftO, was a 
product of the mycoplasmas. Consistent with this idea was the fact that only isolates R19 
and Hill were found to produce HjOj when grown in MFBM. Extended passage of the 
isolate R19 resulted in a significant loss of HjO, production and ciliostatic activity. 
Further evidence suggesting that H2O2 is a contributor to the ciliostatic effect was 
provided by experiments where catalase was added to the tracheal ring cultures. Catalase 
delayed significantly the loss of ciliary activity induced by the isolate R19. Catalase can 
inhibit effects of HjOj generated by the mycoplasmas since addition of catalase to the BBA 
plate inhibited the benzidine test reaction. 
Hydrogen peroxide has been implicated as a possible factor in inducing host cell 
damage by several mycoplasma species.Additionally, some workers have reported 
that both low and high amounts of exogenous HjOj alone disrupted airway epithelial cells 
and mhibited ciliary activity in sheep" as well as in rat'^  and guinea pig" tracheal organ 
cultures. These studies reenforce the importance of HjOj as a mediator of host cellular 
injuries. 
While our observations are consistent with previous reports, the results also suggest 
that H2O2 production may not be solely responsible for the cytopathic effects. Tracheal 
rings infected with isolates that did not produced detectable quantities of H,02 also had 
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significant decreases in ciliary activity as compared with the noninfected tracheal rings. It 
is possible, however, that these isolates were producing tmdetectable amounts of 
Because of the intimate contact of the organisms with the host cell membrane, production 
of a small amoimt of HjOj by the organisms could result in host cell injuries. Catalase 
production by these isolates, although not investigated in the present study, would be 
another possible explanation. 
There are pathogenic mycoplasmas, like M. hyosynoviae that do not produce 
H202,^ and nonpathogenic mycoplasmas like, Acholeplasma laidlawii, that produce HjO,."® 
Also, other researchers who compared in vivo effects of virulent and homologous 
attenuated strains of M. pneumoniae failed to show a consistent relationship between 
pathogenicity and peroxide production." However, HjOj produced by M. pneumoniae and 
other mycoplasmas can be rapidly destroyed by host catalase activity. Therefore, for the 
H2O2 to exert its toxic effects, either host catalase must be depleted or mycoplasmas must 
adhere close enough to host cell surface to maintain a toxic, steady state concentration of 
H2O2 sufficient to cause direct damage to the cell membrane.^® Similarly, Sobeslavsky et 
al. '^ have suggested a correlation between cytoadsorption and peroxide production in 
association with the pathogenesis of M. pneumoniae. Kahane'" and Almagor et al.^ 
presented evidence that the effectiveness of H2O2 may depend on both the intimate contact 
of the organism with the host cell membrane and production of superoxide anions which 
inactivate host cell catalase, thus permitting the oxidative action of ItOj produced by both 
the organism and the host cells. Furthermore, the importance of attachment in enabling 
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mycoplasmas to deliver their toxic factors, including HjOj, into host cell membranes has 
been stressed by Stadtlander and Kirchhoff.^ 
In addition, other toxic substances produced by some mycoplasmas have been 
implicated in the cytopathic effects on organ cultures. However, once again, the relevance 
of such toxic factors to the cytopathic effects of some of these mycoplasmas for organ 
cultures has yet to be proven. For instance, a toxin has been described for M. bovis;^  ^
however, its relevance to the cytopathic effects of this organism for organ cultures could 
not be demonstrated.'® Recently, Debey and Ross  ^related the cytopathic effects of M. 
hyopneumoniae on porcine ciliated cells to disturbance of normal cell membrane functions 
and excluded the involvement of a diffusible toxin because organisms in indirect contact 
with the tracheal rings through a 0.1 ptm membrane were not capable of inducing 
ciliostasis. Other studies have suggested that proteins associated with the mycoplasma cell 
membrane are the toxic factors responsible for these cytopathic effects. Both M. 
pneumoniae live organisms and membrane preparations induced ciliostasis in organ cultures 
of adult hamster trachea.^  ^Similarly, whole cells and purified membranes of M. 
hyopneumoniae were reported to be cytotoxic for porcine lung fibroblasts.^^ In contrast to 
these reports, however, Hu et al.^ were unable to induce ciliostasis or necrosis in tracheal 
organ cultures treated with M. pneumoniae membranes. 
We observed, on the basis of onset and severity of ciliary activity reduction, that 
there were marked differences between isolates. Since all the isolates were recovered in 
high number fi-om the infected tracheal rings throughout the experimentation, these 
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differences should not be attributed to the number of organisms. Although isolates were not 
conq)ared for histopathological changes, there is reason to believe that strain variations in 
virulence, which is related in this case to H2O2 production, accounted for these differences. 
There are reports in the literature of such variations among different strains of 
mycoplasma species. Stadtlander et al.^^ reported a high degree of heterogeneity in the 
ciliostatic effect of different strains of M. fermentans on rat tracheal organ cultures. 
Levishon et al.' reported similar observations for different strains of M. gallisepticwn on 
chicken tracheal ring cultures. Using equine uterine mbes, Bermudez et al.^® noted 
observable differences of ciliostatic effects between different isolates of M. equigenitalium, 
although these differences were not statistically significant. 
Levinshon et al.' also showed that multiple passages in artificial medium resulted in 
reduced pathogenicity of M. gallisepticum for chicken tracheal ring cultures. More 
recently, Debey and Ross^ reported that ciliostasis induced by M. hyopneumoniae in 
porcine tracheal ring cultures diminished with in vitro passage of the organism. This is 
consistent with our observations but differ from the results reported by Stadtlander et al.' 
who did not find any observable differences of cytopathic potential between a high passage 
M. pulmonis strain and its parent low passage strain. Debey and Ros^ also related their 
results to loss of ability of the organism to colonize host cells. While our data did not rule 
out such a possibility, the experimentation revealed loss of HjOj production by the 
organism. There is one report in the literanire which indicates that a mutant strain of the T1 
vaccine strain of M. mycoides subsp. mycoides (Small Colony) derived by repeated 
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passages, produced reduced amount of and lacked a H202-producing enzyme. 
Interestingly, the strain had reduced pathogenicity. '^ Nicholas and Bashiruddin?" suggested 
that this reduced ability of H2O2 production may partly explain the loss of virulence of the 
organism after either extensive subculture or egg passage. In addition, Lipman and Clyde 
Jr '^ previously reported variations in H2O2 production between different strains of 
M. pneumoniae, although no relationship to virulence or degree of attenuation was found. 
In the present study, all mycoplasma-infected tracheal rings released significantly 
more calmodulin than the noninfected controls. However, significant differences were also 
observed between isolates which reflected the degree of ciliary loss induced by the isolates. 
This somewhat agrees with the results reported by Bermudez et al.^ and contrast with those 
of Debey and Ross.® 
Also in the present study, it was found that M. arginini induced loss of ciliary 
activity in tracheal organ cultures, but the onset was less rapid and the effect was less 
pronounced than those of the M. ovipneumoniae isolates, in particular isolates R19 and 
Hill. These results contrast with those reported by Jones et al.'® who showed that the onset 
of M. arginini was more rapid than that of M. ovipneumoniae. The reason for such 
discrepancy is not known but it may be related to the nature of the isolate used. However, 
our findings were consistent with the previous report in regard to an apparent recovery of 
ciliary activity after the 4"* day of infection of tracheal rings with Af. arginini. 
It is apparent that the spectrum of cytopathic effects induced by mycoplasma species 
in organ cultures is complex, involving diverse and interrelated mechanisms such as 
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attachment, liberation of various toxic factors and enzymes, rate and mode of delivery of 
these toxic factors into host cells, and disturbance of normal host cell membrane functions. 
However, published reports indicate that what is true for one species is not necessarily tme 
for an another closely related species. Our findings suggest diat ability of 
M. ovipneumoniae to induce cUiostasis on ovine tracheal ring explants is related, at least in 
part, to HjOj production. However, factors other than HjO, may be involved. Finally, 
these smdies suggest that M. ovipneumoniae is an extracellular pathogen that colonizes only 
the cilia of the respiratory tract and there is marked variability in virulence. 
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Figure 1. Percent ciliary activity in ovine tracheal rings uninfected (uninfect.) or infected 
with Mycoplasma ovipneumoniae isolates R19, R94, HILL, MLA2 or M. arginini isolate 
WNS. Values represent means percentages (+. SEM) of 2 separate experiments (N = 2-3 
tracheal rings per experiment). 
(a)Significantly different (p<0.05) from control values. 
(b)Significantly different (p<0.05) when R19 or HILL was compared with the remaining 
isolates, exclusive of WNS at day 2. 
Figure 2a. Benzidine reaction of the different Mycoplasma ovipneumoniae isolates (R19, 
R94, Hill, MLA2 and WNS). Isolates were grown in modified Friis broth medium and 
placed in wells cut into the benzidine-blood-agar plates. A 30% solution of HjOz and fresh 
Friis broth medium were included as positive and negative controls, respectively. Plates 
were incubated and examined for black coloration around wells as an indicator of the 
presence of HiOj. 
Figure 2b. Inhibitory effect of catalase on benzidine reaction of Mycoplasma 
ovipneumoniae, grown in modified Friis broth medium. Isolate R19 was grown as for Fig. 
2a and placed, along with a 30% solution of HjOj or fresh Friis broth medium, in wells cut 
mto benzidine-blood-agar plate supplemented with catalase. The plate was incubated and 
examined for presence of black coloration. 
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Figure 3. Effect of catalase (Cat.) on the ciliary activity of ovine tracheal rings infected 
with Mycoplasma ovipneumoniae isolate R19. Values represent mean percentages of one 
experiment (N= 2-3 tracheal rings). 
Uninfect. = uninfected rings. 
Figure 4. Electron micrograph of a fetal ovine tracheal ring explant, after 4 day infection 
with Mycoplasma ovipneumoniae and stained with ruthenium red. The epithelial cells have 
lost cilia and a mycoplasma (M) is seen closely associated with remaining cilia (CI). A 
dense thick layer of capsular material apparently bridges not only the mycoplasma and the 
cilia but also adjacent mycoplasmas in the form of a microcolony. Bar = 0.5 im. 

Figure 5. Electron micrograph of a fetal ovine tracheal ring explant, after 8 day infection 
Mycoplasma ovipneumoniae. Numerous mycoplasmas (M) are among the cilia (CI). A 
few mycoplasmas are seen near the microvilli (mv). No mycoplasmas are found associated 
with the basement membrane or within the lamina propria. Bar = 0.5 /zm. 

Figure 6. Electron micrograph of a noninfected fetal ovine tracheal ring explant, after 8 
day cultivation. Section appears normal with intact and organized epithelium. Bar = 0.5 
Ijm. 
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Table 1. Calmodulin levels in tissue culture medium from uninfected ovine tracheal rings 
and rings infected with Mycoplasma ovipneumoniae isolates R19, R94, Hill, MLA2 or M. 
arginini isolate WNS at 2, 6 and 8 days after inoculation. 
Day after inoculation 
Isolate 2 6 8 
None 1.791Ji0.000 1.229 +0.000 0.840+0.000 
R19 2.738ii0.032 3.274+0.000'' 1.832±0.000'' 
R94 1.8874:0.003 1.684+0.113'"' LSSO+O-OOO"^ 
Hill 2.417+.0.142 2.867±0.003'' 2.010+0.014" 
MLA2 1.338ji0.000 '^' 1.404+0.000^ 1.268+0.363 '^' 
WNS 2.603+.0.001 2.088 +0.011^ 0.386+0.008^ 
Results are means (+SD) from two separate ejqperiments (N = 3 pooled tracheal 
ring spent medium). 
^Significantly lower (p<0.05) than the respective R19 and Hill values. 
''Significantly lower (p<0.05) than the respective WNS value. 
'^ Significantly higher (p<0.05) than the respective control value. 
'^ Significantly lower (p < 0.05) than the respective Hill value. 
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CHAPTER 5. IMMUNE RESPONSE IN LAMBS NATURALLY INFECTED WITH 
MYCOPLASMA SPECIES 
A paper to be submitted to the J. Vet. Diagn. Invest. 
Mamadou Niang, MS; Jose Lopez-Virella, BS; Merlin L. Kaeberle, DVM, Ph.D 
Abstract 
Antigens shared by Mycoplasma ovipneumoniae with other species of mycoplasma 
contribute to difficulty in interpreting serologic results. Cross reactivity ^iih. Mycoplasma 
arginini was confirmed and led to development of a serological test specific for 
M. ovipneumoniae. A crude capsular extract obtained from M. ovipneumoniae was found to 
be specific for detecting antibodies to this microorganism. 
This crude capsular material and sodium dodecyl sulfated-treated M. ovipneumoniae 
and M. arginini cells were used in ELISA tests to evaluate antibody responses to M. 
ovipneumoniae and M. arginini in serum samples of lambs with chronic respiratory 
disease. Sera were obtained firom lambs in several flocks at various stages of the clinical 
disease. There were low levels of antibody to M. ovipneumoniae in flocks sampled at the 
early stages of infection whereas increased levels of antibody were present in lambs from 
flocks that had apparently recovered from the clinical disease. Slowly rising titers of 
circulating antibodies to M. ovipneumoniae was confirmed by sequential bleeding of lambs 
during the course of the clinical disease. On the other hand, antibody levels to M. arginini 
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were more likely to increase earlier in the disease process. The results suggest that the 
chronic nature of this disease may result from the failure of the immune system to produce 
antibodies that are protective against M. ovipneumoniae infection. At such a time that 
appreciable levels of specific antibodies appear in the serum (several weeks following 
infection) lambs seem to recover from the clinical disease. 
Introduction 
M. ovipneumoniae (MO) is one of the most commonly isolated microorganisms 
from sheep with respiratory disease worldwide (Davies, 1985; Malone et al., 1988). 
Recently in this laboratory, this microorganism as well as M. arginini (MA) have been 
routinely recovered from young Iambs with a respiratory disease that we have termed the 
"coughing syndrome" since a severe paroxysmal cough leading to rectal prolapses is the 
primary clinical response. This syndrome is widespread in the midwestem states of the 
United State of America (USA) with morbidity and severity variable among flocks. The 
disease is chronic and persists for several weeks in most affected lambs. There is some 
evidence that the extended persistence of the MO organism in the respiratory tract of these 
lambs and the chronic nature of the disease may be due to failure of the immune system to 
generate protective immunity (Chapter 6 in this dissertation), suggesting that infection with 
the microorganism may have manipulative effects upon the respiratory immune system of 
lambs. Reasons for that are not known but marked variation in the MO organisms isolated 
from sheep (Khan, 1993) and expression of a polysaccharide capsule by the organisms 
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(Chapter 3 in this dissertation) are recognized. This study was undertaken to determine the 
levels of antibodies to MO and MA antigens in the serum of naturally-infected lambs to 
better understand the nature of the immune response against these organisms. 
Because of its simplicity, ELISA has been extensively used in detecting antibodies 
to mycoplasma species. However, concerns exist about its specificity because of cross 
reactions among several mycoplasma species inherent in the nature of antigen preparations 
used (Bereiter et al., 1990). Several attempts have been made to overcome such specificity 
problems by using different methods of antigen preparation (Nicolet and Paroz, 1980, 
Kazama et al., 1989). With regard to MO, Donachie et al. (1982) used solubilized whole 
cell antigens and made the same observations. They concluded that a more specific antigen 
was needed for future use. Consequently, a crude capsular material was extracted from MO 
for use as a diagnostic antigen and confirmed the specificity of this reagent in ELISA and 
western immunoblotting procedures. We were able to distinguish humoral response to MO 
from the response to MA as measured with crude capsular material extracted from MO. 
Materials and Methods 
Animals and sample collection 
Full details of the lambs used and collection of sera and nasal swabs from these 
lambs are described elsewhere (Chapter 6 in this dissertation). 
Hyperimmune sera against MO and MA were raised in horses as described 
elsewhere (Khan, 1993). 
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Preparation of mycoplasma antigens 
MO and MA organisms were grown in modified Friis broth medimn for 3 days at 
37°C (Khan, 1993). Cultures were harvested and washed 3 times m phospliate buffered 
saline (PBS, pH 7.4) by centrifiigation at 10,0(K) g and 4°C for 30 minutes. The protein 
concentration of washed mycoplasmas was determined with a Bio-Rad Protein Assay Kit 
(Bio-Rad Laboratories, Hercules, CA) following the instructions of the manufacturer, and 
aliquots were stored at -70°C. 
SDS-treated MO and MA antigens were prepared by mining the respective washed 
organisms with SDS (1 mg/mg of cell protein) at 37'C for 30 minutes (Piffer et al., 1984). 
These preparations were dialyzed in 0.01 M Tris-NaCl buffer (pH 7.2) for 48 hours, and 
aliquots were stored at -20°C. 
Crude capsular material of MO was prepared according to the method of Almeida 
(1991) with some modifications. Washed MO organisms were incubated in PBS at 5&C for 
30 minutes and centrifuged as before. The supernatant containing the capsular material was 
filtered through a 0.22 fim membrane filter. The protein content of the preparation was 
determined as before and aliquots were stored at -2CPC. Removal of the capsule was 
indicated by a experiment demonstrating that the decapsulated cells could not be 
agglutinated by any of the lectins specific for the organism. 
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Enzyme-linked immunosorbent assay (ELISA) 
Both SDS-treated MO and MA antigens were diluted in carbonate-bicarbonate 
buffer to 6 fig protein/mi. Crude capsular MO antigen was diluted in PBS to 15 fig 
protein/ml. 
One hundred fil of each antigen preparation was coated onto individual wells of 96 
well, flat bottom microtiter plates (Immulon 1, Dynatech Laboratories, Inc., Alexandria, 
VA). The plates were incubated overnight at 4°C. The coated wells were washed 9 times 
with an ELISA wash buffer (0.13 mM sodium chloride, 150 mM potassium phosphate 
dibasic, 320 mM phosphate monobasic, 270 mM potassium chloride and 0.05% Tween 
20, pH 7.2) to remove unabsorbed antigens. Then, 100 fil of ammonium chloride (0.1 M) 
was added to each well to block unreacted sites. After 1 hour incubation at 3TC, the plates 
were again washed 9 times with ELISA wash buffer. One hundred fil of each sheep test 
serum, diluted 1:800 in PBS containing 0.05% Tween 80 and 1% horse serum, was added 
in duplicate to individual wells except for 2 wells in each plate that served as background 
controls. Positive and negative control sera were also included in each plate. The plates 
were incubated 2 hours at room temperature and washed again 9 times with ELISA wash 
buffer. Then, 100 fil of rabbit anti-sheep IgG (H+L) conjugated to horseradish peroxidase 
CBvirkegaard & Perry Laboratories Inc., Gaithersburg, MD, KPL), diluted 1:780 in PBS 
containing 1 % horse serum, was added to each well. The plates were incubated and washed 
as described above. The wells were developed with 100 /tl/well of one component 2.2'-
azino-di 3-ethyl-benzthioazoline sulfonate peroxidase substrate (ABTS, KPL) solution at 
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room temperature for approximately 12 minutes and the reaction stopped by adding 100 nl 
of 1% SDS solution. 
The optical density (OD) values were measmred with an automatic microplate reader 
(Dynatech MR600 microplate reader, Dynatech) at 405 mn. The net OD values of 
individual samples were determined by subtracting the OD value of background wells from 
that of each sample. 
The reactivity of the different antigens against horse hyperimmune serum to each 
mycoplasma was tested as described except that each serum was diluted at 1:200, 1:400, 
1:800 and 1:1600 and incorporation of rabbit normal serum instead of horse normal serum 
in the diluents. Peroxidase labeled goat anti-horse IgG (gamma) (KPL) was used as the 
secondary antibody. 
Western immunoblotting 
Washed MO or MA organisms were adjusted to a final concentration of 1 mg of 
protein per ml with PBS. Crude capsular material of MO was adjusted to a final 
concentration of 4 mg protein per ml. Antigens were separated under reducing conditions 
using 4% stacking gel and 10% running gel (Laemmli, 1970) and a vertical slab mini-gel 
apparatus (Bio-Rad). Prestained SDS-polyacrylamide gel electrophoresis standards (broad 
range, Bio-Rad) were included in each gel as molecular mass standards. The 
electrophoresed proteins along with the molecular mass standards were electrophoretically 
transferred onto 0.45 fxm. pore size nitrocellulose membranes (Bio-Rad) at 4?C for 90 
120 
minutes at 100 volts in transfer buffer consisting of 25 mM Tris, 192 mM glycine (Bio-
Rad, pH 8.3) and 20% v/v methanol. 
The membranes containing the separated proteins were blocked overnight at 4'C with 
1 % gelatin in TBS (500 mM NaCl, 20 mM Tris, pH 7.5). The membranes were 
subsequently washed with gentle agitation 3 times (5 minutes each) in TTBS (TBS 
containing 0.05% Tween 20) and reacted 1 hour at room temperature with the appropriate 
test Iamb or horse sera diluted in diluent solution (TTBS containing 1 % gelatin). The 
membranes were again washed as before and incubated at room temperature for 1 hour 
with gentle agitation in peroxidase-labelled anti species IgG (L+H) antibody (KPL) diluted 
in diluent solution. After washing, one component TMB membrane peroxidase substrate 
solution (KPL) was used for color development. After 10-15 minutes incubation at room 
temperature, the reaction was stopped by rinsing the membranes in deionized water. 
Bacterial examination 
Isolation and identification of mycoplasmas and bacteria of pathogenic importance 
from the collected nasal swabs are ftilly described elsewhere (Chapter 6 in this 
dissertation). 
Results 
The presence of both MO and MA organisms in lambs in the various flocks was 
indicated by the presence of serum antibodies and isolation of the agents from nasal swabs. 
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The results in Table 1 highlight the reactivity of SDS-treated MO or MA antigens, 
or the crude capsular material of MO to horse hyperimmune sera against each organism. At 
various serum dilutions, there was substantial cross-reaction of anti-MA serum with SDS-
treated MO antigen, less cross-reaction of anti-MO serum with SDS-treated MA antigen 
and no cross-reaction of the anti-MA serum with crude capsular material of MO. Several 
convalescent sheep sera reactive to MA antigens were tested for their reactivity against the 
SDS-treated or the crude capsular MO antigens. While these sera possessed reactivity with 
SDS-treated MO, there was no detectable reactivity with capsular MO antigen (Table 2). 
Reactivity of the same antigens with each of the horse hyperimmune sera or the 
convalescent sheep sera was also evaluated with immunoblotting. Each antigen preparation 
reacted with the homologous hyperimmune serum (Figure 1). While several bands 
developed to SDS-treated MO antigen when reacted with anti-MA sera, no reactivity could 
be seen when the crude capsular material of MO was reacted with the same anti-MA sera. 
A few bands were present when SDS-treated MA antigen was reacted with anti-MO 
hyperimmune serum (Figures 1, 2). 
The results of serological testing of lambs from the 10 flocks are provided in Tables 
3, 4, 5. Clinical disease was not evident in two flocks (HD, MY and ESI) at the time of 
bleeding while flocks KP, SN, ES2 and AB were at mid-stage of the disease and only a 
small percentage of lambs was still coughing in flocks HR, MR and RB. While there was 
extensive variability in titers among lambs in each flock, interesting trends were noted. 
Appreciable levels of antibodies to MA were present in lambs without clinical disease. 
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High levels of antibody to MA were present in lambs at the mid-stage of the disease 
process. Low levels of antibody to MO were present in lambs in the miaffected flocks and 
there was only a moderate rise during the first several weeks of clinical disease. However, 
lambs had developed high levels of antibody to MO late in the disease process when most 
lambs had apparently recovered. 
A similar pattern of antibody production to MO and MA was observed when lambs 
in a flock in which the disease is endemic were sequentially bled prior to, during, and after 
the disease process (Figure 3). Many of the Iambs in the flock developed a paroxysmal 
cough at 10 to 12 weeks of age. At that time, the mean antibody levels to both MO and 
MA were relatively low, but antibody levels against MO antigens were lower than for MA 
antigen. As the disease progressed, more lambs seroconverted and the mean antibody levels 
to MO antigens rose dramatically late in the disease process when most lambs had 
apparently recovered at approximately 25 to 27 weeks of age. In contrast, the mean 
antibody levels to MA increased early during the disease process and rapidly declined 
during the recovery phase. Both MO and MA were routinely isolated from nasal swabs 
taken from some of the Iambs in the flock throughout the duration of the experimentation. 
Other bacteria that were frequently isolated from the same samples included N. ovis, 
Pasteurella sp. and Escherichia coli. 
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Discussion 
ELISA and western inmunoblotting performed in the present study indicated 
significant cross-reactivity between the SDS-treated antigens of MO and MA when horse 
hyperimmune sera of each specificity or convalescent sheep sera were tested against these 
antigens. The crude capsular material provided specificity in detecting MO antibodies. 
Cross-reactivity has previously been demonstrated between MO and other species of 
mycoplasmas including M. hyopneumoniae, M. dispar and M. floculare by immunoblotting 
(Thirkell et al., 1991). Cross-reactivity has also been observed with ELISA reactions of 
MO whole ceU antigen solubilized in carbonate-bicarbonate buffer with hyperimmune sera 
of a variety of mycoplasma species (Donachie and Jones, 1982; Thirkell et al., 1991). Such 
cross-reactions would certainly interfere with the specificity of any serological assay, but in 
particular the ELISA. This is particularly important when detecting antibody to MO and 
MA since both organisms frequently coexist in sheep. 
Cross-reactions in ELISA between Af. hyopneumoniae and a nonpathogenic M. 
floculare in pigs (Bereiter et al., 1990) is widely recognized and is a limiting factor for its 
use in the serodiagnosis of mycoplasmal pneumonia of swine. Several attempts have been 
made to overcome this specificity problem in ELISA by using different methods for antigen 
preparation. 
Several workers used purified Tween 20 extracts of M. hyopneumoniae and found 
superior specificity (Nicolet and Paroz 1980; Kazama et al. 1989). These improved ELISA 
antigens have been described as suitable for the practical serodiagnosis of mycoplasmal 
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pneumonia of swine (Yagihashi et al., 1993) and are available in a commercial 
M. hyopneumoniae ELISA test kit. 
Likewise, there was a need to develop a more specific ELISA antigen to assist in 
the detection of mycoplasmal pneumonia of sheep and the crude capsular material described 
here should be smtable as a reliable ELISA antigen in detecting MO specific antibodies. 
We further observed that storage at -20PC for at least 2 years did not affect the activity and 
the specificity of the antigen. 
The results of this experimentation indicated that lambs readily produce antibodies 
in response to MA but the response to MO was delayed. This slow development of 
circulating antibodies to MO could be confirmed by sequential bleeding of lambs during the 
course of the disease. 
There is an apparent failure to generate an immune response to MO that will 
eliminate the organisms fi-om the respiratory tract until late in the clinical disease. At such 
a time that levels of specific antibodies rise in the serum, lambs seem to recover from the 
clinical disease. This finding corroborates our previous observations that infection with the 
microorganism has manipulative effects upon the respiratory system of lambs leading to 
development of aberrant immune responses such as immediate hypersensitivity and ciliary 
autoantibodies during early stages of the disease process (Chapter 6 in this dissertation). 
This view can be further supported by reports of temporary abatement of clinical signs in 
lambs treated with antihistamines early during the clinical disease process (Kaeberle, 
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personal observations) and demonstration of respiratory allergy in association with 
mycoplasmal infection in people (Yano et al., 1994). 
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Table 1. Reactivity in ELTSA of crude capsular material of M. ovipneumoniae (MO-
CAP) and sodium dodecyl sulfate-treated MO (MO-SDS) and M. arginim (MA-SDS) 
antigens against horse hyperimmune serum to each mycoplasma. 
OD Values (+SD) 
Antigens 
Hyperimmune serum Dilutions MO-CAP MO-SDS MA-SDS 
Negative 1 200 0.157+0.040 0.196+0.050 0.135 +0.025 
1 400 0.090+0.020 0.119±0.054 0.111Ji0.030 
1 800 0.054+0.010 0.056±0.033 0.079Ji0.028 
1 1600 0.041+0.010 0.046±0.015 0.075Ji0.025 
Anti-MO 1 200 1.693 +0.221 1.734+0.200 0.497 4i0.155 
1 400 1.535+0.116 1.656+0.162 0.266+l0.029 
1 800 1.400±0.013 1.604+0.135 0.165+0.032 
1 1600 1.177+0.105 1.500+0.104 0.100Ji0.027 
Anti-MA 1 200 0.189+0.091 1.161+0.163 1.735+0.197 
1 400 0.173 +0.044 0.890+0.164 1.590+0.139 
1 800 0.096+0.023 0.544+0.165 1.579+0.164 
1 1600 0.062 +0.013 0.295 +0.074 1.493+0.145 
Values represent mean optical densities (OD) of 3 separate experiments. 
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Table 2. Reactivity in ELISA of various convalescent (S4-352 to S5-560) and negative 
(C1-C3) sheep sera with crude capsular material of M. ovipneumomae (MO-CAP) and 
sodium dodecyl sulfate-treated MO (MO-SDS) and Af. arginini (MA-SDS) antigens. 
OD Values (+SD) 
Antigens 
Serum# MO-CAP MO-SDS MA-SDS 
S4-352 0.084±0.013 0.382 +0.033 0.755+0.014 
S4-359 0.213-^0.008 0.571+0.010 1.190+0.030 
S5-485 0.174+0.001 0.348 +0.005 0.769 +0.009 
S5-560 0.191+0.007 0.390+0.018 0.559+0.043 
CI 0.117+0.005 0.164+0.018 0.168+0.013 
C2 0.087 +0.012 0.112+0.000 0.109+0.016 
C2 0.156+0.014 0.123 +0.003 0.115+0.006 
Values represent mean optical densities (OD) in duplicate wells. 
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Figure 1. Immunoblots of sodium dodecyl sulfate (SDS)-treated Mycoplasma 
ovipneumoniae whole cells (lane 2), crude capsular material prepared from the same M. 
ovipneumoniae organisms (lane 3) and SDS-treated M. arginini whole cells (lane 4) 
developed with horse hyperimmune serum prepared against M. ovipneumoniae (panel A) 
and horse hyperimmune serum prepared against M. arginini (panel B). Lane 1 represents 
molecular mass standards in kDa. Peroxidase-conjugated rabbit anti-horse IgG whole 
molecule was used as a secondary antibody. While multiple bands developed to SDS-
treated M. ovipneumoniae whole cell antigens when reacted with anti-M. arginini serum, 
no staining bands could be seen when the crude capsular material from M. ovipneumoniae 
was reacted with the same anti-M. arginini serum. Staining bands were present when the 
SDS-treated M. arginini antigen was reacted with anti-Af. ovipneumoniae serum. 
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Figure 2. Immunoblots of sodium dodecyl sulfate (SDS)-treated Mycoplasma 
ovipneumoniae whole cells (lane 2), crude capsular material prepared from the same M. 
ovipneumoniae (lane 3) and SDS-treated M. arginini whole cells (lane 4) developed with 
convalescent lamb sera (panels A and B) which were positive by ELISA for both SDS-
treated mycoplasma whole cell antigens but negative for M. ovipneumoniae crude capsular 
material. Lane 1 represents molecular mass standards in kDa. Peroxidase conjugated rabbit 
anti-sheep IgG whole molecule was used as secondary antibody. Multiple cross reactive 
bands developed between the two SDS-treated mycoplasma antigens. However, bands were 
absent or very weekly stained in the crude capsular material from M. ovipneumoniae. 
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Table 3. Antibody levels to sodium dodecyl sulfate-treated M. ovipneumoniae in lambs 
from flocks sampled at different stages of disease. 
Flock # Tested Mean TiterC±SD) Range of Titer Disease Stage 
HD 12 19.496±4.196 11.411-27.500 Early 
MY 12 19.390+5.395 10.847-27.258 Early 
ESI 8 28.757+16.414 13.989-58.199 Early 
KP 20 35.284+9.717 25.021-58.285 Middle 
SN 8 27.932+10.783 14.552-48.266 Middle 
ES2 8 46.142+22.146 16.612-84.239 Middle 
AB 6 42.478+15.430 25.638-69.282 Middle 
HR 15 48.874+25.241 18.606-105.913 Late 
MR 10 35.284±9.717 25.021-58.285 Late 
KB 6 70.380 +20.930 38.783-97.872 Late 
Values represent mean titer expressed in S/P ratios. 
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Table 4. Antibody levels to crude capsular material of M. ovipneumoniae in lambs from 
flocks sampled at different stages of disease. 
Flock # Tested Mean TiterC±SD) Range of Titer Disease Stage 
HD 12 11.573 +4.715 5.508-20.469 Early 
MY 12 18.296+10.181 4.946-38.910 Early 
ESI 8 18.493±12.375 10.086-40.393 Early 
KP 20 25.510+13.752 6.453-57.342 Middle 
SN 8 26.777+12.456 13.433-51.102 Middle 
ES2 8 48.012+24.404 17.088-83.737 Middle 
AB 6 36.547+16.862 18.378-62.312 Middle 
HR 15 56.686iil6.139 29.562-90.069 Late 
MR 10 50.874+21.556 33.696-107.325 Late 
RB 6 62.246+28.201 21.930-98.993 Late 
Values represent mean titer expressed in S/P ratios. 
133 
Table 5. Antibody levels to sodium dodecyl sulfate-treated M. argimni in lambs from 
flocks sampled at different stages of disease. 
Hock # Tested Mean Titer(±SD) Range of Titer Disease Stage 
HD 12 26.100±3.462 22.050-32.264 Early 
MY 12 32.299+12.521 11.153-50.379 Early 
ESI 8 21.515+12.709 12.054-50.8260 Early 
KP 20 53.529 +27.910 14.731-113.342 Middle 
SN 8 40.813jil3.470 18.204-62.611 Middle 
ES2 8 45.223 +9.0603 26.809-56.472 Middle 
AB 6 38.772±13.980 25.647-59.2772 Middle 
HR 15 44.952±24.468 20.109-96.468 Late 
MR 10 35.786iil7.518 12.720-64.292 Late 
RB 6 35.044+13.136 20.530-59.138 Late 
Values represent mean titer expressed in S/P ratios. 
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Figure 3. Antibody levels to M. ovipneumoniae (MO) and M. arginini (MA) in sera of 
lambs in an affected flock. 
(MO-SDS) Sodium dodecyl sulfate-treated M. ovipneumoniae whole cells. 
(MO-CAP) M. ovipneumoniae crude capsular material. 
(MA-SDS) Sodium dodecyl sulfate-treated M. arginini whole cells. 
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CHAPTER 6. OCCURRENCE OF AUTOANTIBODIES TO CILIA IN LAMBS 
WITH A "COUGHING SYNDROME" 
A paper to be submitted to the Vet. Immun. Immunopath. 
Mamadou Niang, MS; Ricardo R. Rosenbusch, DVM, Ph.D; John J. Andrews, DVM, 
Ph.D; Merlin, L. Kaeberle, DVM, Ph.D. 
ABSTRACT 
A respiratory disease of lambs that has been termed the "coughing syndrome" has 
been observed in the mid-west region of the United States of America. Mycoplasma 
ovipneumoniae and Mycoplasma arginini were routinely isolated from the respiratory tract 
of lambs with this disease. Using an enzyme-linked immunoabsorbent assay, a high level of 
antibodies reactive with ovine cilia of the upper respiratory tract was detected in the sera 
from many of the lambs in affected flocks but not in sera of lambs from unaffected flocks. 
The reactivity of these antibodies with cilia was confirmed by indirect immimofluorescent 
staining. These antibodies were predominantly of the IgG isotype. They were distinct from 
cold agglutinins and could be absorbed from the sera with cilia but not with antigens of 
common bacterial pathogens of the sheep respiratory tract including M. ovipneumoniae, M. 
arginini, Pasteurella heamotytica, Pasteurella multocida or Neisseria ovis. In addition, 
their occurrence appeared to be independent from the specific antibodies to M. 
ovipneumoniae and M. arginini. The demonstrated antibodies were determined by Western 
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immunoblottiiig to be directed primarily against antigens with apparent molecular weights 
ofSOkDa. 
One flock from which serial serum samples were collected from the same lambs over 
a ten month period indicated that the antibodies developed before the onset of the clinical 
disease and persisted for a period of several months until most of the lambs had apparently 
recovered. However, colonization of the respiratory tract of the lambs by 
M. ovipneumoniae preceded the production of these antibodies. Sequential serum samples 
taken from another flock, with no known history of this coughing, showed no such 
antibodies throughout the bleeding period. On the basis of these results it is suggested that 
an immunopathologic mechanism involving production of autoantibodies directed against 
ciliary antigens of the lambs could be a contributing factor to the pathogenesis of this 
clinical syndrome. Furthermore, the possible association of mycoplasmal infection with the 
production of these autoantibodies is discussed. 
1. Introduction 
M. ovipneumoniae (MO) has been routinely recovered from the respiratory tract of 
sheep with respiratory disease worldwide (Davies, 1985). Recently, in this laboratory, this 
organism as well as M. arginini (MA) have been isolated from a significant number of 
lambs with a respiratory disease that we have termed the "coughing syndrome" because of 
the nature of its clinical signs which include mainly paroxysmal cough predisposing to 
rectal prolapses and reduced weight gain. This syndrome is widespread in the mid-west 
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states of the United States of America (USA) with morbidity and severity variable among 
flocks. The disease is chronic and persists for several weeks, even months, in most affected 
flocks. MO can be consistently demonstrated in association with the cilia of the upper 
respiratory tract of these affected lambs. While investigating the blocking effect of 
convalescent sera from coughing lambs on the attachment of the agent to ovine cilia we 
noted high reactivity of these sera with ciliary antigens. Thus, it was hypothesized that an 
immunopathologic mechanism involving production of autoantibodies against cilia could 
contribute to the pathogenesis of this disease. 
Autoimmune responses associated with mycoplasmal infection, though overlooked, 
has been known for some time. The occurrence of autoantibodies to various tissue antigens 
has been demonstrated in humans after infection with M. pneumoniae (Biberfield, 1985) 
and in pigs infected withM. hyopneumoniae (Baimigartner and Nicolet, 1984; Roberts and 
Littie, 1970; Suter et al., 1985). A role for autoimmune reactions in the pathogenesis of 
pleuropneumonia in cattle infected withAf. mycoides (Cassell et al., 1985; Nicholas and 
Bashiruddin, 1995), as well as polyarthritis in rats infected with M. arthritidis (Kirchhoff et 
al., 1989; Runge et al., 1990) have been suggested. 
The purposes of the present study were to investigate the occurrence of 
autoantibodies to cilia in sera of lambs with the coughing syndrome and to determine the 
clinical significance of these autoantibodies. 
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2. Materials and methods 
2.1. Animals and sample collection 
Lambs from twenty different sheep flocks around the state of Iowa, USA were 
included in this study. The lambs were of various breeds and most were approximately 10 
to 12 weeks of age when bled for serum during the period of 1989-1995. The disease 
status, as determined on the basis of clinical signs which included nasal discharge, cough, 
prolapses and poor growth, for each flock was recorded at the time of the bleeding by the 
investigators or as reported by the owner or attending veterinarian. In one flock with a 
history of clinical disease, three week-old lambs were sequentially bled and nasal swabbed 
at 2-3 week intervals over a period of approximately 10 months. In a second flock (with no 
observable disease) sequential samples were obtained over an eight-month period. In 
addition, blood samples were taken from nine lambs in another flock with no history of 
clinical respiratory disease and were free of mycoplasmas at the time of bleeding; these 
served to provide reference serum samples. 
Sera were harvested within 24 hours of bleeding and stored at -20'C until tested. 
Nasal swabs were processed immediately for mycoplasmas and bacterial isolation. 
2.2. Preparation of cilia antigen 
Tracheas were obtained from new-bom lambs that either died immediately after birth 
or were sacrificed by intravenous injection of Beuthanasia-D special containing 350 mg 
pentabarbitone/ml (Schering-Plough Animal Health Corp., Kenilworth, NJ). The tracheas 
139 
were immediately exposed and tied below the larynx with a piece of cord and separated 
from the Imigs by cutting at the bifurcation. Connective tissues were removed from the 
outer surfece. Thereafter, tracheas were washed 3 times with sterile M199 medium (Gibco 
BRL, Life Technologies, Inc., Grand Island, NY) and cut into small fragments. For cilia 
extraction and piirificatiou, the methodology of Zhang et al. (1994) originally described by 
Tuomanen et al (1988) was used. The purity of the cilia was determined by light 
microscopy after staining with trypan blue. The protein concentration of the cilia was 
determined by a Bio-Rad Protein Assay Kit (Bio-Rad Laboratories, Hercules, CA) 
following the instructions of the manufacturer, and aliquots were stored at -70PC. 
Sodium dodecyl sulfate (SDS)-treated cilia antigen was prepared by incubating 
purified cilia with SDS (1 mg/mg cilia protein) at 3TC for 45 minutes (Zhang et al., 1994), 
and aliquots were stored at -20°C. 
2.3. Enzyme-linked immunosorbent assay (ELISA) 
2.3.1. Detection of autoantibodies to cilia antigen 
The assay was performed using 96 well, flat bottom microtiter plates (Immulon 2, 
Dynatech Laboratories, Inc., Alexandria, VA). SDS-treated cilia were diluted in carbonate-
bicarbonate buffer (pH 9.5) to a final dilution of 10 /xg/ml. Some wells of the microtiter 
plates were coated overnight at room temperature with 100 [il of the antigen preparation 
while the remaining wells were left uncoated and served as controls. Plates were washed 4 
times with PBS to remove unabsorbed antigen. Then, 200 fil of PBS containing 1 % gelatin 
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was added to each coated or non-coated well and plates were incubated for 2 hours at 37C. 
After 4 washings with PBS, 100 n\ of each test serum, diluted 1:400 in PBS containing 
0.5% gelatin, was added to duplicate cilia-coated or noncoated wells. Positive and negative 
control sera were also included in each plate. The plates were incubated for 70 minutes at 
37°C and washed again 4 times with PBS. Then, 100 ^1 of rabbit anti-sheep IgG (H-l-L) 
conjugated to horseradish peroxidase (Kirkegaard & Perry Laboratories Inc. (KPL), 
Gaithersburg, MD), diluted 1:700 in PBS containing 0.5% gelatin, was added to each well. 
The plates were incubated and washed as described above. The wells were developed with 
100 ^1/well of one component 2.2'-azino-di 3-ethyl-benzthioazoline sulfonate peroxidase 
substrate (ABTS, KPL) solution at room temperatiure for 14 minutes and the reaction 
stopped by adding 100 ptl of 1 % SDS solution to each well. 
The optical density (OD) values were measured with an automatic microplate reader 
(Molecular Devices Corporation, Menlo Park, CA) at 405 nm. The net OD value of each 
serum sample and the positive and negative control sera was determined by subtracting 
from the mean OD value of the serum wells the mean OD value of the corresponding 
background control wells. Then, the serological cut-off for each test serum was determined 
according to the method of Morris et al. (1995) with some modifications. The mean OD 
value for each test serum (S) was divided by the mean OD value of the positive control sera 
(P), the resulting value multiplied by 100, and results were expressed as S/P ratios. Values 
in excess of two standard deviations (SD) from the average S/P ratio values of the nine 
senmi samples obtained from a herd with no known history of coughing, as described 
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earlier, were considered as positive. Thus, seropositive lambs for autoantibodies to cilia 
were defined as those with a S/P ratio greater than 23.822, which is an average S/P ratio of 
14.782 +9.04. 
For absorption of autoantibodies, positive sera containing autoantibodies were diluted 
1:10 in PBS and mixed with 2 parts of a concentrated suspension of either purified cilia or 
various bacterial whole washed cells including MO, MA, P. haemolytica (PH), P. 
multocida (PM) and N. ovis (NO). The mixtures were incubated overnight at 4?C with 
gentle agitation, centrifuged at 48,(XX) g for 30 minutes at 4?C, and the supernatant 
representing the absorbed sera harvested. Antibody activity to cilia, MO and MA antigens 
of absorbed and the corresponding unabsorbed sera was determined by the ELISA. The OD 
values of individual samples were determined by subtracting the OD value of background 
wells from that of each sample. 
2.3.2. Autoantibody isotyping 
Levels of the different immunoglobulin classes of autoantibodies in different positive 
and negative sera were determined by the ELISA protocol described above except that 
backgroxmd controls consisted of both cilia-coated and noncoated wells. Unlabeled rabbit 
anti-sheep IgG heavy-chain specific or IgM-mu chain specific or IgA-alpha chain specific 
antibodies (Bethyl Laboratories, Inc., Montgomery, Tx), each diluted 1:150 were used as 
secondary antibody. Peroxidase-labelled donkey anti-rabbit IgG (H+L, Bethyl 
Laboratories, Inc., Montgomery, TX), diluted 1:2000 was the detecting conjugate. The net 
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OD values of each serum sample was determined by subtracting the mean OD value of the 
background control wells from the mean OD value of the serum wells. 
2.3.3. Detection of specific antibodies to mycoplasmas 
Antigens and protocol used to test for specific antibodies to MO and MA are fiilly 
described elsewhere (Chapter 5 in this dissertation). 
2.4. Detection of cold agglutinins 
Selected positive lambs for autoantibodies, as determined by the ELISA results, were 
bled. Freshly collected sera were tested for cold agglutinins by the method described by 
Baumgartner and Nicolet (1984). 
2.5. Indirect immunofluorescence staining 
Tracheal rings from newborn lambs were either frozen at -70PC in embedding 
mediimi for frozen tissue sections (O.C.T. Compound, Miles Inc., Diagnostics Division, 
Elkhart, IN), sectioned and mounted on polylysine-coated slides, or fixed in 10% buffered 
neutral formalin, processed by a routine paraffin embedding technique, and 
microsectioned. The formalin-fixed tracheal ring section slides were deparaffinized by a 
standard method while the fresh frozen sections slides were fixed with acetone at 4'C for 
10 minutes. 
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For indirect immunofluorescence staining, sections were treated overnight at 4°C with 
an autoantibody-positive or -negative serum, each diluted 1:40 in PBS. After washings 
fluorescein-labelled rabbit anti-sheep IgG (H-f-L, BCPL), diluted 1:20 in PBS, was added 
onto the slides and incubated at room temperature for two hours. The slides were mounted 
in glycerinated PBS (9 parts of glycerol plus 1 part of PBS) and observed under a 
fluorescence microscope. 
2.6. SDS-polyacryiaimde gel electrophoresis and western immunoblotting 
Aliquots of purified cilia, washed MO or MA organisms were adjusted to a final 
concentration of 1 mg of protein per ml with PBS. Antigens were separated under reducing 
conditions using 4% stacking gel and 10% miming gel (Laenunli, 1979) with a vertical slab 
mini-gel apparatus (Bio-Rad). Prestained SDS-PAGE standards (broad range, Bio-Rad) 
were included in each gel as molecular mass standards. The electrophoresed proteins along 
with the molecular mass standards were electrophoretically transferred onto 0.45 ^m pore 
size Immobilon membranes (Millipore, Millipore Corporation, Bedford, MA) according to 
the instructions provided with the product. 
Blocking and subsequent washing and labelling of membranes containing separated 
proteins was as described in the Immobilon Technical Protocol (Millipore, Millipore 
Corporation, Bedford, MA) except that the membranes were blocked for six hours at room 
temperature and reacted overnight at 4°C with the appropriate test sera. Alkaline 
phosphatase-conjugated rabbit anti-sheep IgG (H-l-L, KPL) and alkaline phosphatase 
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membrane substrate solution (BCIP/NBT, KPL) were used as secondary antibody and for 
color development, respectively. 
2.7. Bacteriological eacaiiiiiiation 
Immediately after collection, nasal swabs were placed in tubes containing brain heart 
infusion broth without antibiotics for transport to the laboratory. Ten-fold serial dilutions 
were made in modified Friis broth medium culture, and the mycoplasmas isolated and 
identified as described previously (Khan, 1993). All the nasal swabs were also streaked 
onto 5% blood agar and McConkey's agar plates for isolation and identification of bacteria 
of pathogenic importance. 
3. Results 
While investigating the potential of convalescent sera to block attachment of MO to 
ovine cilia (unpublished data), we noticed high reactivity of these sera with the cilia 
antigen. This apparent presence of antibodies to cilia was tested by developing an ELISA 
utilizing purified cilia firom newborn lambs as the antigen. Specificity of this ELISA was 
determined in preliminary experimentation by reactivity of various sera including sheep 
sera that were either positive or negative to MO and MA, horse anti-MO and anti-MA 
hyperimmune sera, and convalescent swine serum positive to M. hyopneumoniae (courtesy 
DR. R.F. Ross, Veterinary Medical Research Institute, College of Veterinary Medicine, 
Iowa State University, Ames, LA). Among the different sheep sera tested, some were 
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positive while others were negative irrespective of their reactivity against the mycoplasma 
antigens (Table 1). In addition, neither of the horse sera nor the swine serum reacted with 
the cilia antigen. Further testing of sera of lambs in several flocks indicated the prevalence 
of these autoantibodies (Table 2). The results also indicated that these autoantibodies were 
present in sera of many lambs in affected flocks but not in sera of lambs in unaffected 
flocks. 
The apparent association between the presence of autoantibodies and the development 
of the clinical disease led to investigation of the time of appearance and persistence of the 
autoantibodies. Sequential serum samples from lambs in two separate flocks, one in which 
the disease has occurred annually and the other with no history of the disease, were tested. 
Lambs were initially bled at three weeks of age and a paroxysmal cough developed at 10-12 
weeks of age in one group of lambs whereas no clinical evidence of respiratory disease was 
noted in the second flock throughout the duration of the experimentation. While all lambs 
in the diseased flock lacked detectable autoantibodies at 3 weeks of age, a few lambs were 
positive at the second bleeding (five weeks of age) and additional lambs seroconverted and 
the mean autoantibody levels increased at each bleeding until the seventh bleeding at 
approximately 15-17 weeks of age. This level was maintained imtil the 11'*' bleeding and 
then significantly declined when most lambs had apparently recovered fi:om the clinical 
disease (Figure 1). The percentage of positive lambs also steadily increased at each 
bleeding until almost 90% of the lambs had seroconverted at the ll"* bleeding and then 
declined significantly after the n"" bleeding when most lambs had apparently recovered 
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from the clinical disease (Figure 2). The autoantibodies were detected prior to the onset of 
clinical disease; however, MO was isolated from nasal swabs from some of the lambs 
before the detection of autoantibodies. MA was also isolated from lambs in the same flock, 
but not until the mid-point of the experimentation. In contrast, lambs in the healthy flock 
had an undetectable level of autoantibodies in their serum throughout the duration of the 
experimentation (Figure 3). Although both MO and MA were recovered from Iambs in the 
healthy flock, this was inconsistent and late in the course of the experimentation. Other 
bacteria that were frequently isolated from both flocks included NO, PH, PM, Escherichia 
coli and Klebsiella sp. 
Reactivity of these autoantibodies with the ovine cilia was demonstrated by indirect 
immunofluorescence with either frozen or formalin-fixed trachea and lung tissue sections 
obtained from newborn lambs. Strong fluorescence was present when sections were treated 
with serum from coughing lambs and ELJSA-positive for autoantibodies (Figure 4). This 
fluorescence was strongly localized to the basal bodies of the cilia. In contrast, no 
fluorescence was observed on any part of the surface epithelium of the sections treated with 
serum from normal lambs or ELISA-negative serum (Figure 4). Sera containing 
autoantibodies were tested by immunoblotting for their reactivity against the cilia antigen. 
The results indicated that the predominant reactivity of the autoantibodies was with a 
molecule having an apparent molecular weight of 50 kDa (Figure 5). A few weakly 
staining bands with apparent moleciilar weights higher or lower than the 50 kDa were also 
present. 
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The potential cross-reactivity of the ciliary autoantibodies with antigens of common 
bacterial pathogens including MO, MA, Pasteurella sp and NO, was investigated with 
absorption studies. Autoantibody positive sera were absorbed with the various agents or 
cilia and the absorbed sera along with their corresponding nonabsorbed sera were tested by 
EUSA. Results are shown in Table 3. Cilia antigen markedly reduced levels of 
autoantibodies in all sera. Bacterial whole cells did not influence reactivity with cilia while 
reducing significantly levels of antibodies specific to these organisms. Strain variation is 
recognized among different MO isolates and that could be related to a specific cross-
reactive antigen with the cilia. To rule out such a possibility, several sera containing 
autoantibodies were absorbed with different MO isolates, but no significant reduction in the 
ciliary autoantibody activity was observed when these absorbed sera were tested against the 
cilia antigen (Table 4). Cross-reactivity of the autoantibodies with mycoplasma antigens 
was also evaluated with an immunoblotting assay utilizing cilia and mycoplasma antigens. 
Two bands that developed to MO antigen indicated antigens with a very similar molecular 
weight to the 50 kDa component in cilia antigen (Figure 6). However, absorption of these 
sera with cilia antigen removed or reduced significantly the intensity of the 50 kDa band in 
cilia antigen but not the reactivity with MO antigen. Also, absorption with MO antigen 
removed reactivity for MO but not for the cilia antigen. 
Potential cross-reactivity was evaluated further by testing a group of sera with 
autoantibodies for antibodies to MO and MA. Marked variations were noted in the 
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reactivity of these sera with some being positive while others negative for one or both 
mycoplasma organisms (Table 1). 
Determination of the isotypes of the autoantibodies indicated that these autoantibodies 
were predominantly of the IgG class (Figure 7). However, low levels of IgM and traces of 
IgA could also be demonstrated in these sera. The type of antibody did not seem to change 
with time as indicated by testing a pool of sequential serum samples positive for 
autoantibodies (Figure 8). 
4. Discussion 
A respiratory disease of lambs that we have termed the coughing syndrome continues to be 
a major problem in the mid-west states of the USA. The major clinical feamres in lambs 
affected with the disease are a paroxysmal cough leading to rectal prolapses and poor 
weight gain. We have found that a high percentage of lambs with the disease have a high 
level of antibodies in their serum that react with cilia of the upper respiratory tract. These 
antibodies can be regarded as autoantibodies and probably contribute to the disease process. 
Association of viruses with this disease is unlikely on the basis of evidence available, 
including absence of serological responses in paired serum samples to several common 
sheep viruses during outbreaks of the disease and absence of histopathological lesions 
consistent with viral infections (unpublished observations). On the other hand, previous 
studies in this laboratory indicate prevalence and possible association of mycoplasmas, in 
particular MO, with the disease process (Khan, 1993). 
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An autoinumine response to various tissue antigens associated with mycoplasmal 
infection has been described in humans (Biberfeld, 1985), in cattle (Cassell et al., 1985; 
Nicholas and Bashiruddin, 1995), in pigs (Suter et al., 1985; Baumgarter and Nicolet, 
1984; Roberts and Litfle, 1970) and in rats (Runge et al., 1989; BCirchhoff, et al., 1990). 
Therefore, occurrence of autoantibodies seems to be a rather common finding in 
mycoplasmal infection. However, opinions differ about their clinical relevance during the 
development of the disease, and there are suggestions that such antibodies result from a 
nonspecific inflanmiatory response. 
This experimentation clearly demonstrated that autoantibodies to cilia develop during 
the course of a respiratory disease in lambs and possibly contribute to the disease process. 
The results indicated a high level of autoantibodies in the sera of many lambs in the 
affected flocks but not in sera from the imaffected flocks. This clearly suggests a 
correlation between presence of autoantibodies and occurrence of the clinical disease. This 
was confirmed by clinical observation and serologic smdies on lambs in two separate 
flocks. Fortunately, many lambs in the flock with history of the disease developed the 
clinical disease at 10-12 weeks of age, which is the usual age when the disease starts. 
Lambs in the second flock remained healthy throughout the duration of the 
experimentation. Sequential serum samples taken from the two flocks showed a high level 
of autoantibodies in the serum of lambs in the diseased flock but not in serum of lambs in 
the healthy flock. Interestingly, the mean autoantibody levels in these lambs rose before the 
start of the clinical disease, persisted for a period of approximately 8 weeks and 
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significantly declined when most lambs had apparently recovered jfrom the clinical disease. 
MO was isolated from the nasal swabs of these lambs prior the appearance of the 
autoantibodies. Therefore, based on the circumstantial evidence presented here, it is 
tempting to suggest that colonization of the respiratory tract of young Iambs by MO and 
maybe MA modulates the immune response of lambs resulting in the production of 
autoantibodies against the cilia, leading to inflammation. 
However, this view is apparently inconsistent with the finding that both MO and MA 
were also isolated from the lambs in the normal flock. Isolation of MO from the respiratory 
tract of normal lambs has been reported previously (Bakke and Nostvold, 1982; Bakke, 
1982; lonas and Mew, 1985), but as in the present study, the isolation rate in these normal 
animals was inconsistent and not overwhelming. In addition, our study showed isolation of 
the organism from the normal lambs was possible only in the latter stages of the 
experimentation. Therefore, it would be arguably possible that early and massive 
colonization of the respiratory tract of lambs is necessary for the events that lead to 
development of autoimmunity. Massive colonization of the upper respiratory tract of lambs 
by MO shortly after birth has been demonstrated (Jones, et al., 1979) and suggested to play 
a potentiating effect on the future development of lung lesions in young lambs (Bakke and 
Nostvold, 1982). Other explanations could be strain variation or environmental factors as 
has been suggested (Bakke and Nostvold, 1982, lonas and Mew, 1985; lonas et al., 1991); 
marked variation in the MO organisms isolated from sheep is recognized (Khan, 1993). In 
any event, it seems that the ability to elicit autoantibody production may be linked to the 
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differences in pathogenicity of the agent, the background of the lambs, and perhaps the 
environment. This may also partially explain the difficulties encountered when trymg to 
reproduce the clinical disease. 
The results suggest that these autoantibodies are not cross-reactive with antigens of 
several cormnon bacterial pathogens of the sheep respiratory tract since they could be 
absorbed from the sera with cilia but not with MO, MA, PM, PH or NO whole cells. 
Additional evidence comes from the observation that presence of these autoantibodies did 
not correlate with MO or MA specific antibodies. In fact, when the sequential serum 
samples taken from lambs in the diseased flock were tested for presence of specific 
antibodies to these mycoplasmas (data to be reported elsewhere), it was noticed that the 
autoantibodies were present long before the appearance of these specific antibodies. Based 
on this difference in time of appearance, it is likely that autoantibodies to cilia and specific 
antibodies to the mycoplasmas are distinct populations. The present observations are 
consistent with those made by Neu et al. (1987) who showed by absorption and serum 
neutralization tests that autoantibodies to heart myosin were not cross-reactive with 
Coxsackie-virus B3 which has been implicated in the induction of autoimmune disease 
including myocarditis in hmnans. Also, tissues autoantibodies that are not cross-reactive 
with Af. pneumoniae have been reported to occur in people following infection with the 
agent (Lind et al., 1988; Biberfield, 1985). However, we recognize that our data do not 
completely exclude the possibility of shared epitopes between the cilia and the bacteria 
examined here. The observations also do not exclude the possibility that there are other 
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autoantigens in addition to cilia. As Neu et al. (1987) suggested, one way to explore this 
question is by production of monoclonal antibodies to cilia and to the organisms 
Several mechanisms have been proposed to explain the occurrence of 
immunopathological responses during microbial infections. Among these, molecular 
mimicry and nonspecific polyclonal B-cell activation have been emphasized. Alternatively, 
the possible induction of autoimmime response as a consequence of aberrant expression of 
MHC molecules on recognized antigen presenting cells, or on cells that normally do not 
present antigen such as epithelial cells, during infection has been suggested. The relevance 
of this theory is indicated by several autoimmune conditions in which abnormal expression 
of HLA class n molecules by specific cells of the target organs has been demonstrated 
(Bottazzo et al., 1986; Smith and Allen, 1992). More recently, the in vitro upregulation of 
MHC molecules on macrophages by several mycoplasmas has been demonstrated and 
proposed to be responsible of the generation of autoimmune pathology (Stuart et al., 1989; 
Smart et al., 1990). Therefore, it is highly conceivable that during infection of lambs with 
MO and MA there is concurrent activation of alveolar macrophages, increase in MHC 
antigen expression on these macrophages, and local tissue damage, induced by the 
organisms. This inappropriate expression of MHC antigens may enable these macrophages 
to present self antigens to autoreactive T cells during their attempt to eliminate the 
organisms as well as the damaged tissues. Thus the sequence of the events that lead to the 
clinical disease in these lambs infected with the mycoplasmas may have been early and 
massive colonization of the respiratory tract during the early age, ciliostasis with 
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concurrent activation of alveolar macrophages and direct or indirect aberrant MHC 
antigens expression on these cells. The consequences of all this would be the potential for 
self antigen presentation to autoreactive T cells leading to autoimmunity. Indeed such a 
scenario has already been postulated for mycoplasmal infections by Stuart et al. (1990). 
Experimental evidence for similar suggestions have also been provided by Neu et al. (1987) 
in heart-specific autoantibodies induced by Coxsackie-virus B3 in a murine model. A 
second likely scenario would be inappropriate expression of MHC antigens by the epithelial 
cells, in particular ciliated cells, which enables these cells to present their own surface 
antigens to autoreactive T cells, therefore by-passing the requirement for antigen presenting 
cells as has been reported in several organ-specific autoimmune diseases (Bottazo et al., 
1986). 
Polyclonal B and T cell activation by several mycoplasma species has also been 
demonstrated and suggested as mechanisms for development of autoimmimity. While the 
possibility exists that MO or MA organisms are mitogenic for B and T cells, the present 
fmdings imply a role for T-cell help in the production of these autoantibodies since they 
belong predominantly to the IgG class. While some level of IgM antibody was present, an 
increasing level of IgG but not IgM was evident when sequential sera from positive lambs 
were isotyped. In addition, unlike cases of M. pneumoniae infection in human, these 
autoantibodies are distinct from cold agglutinins (Data not shown). However, as we pointed 
out before, this does not rule out the possibility of cross-reaction with other tissues as has 
been demonstrated in M. pneumoniae infection (Biberfeld, 1985). 
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Another fundamental question that needs to be addressed here is how the 
autoimmunity contributes to disease? An inq)ortant aspect of pathologic consequences of 
autoimmunity is the formation of immune complexes with potential activation of 
complement. The inflammatory processes that arise from the complement activation include 
cellular cytotoxicity, but most importantly, at least in our case, could be the generation of 
anaphylatoxic fragments that possess various important biological activities including 
degranulation of mast cells and basophils. While it is apparent that IgE is the primary 
mediator in triggering mast cell and basophil degranulation, otiier immunoglobulin classes 
may also contribute through activation of complement. 
Apart from complement activation, simple binding of an autoantibody to its target 
autoantigen can affect the host cells through several mechanisms including induction of 
signal transduction across host epithelial cell membranes with possible physiological effects 
on biologically active molecules (Sell, 1987). Other potential allergic airway reaction 
mediators include arachidonic metabolites that could act on mast cells or basophils. For 
instance, activated macrophages are known to release a variety of inflammatory mediators 
which in turn initiate the activation of membrane-bound phospholipase A2 (PLA2) in mast 
cells or basophils and a variety of other target cells, leading to release of prostaglandins, 
leukotrienes and platelet activating factor (Pruzanski and Vadas, 1991). Alternatively, 
soluble PLA2 can be released extracellularly from a variety of activated cells including 
macrophages and exert their pro-inflammatory effects through reactive oxygen radicals 
(Pruzanski and Vadas, 1991). Therefore, since there is potential for immune complex 
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formation during the stage of autoimmuniQ^, and macrophages are known to have receptors 
that interact with boimd IgG in soluble immune complexes (Levy et al., 1991), it is not 
unreasonable to think that uptake of these inomune complexes by the macrophages would 
activate and induce release of a variety of inflammatory products including soluble PLA2 
which in turn initiate the activation of membrane-bound PLA A2 of different lung cell 
types. Indeed, there are experimental reports in guinea pigs which support such a 
possibility (Al-Laith et al., 1993). Additionally, Pruzanski and Vadas (1991) reported 
release of soluble PLA2 from activated macrophages isolated from the lymph of sheep and 
from mouse and rabbit peritoneal exudate. 
The possibility also exists that IgE-mediated hypersensitivity may be involved in the 
pathogenesis of this syndrome as has been suggested in asthmatic patients infected with M. 
pneumoniae (Tipimeni et al., 1980). More recently, Yano et al. (1994) found also high 
level of IgE specific to M. pneumoniae in the serum of an asthmatic patient and suggested 
involvement of IgE-mediated hypersensitivity. The authors speculated on the possibility 
that the production of these M. pneumoniae-s^tciSic IgE may arise from epitopes that are 
cross-reactive with components of the airway. Whether some of the autoantibodies 
demonstrated here belong to IgE class or whether MO elicits production of specific or 
cross-reactive IgE class antibodies in these lambs was not determined due to lack of 
specific reagent. However, oiu- previous smdies have demonstrated marked immediate skin 
reaction to intradermal injection of MO antigen in many of the coughing lambs 
(unpublished observations). In any event, it is very tempting to speculate that development 
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of aberrant inunune responses associated with the mycoplasmal infection is the contributing 
factor for the pathogenesis of Uiis clinical syndrome. 
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Table 1. Reactivity of various sheep sera (S1-S13), anti-M. ovipneumomae 
hyperimmune horse serum (H-MO), anti-ilf. arginini hyperimmune horse serum (H-
MA) and anti-Af. hyopneumoniae convalescent swine serum (SW) with ovine cilia, 
AT. ovipneumomae (MO) or M. arginini (MA) antigens. 
Serum# 
EUSA Value (OD) 
Cilia MO MA 
SI 1.780 0.090 0.174 
S2 1.968 0.151 0.153 
S3 1.281 0.182 0.723 
S4 1.068 0.174 0.769 
S5 0.185 0.198 1.907 
S6 1.180 1.487 0.162 
S7 1.852 2.068 1.926 
S8 1.996 1.085 0.726 
S9 1.947 0.402 0.452 
SIC 0.144 0.198 0.077 
811 0.143 0.187 0.098 
S12 0.112 0.790 1.043 
S13 0.308 1.179 0.398 
HS-MO 0.097 1.336 0.168 
HS-MA 0.104 0.094 1.591 
SW 0.123 - -
Values represent mean optical densities (CD) in triplicate wells. 
(-)Not tested. 
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Table 2. Occurrence of ciliary autoantibodies (AA) in sera of Iambs in different flocks. 
Flock of Origin Mean AA Titers 
(S/P Ratio) 
Positive Lambs Disease Status 
NC 12.175 0(8)* -
VR 13.149 0(13) -
IFl 46.23 14(16) + + 
IF2 12.025 0(7) -
ES 21.297 2(9) + 
MY 45.025 17(22) + + 
KP 32.554 7(10) + + 
KR 30.328 8(10) + + 
LD 21.712 3(9) + 
m 33.665 4(10) + + 
AM 34.420 5(5) + + 
ER 32.145 4(9) + + 
HR 40.493 7(10) + + 
GN 43.469 5(10) + + 
MC 33.426 10(10) + + 
SK 50.824 7(8) + + 
VL 20.712 1(10) -
SN 42.783 3(6) + + 
HN 20.233 3(10) + 
HL 13.223 0(8) -
•Numbers in parenthesis indicate total lambs sampled per flock. 
(-)Absent. 
(+)Mild. 
(++)Severe. 
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Figure 1. Mean ciliary autoantibody (AA) levels in sera of lambs in an affected flock 
during the course of the clinical disease (N = 16-20 lambs for each bleeding). 
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Figure 2. Percentage of lambs with ciliary autoantibodies in an affected flock during the 
course of the clinical disease (N = 16-20 lambs for each bleeding). 
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Figure 3. Antibody levels to ovine cilia in sera of lambs in flock with and without clinical 
disease (N = 16-20 and 5 lambs for each bleeding period, respectively). 
Figure 4. Indirect immunofluoscence of formalin-fixed trachea and lung sections from a 
new bom lamb treated with serum firom coughing lambs and ELISA-positive for 
autoantibodies (A) or with serum from normal lambs and ELISA-negative for 
autoantibodies (B). 
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Figure 5. Immunoblots of ovine cilia antigen developed with different convalescent sheep 
sera and ELISA-positive for autoantibodies (lanes 2, 3), serum firom normal Iamb and 
ELISA-negative for autoantibodies (lane 4) and serum as in lane 2 but absorbed with cilia 
antigen (lane 5). Lane 1 represents molecular mass standards in kDa. Alkaline phosphatase 
conjugated rabbit anti-sheep IgG whole molecule was used as a secondary antibody. The 
autoantibody-positive sera reacted predominantly with a molecule having an apparent 
molecular weight of 50 kDa. 
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Table 3. Reactivity of sera with cilia, Mycolasma ovipneumoniae (MO) or M. 
arginini (MA) antigens following absorbtion with cilia, MO, MA, Neisseria oyds 
(NO), Pasteurella multocida (PM) or P. haemofytica (PH) antigens. 
OD values 
Serum# Absorbent Cilia MO MA 
S5-595 None 1.773 1.085 0.726 
Cilia 0.283 0.869 0.839 
MO 1.645 0.358 0.710 
MA 1.639 0.858 0.087 
NO 1.643 - -
PM 1.744 - -
PH 1.590 - -
S5-557 None 1.026 0.338 0.294 
CUia 0.222 0.229 0.195 
MO 0.705 0.135 0.185 
MA 0.859 0.458 0.070 
NO 0.913 - -
PM 0.963 - -
PH 1.024 - -
S5-561 None 1.677 0.621 0.595 
Cilia 0.161 0.485 0.476 
MO 1.114 0.198 0.325 
MA 1.239 0.349 0.066 
An ELISA was used to determine the serum activity before and after absorption with each 
of the indicated antigens. Values represent mean optical densities (OD) in duplicate wells. 
(-)Not tested. 
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Table 4. Reactivity of sera with cilia following absorption with different Mycoplasma 
ovipneumoniae (MO) isolates. 
Serum# 
OD values 
None MO (R88) MO (G76) MO (R19) 
S5-557 1.046 0.786 0.749 0.827 
S5-561 1.296 1.219 1.165 1.077 
S5-572 0.763 0.679 0.644 0.713 
S5-574 1.036 1.076 1.017 0.931 
S5-595 1.585 1.446 1.578 1.098 
An EUSA was used to determine the serum activity to cilia antigen before and after 
absorption with each of the indicated isolates. Values represent mean optical densities 
(OD) in duplicate wells. 
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Figure 6. Determination of cross-reactivity of the ciliary autoantibodies with mycoplasma 
antigens using an immmioblotting assay. (A) convalescent serum and ELISA-positive for 
autoantibodies was reacted with ovine cilia (lane 2), sodiimi dodecyl sulfate (SDS)-treated 
Mycoplasma ovipneumoniae Qane 3) and SDS-treated M. arginini (lane 4). The same 
convalescent serum absorbed with cilia antigen (B) or with Af. ovipneumoniae antigen (C) 
was reacted with the same antigens as in A. Lanes 1 represent molecular mass standards. 
Alkaline phosphatase conjugated rabbit anti-sheep IgG whole molecule was used as a 
secondary antibody. One band that developed to M. ovipneumoniae antigen indicated a 
molecule with a very similar molecular weight to the 50 kDa component in cilia antigen. 
However, absorption with the cilia antigen did not remove reactivity with the band in M. 
ovipneumoniae antigen. Likewise, absorption with M. ovipneumoniae did not remove the 
band in cilia antigen. 
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Figure 7. Levels of different immunoglobulin (Ig) classes of ciliary autoantibody in 
positive and negative sera. Values represent mean optical densities (OD) C±SEM) of 2 
separate experiments (N = 4 positive or negative sera). 
*(p<0.05) when mean OD values of positive sera were compared with that of negative 
sera for each Ig class. 
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Figure 8. Measurement of different immunolglobulin classes of ciliary autoantibody in sera 
of lambs during the course of the clinical disease. Values represent mean optical densities 
(OD) from a pool of two sera at each bleeding. 
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CHAPTER 7. GENERAL CONCLUSIONS 
A chronic respiratory disease of lambs that we have termed the coughing syndrome 
continues to be a major problem in sheep flocks in the mid-west states of the United States 
of America. The clinical disease is mainly characterized by a severe paroxysmal cough that 
contributes to a reduced rate of gain and predisposes to secondary bacterial pneumonias and 
rectal prolapses. Initial experimentation suggested prevalence and possible association of 
mycoplasmas, in particular M. ovipneumoniae, with outbreaks of the disease (Kaeberle and 
Eness, 1988; Eness etal., 1990; Niang, 1992; Khan, 1993). Consequently, our 
experimentation has concentrated on the potential role of the mycoplasmas in the 
pathogenesis of the disease which seems to be very complex. Although infection and limg 
lesions can be induced by intratracheal exposure of lambs to live M. ovipneumoniae, we 
have not been able to routinely reproduce the clinical syndrome. However, this failure 
cannot be accepted as a basis for dismissing the causal relationship. Fulfillment of Koch's 
posmlates has been difficult to achieve with mycoplasmas even with M. mycoides subsp. 
mycoides, the most pathogenic of mycoplasmas (Gourlay and Howard, 1982; Stalheim, 
1983; Cassell et al., 1985). 
In assessing the etiological significance of such microorganisms, suggestions have 
been made to look for evidence relative to their ability to produce certain factors that may 
be suggestive of pathogenic potential, or their ability to cause damage to any host tissue, or 
their ability to manipulate the elements of the host immune system (Gourlay and Howard, 
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1978; Gouriay and Howard, 1982). Consequently, we have undertaken investigations 
aiming at identifying M. ovipneumoniae specific factors or components that may contribute 
to its disease producing potential. This led to demonstration of a polysaccharide capsule on 
the microorganism and possible role of this capsule in the colonization process of ovine 
respiratory ciliated cells by the organism. N-acetyl-D-glucosamine and probably D-glucose 
and D-mannose are the predominant lectin-reactive sugar residues of this capsule. Also, 
extensive strain variation among isolates of the microorganism was associated with the 
reactivity of the capsule with different lectins. Expression of a polysaccharide capsule by 
mycoplasmas can be suggestive of virulence since only those species that are proven 
pathogens are known to express such a component structure. A positive correlation 
between increased capsule production, ability to attach to host cells, and perhaps to 
colonize the host respiratory tract has been suggested for several respiratory mycoplasma 
pathogens (Wilson and Collier, 1976; Allan and Pirie, 1977; Taylor-Robinson et al., 1981; 
Tajima et al., 1982; Tajima and Yagihashi, 1984). In addition, mycoplasma capsules have 
been reported to lack immunogenicity (Bansal et al., 1995), to interfere with phagocytosis 
and killing of a second bacterial target by phagocytic cells (Almeida et al., 1992), and to 
have toxic effects (Nicholas and Bashiruddin, 1995). More recently, evidence of a direct 
involvement of mycoplasma capsules in the adherence of the organisms to host cells has 
been reported (Yoimg et al., 1996). It is quite possible, therefore, to imply that expression 
of a capsule by M. ovipneumoniae may be related to its pathogenicity. 
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The second part of this work examined the cytopathic effect of Af. ovipneumordae on 
ovine tracheal ring cultures. It was found that M. ovipneumoniae induced loss of ciliary 
activity in these tracheal organ cultures. There were marked differences between isolates of 
the microorganism in the onset and severity of the effects which correlated with their 
ability to produce hydrogen peroxide. In vitro passages decreased hydrogen peroxide 
production and this also correlated with diminished ability of the organisms to induce 
ciliostasis. These findings suggest that the ability of M. ovipneumoniae to induce ciliostasis 
on ovine tracheal ring explants is related, at least in part, to hydrogen peroxide production, 
although this does not rule out a role for other factors. The mucociliary clearance 
mechanisms of the mucosal surfaces play an important role in the host defenses by trapping 
and propelling infectious agents along these surfaces. Therefore, this adverse effect of 
M. ovipneumoniae on tracheal ciliary movement has implications for pathogenic properties, 
as has been suggested for several mycoplasma respiratory pathogens (Gabridge et al., 
1974; Levishon et al., 1986; Stadtlander et al., 1991; Debey and Ross, 1994). Presence of 
M. ovipneumoniae organisms or antigens associated only with the ciliated epithelium of the 
infected tracheal rings was detected by transmission electron microscopy and histochemical 
staining, respectively. This suggests thatM. ovpneumoniae, like many other respiratory 
mycoplasma pathogens, is not invasive and colonizes only the ciliated epithelium. 
The third part of this work was related to the characteristics of the immune responses 
associated with the mycoplasmal infection in lambs with this clinical syndrome. It was of 
interest to conduct a serological study to gain a better understanding of the nature of 
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specific iimnune response against the mycoplasmas. However, substantial cross-reaction 
between M. ovipneumoniae and a variety of mycoplasma species has been recognized 
(Donachie and Jones, 1982; Thirkell et al., 1991) and been a liniiring factor in the 
development of a reliable serological test, which could be used in serodiagnosis of 
mycoplasmal pneumonia in sheep. Therefore, our efforts originally focussed on 
overcoming such a cross-reaction. A crude capsular material prepared from 
M. ovipneumoniae organisms was used as antigen in an ELISA system and was found to be 
more specific in detecting M. ovipneumoniae antibodies than the conventional whole cell 
antigens. Results from this serological investigation revealed a somewhat interesting 
observation that the specific response to M. ovipneumoniae in lambs with the clinical 
disease is delayed and associated with the recovery phase. This suggested that infection 
with the microorganism has a manipulative effect upon the respiratory system of lambs and 
could result in development of aberrant immune responses as has been demonstrated in 
M. pneumoniae infection in himians (Tipimeni et al., 1980; Biberfeld, 1985; Yano et al., 
1994). Also, this idea was supported by the fact that, when investigating the blocking effect 
of convalescent sera from Iambs with the disease on the attachment of M. ovipneumoniae to 
ovine cilia, high reactivity of these sera with the cilia was noted. 
By the application of ELISA, IFA and western immunoblotting, we were able to 
demonstrate the occurrence of autoantibodies to cilia in the sera of many lambs in affected 
flocks but not in sera of lambs from unaffected flocks. These autoantibodies were 
predominantly of the IgG isotype and seemed not to be cross-reactive with antigens of 
177 
common bacterial pathogens of sheep respiratory tract including the mycoplasmas. These 
observations could imply a role for T-cell help in the production of these autoantibodies. 
Interestingly, sequential serum samples taken firom one flock in which the disease has 
occurred annually indicated that these autoantibodies developed before the onset of the 
clinical signs, persisted for the duration of the clinical disease, and significantly declined 
during the recovery phase when levels of specific antibodies to M. ovipneumoniae 
increased. Although evidence for the involvement of the autoantibodies in the pathogenesis 
of the disease remains debatable, their relevance, based on the circumstantial evidence 
presented here, merits special attention. 
Investigations into possible mechanisms to explain the occurrence of the 
autoantibodies indicated a significant increase in MHC antigen expression on sheep 
alveolar macrophages induced by both M. ovipneumoniae and M. arginini. This 
upregulation of MHC antigens may enable the macrophages to present self antigens to auto­
reactive T cells during their attempt to eliminate the organisms as well as the damaged host 
cells produced during the ciliostasis event. The in vitro upregulation of MHC molecules on 
antigen presenting cells by several mycoplasma species has recentiy been demonstrated and 
proposed to be responsible of the generation of autoimmune pathology (Smart et al., 1989; 
Stuart etal., 1990). 
Furthermore, we initiated limited experimentation to investigate the possibility of 
involvement of an immediate hypersensitivity in the pathogenesis of this clinical syndrome. 
This was based on reports of temporary abatement on clinical signs in lambs treated with 
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antihistamines (Kaeberle, personal commumcations) and also demonstration of respiratory 
allergy in association with mycoplasmal infection in people (Yano et al., 1994). Results 
from this study indicated a marked, immediate skin reaction when lambs with the clinical 
disease were tested for their skin reactivity to M. ovipneumoniae antigens. 
Based on the information gathered in the different experiments of this smdy, the 
following hypothesis as to the possible role of M. ovipneumoniae, and maybe M. arginini, 
in the pathogenesis of the respiratory infection in lambs is suggested. Mediated by the 
polysaccharide capsule, there is massive colonization of the respiratory tract of lambs by 
the mycoplasmas during the very early age. It is assumed that shortly after infection, the 
toxicity of the hydrogen peroxide produced by mycoplasmas causes ciliostasis with massive 
local cellular necrosis. Also, there is a concomitant activation of alveolar macrophages and 
increased MHC molecule expression on these macrophages. Since activated macrophages 
are not specific in their phagocytic functions they would engulf local damaged tissues in 
their attempt to eliminate the mycoplasmas. The inappropriate expression of MHC 
molecules may enable these macrophages to present self antigens to auto-reactive T cells. 
The logical consequences of all this would be production of auto-reactive antibodies leading 
to inflammation. Also, there is additionally the suggestion of involvement of an immediate 
type hypersensitivity as another contributor to this clinical syndrome. 
We do recognize that numerous aspects concerning the present model need 
clarification. Additional experimentation should be directed at purification and chemical 
characterization of the polysaccharide capsule for fimctional activities. Another study that 
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may help would be to deteimine how MHC molecule expression is modulated by the 
mycoplasmas. Also, evidence of immune complex and complement deposition in Imig 
tissues from lambs with the clinical disease warrants investigation. 
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APPENDIX A. ASSOCIATED OBSERVATIONS: EXPRESSION OF MHC CLASS I 
AND n ANTIGENS ON SHEEP ALVEOLAR MACROPHAGES 
Abstract 
Experiments were conducted to investigate the modulation of sheep alveolar 
macrophage MHC molecule expression by Mycoplasma ovipneumoniae and Mycoplasma 
arginini, isolated from lambs with respiratory diseases. Macrophages were cultured alone, 
or in the presence of live or heat killed organisms, and reacted with anti-MHC class I or 
class n monoclonal antibodies followed by labelling with fluorescein- or R-phycoerythrin-
conjugated second antibody. Fluorescence measurements indicated substantial increases in 
the expression of both MHC classes by the mycoplasma-induced macrophages when 
compared with the control unstimulated macrophages. Live mycoplasmas were more 
effective in inducing expression of both MHC classes than killed mycoplasmas. This ability 
of mycoplasmas to upregulate the expression of MHC molecules may result in increased 
ability of the macrophages to present self antigens to autoreactive T cells. This mechanism 
may be a contributing factor in the pathogenesis of disease induced by these organisms. 
Short Communication 
Autoimmune responses associated with mycoplasmal infection, although overlooked, 
have been known for some time (Biberfield, 1985; Baumgartner and Nicolet, 1984; 
Kirchhoff et al, 1989; Runge et al, 1990; Rosendal, 1994). We have recently demonstrated 
the occurrence of autoantibodies to cilia in the sera of lambs with a respiratory disease 
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associated with mycoplasmal infection (Chapter 6 in this dissertation). These 
autoantibodies, based on absorption studies, seemed not to be cross-reactive with antigens 
of several common bacterial pathogens, including M. ovipneumoniae and M. arginini, 
isolated from the respiratory tract of these lambs. Thus, the possibility that the production 
of these autoantibodies could arise as a consequence of immunomodulatory effects induced 
by the mycoplasmal infection was raised. 
Studies on infection and autoimmunity have emphasized antigenic epitopes shared by 
the pathogen and the host, and polyclonal B-cell activation, as the possible mechanisms 
contributing to inamunopathological responses. Alternatively, the possible induction of an 
autoimmune response as a consequence of aberrant expression of MHC molecules on host 
cells has been suggested. In support of this theory, several mycoplasma species have been 
reported to upregulate the expression of MHC molecules on macrophages (Stuart et al., 
1989; Stuart et al., 1990) and were proposed to be responsible for the generation of 
autoimmime pathology. 
The purpose of this smdy was to investigate the effect of M. ovipneumoniae and 
M. arginini, isolated from lambs with a respiratory disease, on the expression of MHC 
molecules on normal sheep alveolar macrophages. Findings might explain a possible 
immimological relationship between mycoplasmal infection in lambs and the production of 
the autoantibodies to cilia. 
M. ovipneumoniae and M. arginini, isolated from lung tissues of a lamb with 
respiratory disease, were grown in modified Friis broth medium (Khan, 1993). Cultures 
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were harvested and washed twice in phosphate buffered saline (PBS, pH 7.4) by 
centrifugation at 10,000 g for 30 minutes at 4°C. Washed organisms were resuspended in 
PBS and aliquots were stored at -70°C. 
Details of methods for collection and culturing sheep alveolar macrophages have been 
fully described elsewhere (Niang, 1992). Briefly, bronchial lavage of whole normal lungs 
obtained from freshly slaughtered Iambs was performed by infusing 500 ml of sterile warm 
PBS containing heparin and antibiotics into the lungs through the trachea. Lungs were free 
of mycoplasmas as attested by bacterial culture of tracheal swabs taken deep into the 
trachea just before the lavage. The obtained lavage fluid was filtered through a double layer 
of cheesecloth, washed by centrifugation, and cultured in flasks in RPMI1640 medium 
(Sigma Chemical Co., St Louis, MO) supplemented with 10% fetal calf serum (FCS) and 
antibiotics. The flasks were incubated overnight at 37C in a 5% CO2 himudified 
atmosphere to allow macrophages to adhere. The medium was removed from the flasks to 
eliminate nonadherent cells. Fresh mediimi was added and flasks were reincubated for an 
additional 24 hours. At that time, the adherent macrophages were harvested from the flasks 
by using 0.2% trypsin (Difco Labs., Detroit, MI). The number of macrophages was 
coimted in a hemocytometer and their viability when checked by trypan blue exclusion was 
greater that 95%. 
Two himdred ^1 of the macrophage suspensions in RPMI 1640 medium without 
antibiotics at a concentration of about 1 X 10^ cells per ml were placed in each well of a 
96-weIl, flat bottom sterile microliter plates (Coming Glass Works, Coming, NY) in the 
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presence or absence of live or heat killed preparations of each mycoplasma to give a 
macrophagermycoplasma ratio of about 1:50. After an incubation of 1 or 2 days, the 
medium was removed from the wells and macrophages were fixed with cold acetone for 5 
minutes and washed 3 times (5 minutes each) with warm Hanks balanced salt solution 
without phenol red (HBSS, Sigma Chemical Co., St. Louis, MO) containing 5% FCS. All 
subsequent washes were performed in this manner, and all dilutions were made in the same 
HBSS. 
For the fluorescence assay, 100 /zl of anti-mouse class I and class U monoclonal 
antibodies species cross-reactive (VMRD, Inc., Pullman, WA), each diluted at 1:100, were 
added to an individual well. After an incubation of 90 minutes at 37'C, the plates were 
washed, and labelled with 100 lA of either fluorescein-conjugated (BCirkegaard & Perry 
Laboratories Inc., Gaithersburg, MD) or R-phycoerythrin-conjugated (Sigma Bio Sciences, 
St. Louis, MO), goat anti-mouse antibody (IgG gamma-chain specific) diluted at 1:50 and 
1:11, respectively. After incubation and washing, the plates were read in a fluorometric 
microtiter plate reader (Cambridge Technology Inc., Watertown, MA) at appropriate 
excitation and emission filter wavelengths for each fluorochrome. Results were reported as 
fluorescent values. Comparisons were made between values of unstimulated control 
macrophages and those of mycoplasma-induced macrophages, or values of live 
mycoplasma-induced macrophages and those of heat killed mycoplasma-induced 
macrophages. To rule out nonspecific binding, several background control wells were 
included in each plate. These consisted of wells with mycoplasmas or unstimulated 
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macrophages, reacted with each of the secondary conjugated antibodies alone in the case of 
the macrophages, or with each of the monoclonal antibodies and the secondary conjugates 
in the case of the mycoplasmas. 
Fluorescent values of the background control wells were quite similar to those of 
empty wells in each plate, suggesting that nonspecific binding of the reagents was 
reasonably minimal. Of the two conjugates used, R-phycoerythrin appeared to be the most 
sensitive. Therefore, results were concentrated on the fluorescence meastirements with the 
R-phycoerythrin conjugate. In a separate experiment, unstimulated macrophages were 
cultured on Teflon-coated microscope slides (Cel-line, Newfield, NJ), and monolayers 
were subsequently reacted with the monoclonals and the fluorescein conjugate and 
examined under a fluorescence microscope. The number of fluorescent cells in the 
monolayers that had been reacted with the anti-class I antibodies was far greater than that 
in the monolayers reacted with the anti-class n antibodies (data not shown). This suggests 
that the level of MHC class I expression on normal sheep alveolar macrophages could be 
higher than that of class n. Also, great variation in the intensity of the positively stained 
cells was noticed between cells reacted with each monoclonal, suggesting that the extent of 
expression of both classes may vary between individual cells. 
Although there was a noticeable increase on the expression of both classes when 
macrophages were stimulated by the mycoplasmas, the rate of induction differed markedly 
depending on the mycoplasma species (Tables 1 and 2). Live M. ovipneumoniae organisms 
induced a rapid increase in both class I and class n molecules. That rise was more than a 
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onefold increase at day 1 as compared with levels of expression on respective unstimulated 
macrophages. By day 2, however, expression was decreased, in particular for class I, to a 
level below that of unstimulated controls. In contrast, mayitnal induction of both MHC 
classes by M. arginini was at day 2. Also, there was an indication that live M. 
ovipneumoniae and M. arginini organisms, at all times, were more effective in inducing 
expression of both classes than killed organisms. 
The data in this report on the ability of M. ovipneumoniae and M. arginini to 
positively influence MHC molecule expression on sheep alveolar macrophages could 
account for our previously observed prevalence of autoantibodies to cilia that develop 
during the course of a respiratory disease in lambs infected with these organisms (Chapter 
6 in this dissertation). That production of these autoantibodies was the result of molecular 
mimicry or nonspecific polyclonal B-cell activation was imlikely. This was based on our 
failure to absorb these autoantibodies from sera with antigens of several common bacterial 
pathogens of the sheep respiratory tract including the mycoplasmas and the fact that they 
predominantly belong to the IgG class. It is likely, therefore, that their production may 
arise as a consequence of immunomodulatory effects induced by the mycoplasmal infection 
as demonstrated in this study. 
A direct relation between the increased ability of macrophages to present antigen and 
an increased level of MHC molecule expression on these macrophages has been reported 
(Ziegler et al., 1984). However, defective macrophage antigen presentation associated with 
the reduced expression of MHC class U antigens has also been reported (Ayala et al.. 
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1990). In view of this, it could be argued that uncontrolled expression of these molecules 
on antigen presenting cells could also lead to autoantigen presentation as suggested in the 
present study. The in vitro upregulation of MHC molecules on macrophages by several 
mycoplasmas including M. arginini, M. arthritidis, M. pulmonis, M. hominis and 
M. fermentans, has been reported and suggested to be responsible of the generation of 
autormmime pathology (Stuart et al., 1989; Stuart et al., 1990). 
Based on the aforementioned reports, and on our previous experiments (Chapters 3-6 
in this dissertation) and on the results presented herein, we suggest the following pathologic 
events that lead to development of immunopathological responses observed in lambs in 
association with mycoplasmal infection, in particular M. ovipneumoniae. These include 
massive colonization of respiratory tract of young lambs during their very early age by the 
mycoplasmas, probably with the aid of a polysaccharide capsule. It is assumed that shortly 
after infection, the toxicity of hydrogen peroxide produced by the organism causes 
ciliostasis with massive local cellular necrosis. Also, there is a concomitant activation of 
alveolar macrophages and increased in the expression of MHC molecules on these 
macrophages. Since activated macrophages are not specific in their phagocytic functions, in 
their attempt to eliminate the mycoplasmas they would take up local damaged tissues. As a 
result of the high level of MHC expression on these cells, self antigens are presented to 
autoreactive T lymphocytes. The logical consequences of all this would be production of 
auto-reactive antibodies leading to inflammation. 
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Table 1. Effects of Mycoplasma ovipneumoniae (MO) and Mycoplasma arginini (MA) 
on expression of MHC class n on sheep alveolar macrophages. 
Ruorescence values 
Day Treatment Experiment 1 Experiment 2 Experiment 3 Average* 
Control 729 634 776 713.000 
MO-Live 2163 1824 2133 2040.000 
MO-HK 1419 1148 1409 1325.333 
MA-Live 1455 1400 1472 1442.333 
MA-HK 1274 1114 1291 1226.333 
Control 358 288 506 384.000 
MO-Live 643 493 719 618.333 
MO-HK 388 361 486 411.667 
MA-Live 1156 948 706 936.667 
MA-HK 885 681 566 710.667 
Macrophages were cultured alone (control), or in the presence of live or heat killed (HK) 
mycoplasma organisms. After 1 or 2 days incubation, macrophages were reacted with 
anti-MHC class n monoclonal antibodies followed by labeling with R-phycoerythrin 
conjugated second antibody. 
* Average values of the 3 separate experiments. 
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Table 2. Effects of Mycoplasma ovipneumoniae (MO) and Mycoplasma arginim (MA) 
on expression of MHC class I on sheep alveolar macrophages. 
Ruorescence values 
Day Treatment Experiment 1 Experiment 2 Experiment 3 Average* 
Control 2094 1726 2023 1947.667 
MO-Live 3972 3055 4046 3691.000 
MO-HK 2377 1945 2466 2262.667 
MA-Live 2432 1786 2477 2231.667 
MA-HK 2173 1816 2270 2086.333 
Control 1324 959 1197 1160.000 
MO-Live 1189 942 1099 1076.667 
MO-HK 897 721 1079 899.000 
MA-Live 2018 1563 1230 1603.667 
MA-HK 1560 1274 1574 1469.333 
Macrophages were cultured alone (control), or in the presence of live or heat killed (HK) 
mycoplasma organisms. After 1 or 2 days mcubation, macrophages were reacted with 
anti-class I monoclonal antibodies followed by labeling with R-phycoerythrin conjugated 
second antibody. 
* Average values of the 3 separate experiments. 
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APPENDIX B. ASSOCIATED OBSERVATIONS; TYPE I HVPERSENSmVITY IN 
LAMBS WITH COUGHING SYNDROME 
Summary 
Lambs from two flocks with a chronic respiratory disease characterized by 
paroxysmal cough and rectal prolapses were tested for their skin reactivity to Mycoplasma 
ovipneumoniae (MO) and M. arginini (MA) antigens (Ags). There was a marked, 
immediate skin reaction to intradermal injection of MO Ag in many of the tested lambs. 
Some of these positive lambs also reacted to MA Ag. Phosphate buffered saline (PBS) used 
as a negative control gave no skin reaction in any of the tested animals. In addition, 
simultaneous serological tests revealed low antibody levels against MO and MA. However, 
both agents could be routinely isolated from nasal swabs of the affected Iambs. There is 
reason to suspect that an immediate type hypersensitivity to MO Ag and perhaps to other 
allergens that develops in association with the mycoplasmal infection contributes to this 
coughing syndrome. 
Brief Report 
M. ovipneumoniae has been routinely recovered from the respiratory tract of sheep 
with respiratory disease worldwide. Recently, in our laboratory. Khan (1993) also 
consistently isolated both MO and MA from lambs with a coughing syndrome. This 
respiratory disease is a major problem in Iowa and neighboring states due to widespread 
192 
occurrence in young lanabs predisposing to rectal prolapses and secondary bacterial 
pneumonia, as well as reducing the rate of gain. 
The mechanisms of pathogenesis of MO infection in sheep still remain unclear. 
However, we believe that an immediate type hypersensitivity to the organism contributes to 
the clinical sjoidrome. This was based on reports of temporary abatement of clinical signs 
in lambs treated with antihistamines (Kaeberle, personal communication) and also 
demonstration of respiratory allergy in association with mycoplasmal infection in people 
(Yano et al., 1994). Production of IgE antibodies specific for the allergen dimng the 
infection is responsible for the allergic reactions involving mast cells or basophils. 
Diagnosis of an allergy is usually based upon detection of specific IgE antibodies or 
immediate skin reactions following intradermal injection of the allergen. 
Since an antibody specific for sheep IgE is not available the only suitable means of 
allergy diagnosis in sheep is skin testing. This is a classical test that has been widely used 
for indirect demonstration of IgE antibodies specific for allergens. Our objective was to 
investigate the immediate skin reactivity of lambs with coughing syndrome to MO and MA 
Ags as a demonstration of allergic respiratory disease in these animals. 
Coughing lambs in the Iowa State University McNay sheep research farm or 
purchased from the same flock (Table 1) and housed in our facilities were utilized for this 
experimentation. These lambs were approximately 10 to 12 weeks of age and of mixed 
breeding. As Ags, cultures of MO and MA organisms were washed, sonicated and diluted 
to 5 ixg protein/ml. Lambs were injected intradermal on the inside of the thigh with 0.1 ml 
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of each Ag preparation and PBS as a control preparation. To improve the observation of 
the skin reaction, some animals were injected intravenously with 5 ml of a suspension of 
0.5% Evans blue just before testing. The sites were observed for at least 30 minutes for 
development of blue stained wheals indicative of positive skin reactions. In lambs which 
were not injected with Evans blue, development of a wheal and flare response (swelling, 
redness) was considered as a positive skin reaction. Reactions were graded on the basis of 
size as a moderate reaction of 5-10 mm diameter (1 +) and a strong reaction of 10-25 mm 
diameter (2+). 
Also, sera collected from the lambs were tested with an ELISA using sodium dodecyl 
sulfate (SDS)-treated MO and MA organisms and capsular material of MO as Ags. 
The results of the skin tests on animals originating at McNay farm are shown in 
Table 1. There was an immediate skin reaction in about 56 % (19/34) of the lambs injected 
with MO Ag, whereas only 29 % (10/34) reacted to MA Ag. All the lambs that were 
positive to MA Ag reacted also to MO Ag. This response usually began within 5 minutes 
after injection and reached its maximum within 30 minutes. Although some of the wheals 
lasted for more than 6 hours, no induration at the site of injection was observed at 48 hours 
post-injection indicating absence of delayed hypersensitivity. 
ELISA tests conducted on serum of animals in group B demonstrated low circulating 
antibody levels in many of the tested animals . However, this lack of response was more 
evident against MO capsular Ag (average mean OD values = 0.385, range 0.152 to 0.785) 
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and MO SDS treated Ag (average mean OD values = 0.385, range 0.135 to 0.863) than 
MA Ag (average mean OD values = 0.456, range 0.054 to 1.026) (data not shown). 
Sheep from a second flock of purebred Suffolks were also skin-tested. Strong 
reactions to MO AG were observed in some coughing lambs of approximately 10 to 12 
weeks of age and also in some yearling ewes that had apparently recovered from the 
clinical disease. 
Results of this stody indicate that an unmediate type of hypersensitivity specific for 
MO can develop during infection of lambs with this microorganism. The reaction is 
apparently specific, since not all the Iambs injected showed positive reaction, the resultant 
wheals in various lambs were not always equal in size and PBS injection induced no 
reaction. Whether or not the responses to MA are specific is unclear since lambs 
responding to Ag from this microorganism also responded to MO Ag. Therefore, the 
possibility of cross reactivity exists. 
Skin testing has been routinely used to demonstrate allergic responses of humans and 
animals to allergens from microorganisms (Yano at al., 1994; Chen et al., 1990; Gershwin 
and Craig, 1984). The characteristics of the response observed in this smdy are quite 
similar to those previously described in sheep hypersensitivity induced by Ascaris suum 
extract (Chen et al., 1990) and in the human allergic reaction to M. pneumoniae (Yano et 
al., 1994), including formation of raised blebs immediately after injection with no late 
reaction. 
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The relatively low levels of IgG specific antibodies to both MO and MA during the 
early stages of the clinical disease, as seen here, is likely an indication of a predominant 
IgE response. In such a situation, this IgE may play a role in the development of allergic 
airway reactions in these lambs involving release of histamine and serotonin mainly from 
mast cells and basophils as has been suggested in asthmatic people infected with M. 
pneumoniae (Yano et al., 1994). Unfortunately however, due to lack of anti-sheep IgE we 
cannot at the moment measure the level of IgE antibodies in these sheep. 
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